Method for controlling resistant harmful arthropod using heterocyclic compound and composition comprising same

Abstract

This invention provides a compound with excellent efficacy against drug-resistant harmful arthropods, a composition containing the compound, and a method for controlling them. The compound shown in formula (I) or its N-oxide or salt thereof has excellent control effects against drug-resistant harmful arthropods [wherein, R1 represents a C1-C6 chain hydrocarbon group, R2 represents a C1-C6 chain hydrocarbon group, R3 and R7 represent hydrogen atoms, R4 and R6 represent hydrogen atoms, R5 represents hydrogen atoms, Q represents the group shown in Q1, # represents the bonding site with the pyridine ring, ● represents the bonding site with the benzene ring, A1 represents a nitrogen atom, A2 represents a nitrogen atom, A3 represents a nitrogen atom, etc.].

Description

Technical field

[0001] This patent application claims priority and benefits under the Paris Treaty based on Japanese Patent Application No. 2021-107328 (application on June 29, 2021), and is cited here, thereby incorporating the entire content recorded in the above application. in this manual. The present invention relates to methods for controlling drug-resistant harmful arthropods using heterocyclic compounds and compositions containing them. The present invention also relates to heterocyclic compounds and compositions containing them for controlling harmful harmful arthropods.

Prior technology

[0002] Various compounds have been studied so far for the purpose of controlling harmful arthropods. For example, Patent Document 1 describes that a certain compound has a pest control effect. [Prior art documents] [Patent documents]

[0003] [Patent Document 1] Japanese Patent Application Laid-Open No. 2002-114783 [Content of the invention]

[0004] [Problem to be solved by the invention]

[0005] The object of the present invention is to provide an excellent method for controlling harmful harmful arthropods that are resistant to antibiotics. Another object of the present invention is to provide a compound having excellent control effect against drug-resistant harmful arthropods. [Means to solve the problem]

[0006] As a result of research conducted by the present inventors in order to find a control method that exhibits excellent control efficacy against drug-resistant harmful arthropods, it was found that the compound represented by the following formula (I) and a composition containing the same are effective against drug-resistant harmful arthropods. Animals show excellent control efficacy. The invention is as follows. [1] A method for controlling drug-resistant harmful arthropods, which is to use a compound represented by formula (I) (hereinafter, the compound represented by formula (I) is recorded as the compound N), or its N-oxide ( N-oxide) or the salt thereof (hereinafter, the compound represented by formula (I) or the N-oxide thereof or the salt thereof is referred to as the present compound) is applied to drug-resistant harmful arthropods or drug-resistant harmful arthropods. The habitat of arthropods, [where R1 represents a C1-C6 chain hydrocarbon group and a C1-C6 alkoxy group {the C1-C6 chain hydrocarbon group and the C1-C6 alkoxy group can be selected from group A Substituted with 1 or more substituents}, C3-C7 cycloalkyl, C3-C7 cycloalkenyl, phenyl, 3-7 membered non-aromatic heterocyclic group that may be substituted with 1 or more substituents selected from Group B , 5- or 6-membered aromatic heterocyclic group {the C3-C7 cycloalkenyl group, the phenyl group, the 3-7-membered non-aromatic heterocyclic group, and the 5- or 6-membered aromatic heterocyclic group, can be selected Substituted from 1 or more substituents in group C}, nitro, NR8R9, S(O)mR10, or halogen atom, m represents 0, 1 or 2, R2 represents C1-C6 chain hydrocarbon group, C1-C6 alkoxy group {the C1-C6 chain hydrocarbon group and the C1-C6 alkoxy group may be substituted by more than 1 substituent selected from group A}, C3 may be substituted by more than 1 substituent selected from group B - C7 cycloalkyl, C3-C7 cycloalkenyl, phenyl, 3-7 membered non-aromatic heterocyclic group, 5 or 6 membered aromatic heterocyclic group {the C3-C7 cycloalkenyl, the phenyl, the 3-7-membered non-aromatic heterocyclic group, and the 5- or 6-membered aromatic heterocyclic group, can be substituted with more than 1 substituent selected from group C}, nitro, NR8aR9a, S(O)nR10a, Halogen atom or hydrogen atom, n represents 0, 1 or 2, R3 and R7 are the same or different, represent a C1-C6 chain hydrocarbon group, halogen atom or hydrogen atom that can be substituted by more than 1 halogen atom, R4 and R6 are the same or Different, representing C1-C6 chain hydrocarbon group, C1-C6 alkoxy group, C3-C6 alkenyloxy group, C3-C6 alkynyloxy group, C1-C6 alkyl mercapto group, C1-C6 alkyl sulfenyl group , C1-C6 alkylsulfonyl group, C3-C6 cycloalkyl group, phenyl group, 5- or 6-membered aromatic heterocyclic group {the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, the C3-C6 Alkenyloxy group, the C3-C6 alkynyloxy group, the C1-C6 alkylmercapto group, the C1-C6 alkylsulfenyl group, the C1-C6 alkylsulfonyl group, the C3-C6 cycloalkyl group , the phenyl group, and the 5- or 6-membered aromatic heterocyclic group, can be substituted by more than 1 halogen atom}, cyano group, nitro group, halogen atom or hydrogen atom, R5 represents a C1-C6 chain hydrocarbon group, C1- C6 alkoxy, C3-C6 alkenyloxy, C3-C6 alkynyloxy, C1-C6 alkylmercapto, C1-C6 alkylsulfenyl, C1-C6 alkylsulfonyl {the C1- C6 chain hydrocarbon group, the C1-C6 alkoxy group, the C3-C6 alkenyloxy group, the C3-C6 alkynyloxy group, the C1-C6 alkyl mercapto group, the C1-C6 alkyl sulfenyl group, And the C1-C6 alkylsulfonyl group, which may be substituted by more than 1 halogen atom, nitro group, halogen atom or hydrogen atom, R8 and R8a are the same or different, indicating C1- which may be substituted by more than 1 halogen atom. C6 chain hydrocarbon group, or hydrogen atom, R9 and R9a are the same or different, indicating C1-C6 chain hydrocarbon group, C3-C7 cycloalkyl group, C3-C7 cycloalkenyl {the C1-C6 chain hydrocarbon group, the C3- The C7 cycloalkyl group and the C3-C7 cycloalkenyl group can be substituted by more than 1 substituent selected from group C}, or a hydrogen atom. R10 and R10a are the same or different, indicating that they can be substituted by more than 1 halogen atom. C1-C6 chain hydrocarbon group, Q represents the group represented by formula Q1, the group represented by formula Q2, the group represented by formula Q3, or the group represented by formula Q4 (# represents the bonding site with the pyridine ring, ● Represents the bonding site with the benzene ring), A1 represents a nitrogen atom, or CR11, A2 represents an oxygen atom, a sulfur atom, or NR12, A3 represents a nitrogen atom, or CR13, A4 represents a nitrogen atom, or CR14, A5 represents a nitrogen atom, Or CR15, A6 represents a nitrogen atom, or CR16, R11, R13, R14, R15 and R16 are the same or different, representing a C1-C6 chain hydrocarbon group, halogen atom or hydrogen atom that can be substituted by more than 1 halogen atom, R12 represents A C1-C6 chain hydrocarbon group that can be substituted by more than 1 halogen atom, or a hydrogen atom. Group A: composed of C1-C6 alkoxy, C3-C6 alkenyloxy, C3-C6 alkynyloxy, C1-C6 alkylmercapto, C1-C6 alkylsulfinyl, C1-C6 alkyl Sulfonyl group, C3-C6 cycloalkyl {the C1-C6 alkoxy group, the C3-C6 alkenyloxy group, the C3-C6 alkynyloxy group, the C1-C6 alkyl mercapto group, the C1-C6 alkyl group The group consisting of sulfinyl group, the C1-C6 alkylsulfonyl group, and the C3-C6 cycloalkyl group, which can be substituted by more than 1 halogen atom, cyano group and halogen atom. Group B: consisting of C1-C6 chain hydrocarbon group, C1-C6 alkoxy group, C3-C6 alkenyloxy group, C3-C6 alkynyloxy group {the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group , the C3-C6 alkenyloxy group, and the C3-C6 alkynyloxy group, may be substituted by more than 1 halogen atom}, a group consisting of hydroxyl, cyano group, nitro, and halogen atoms. Group C: A group consisting of C1-C6 alkyl groups, cyano groups and halogen atoms that can be substituted by more than 1 halogen atom]. [2] The method described in [1], wherein in the compound represented by formula (I) or its N-oxide or salt thereof, Q is a group represented by formula Q1 or a group represented by formula Q4, A1 And A3 is a nitrogen atom, A2 is an oxygen atom or NR12, R1 is a C1-C6 chain hydrocarbon group, C1-C6 alkoxy group, C3-C7 cycloalkyl {the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group group, and the C3-C7 cycloalkyl group can be substituted by more than 1 halogen atom, nitro group, S(O)mR10, or halogen atom, R2 is a C1-C6 chain hydrocarbon group, C1-C6 alkoxy group, C3-C7 cycloalkyl {the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, and the C3-C7 cycloalkyl group may be substituted by more than 1 halogen atom}, nitro group, S(O)nR10a , halogen atoms or hydrogen atoms. [3] The method as described in any one of [1] or [2], wherein in the compound represented by formula (I) or its N-oxide or salt thereof, Q is the base represented by formula Q1 Show the basis. [4] The method described in [1], wherein in the compound represented by formula (I) or its N-oxide or salt thereof, Q is a group represented by formula Q2 or a group represented by formula Q3, A4 is CR14, A5 is a nitrogen atom, or CR15, A6 is a nitrogen atom, R1 is a C1-C6 chain hydrocarbon group, C1-C6 alkoxy group, C3-C7 cycloalkyl {the C1-C6 chain hydrocarbon group, the C1- C6 alkoxy group, and the C3-C7 cycloalkyl group, can be substituted by more than 1 halogen atom}, nitro group, S(O)mR10, or halogen atom, R2 is a C1-C6 chain hydrocarbon group, C1-C6 alkyl Oxygen group, C3-C7 cycloalkyl {the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, and the C3-C7 cycloalkyl group can be substituted by more than 1 halogen atom}, nitro group, S ( O)nR10a, halogen atom or hydrogen atom. [5] The method as described in any one of [1] or [4], wherein in the compound represented by formula (I) or its N-oxide or salt thereof, Q is the base represented by formula Q2 Show the basis. [6] A compound represented by formula (II) or its N-oxide or its salt (hereinafter, the compound represented by formula (II) or its N-oxide or its salt is recorded as the present invention Compound AA), [in the formula, R21 represents a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group, a C3-C7 cycloalkyl {the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, and the C3 - C7 cycloalkyl, which can be substituted by more than 1 halogen atom}, S(O)pR28 or halogen atom, R22 represents C1-C6 chain hydrocarbon group, C1-C6 alkoxy group, C3-C7 cycloalkyl {the C1 - The C6 chain hydrocarbon group, the C1-C6 alkoxy group, and the C3-C7 cycloalkyl group may be substituted by more than 1 halogen atom}, S(O)qR29, halogen atom or hydrogen atom, R23, R25 and R27 Identical or different, represents a fluorine atom or a hydrogen atom, R24 represents a C1-C6 alkoxy group that can be replaced by more than 1 halogen atom, or a fluorine atom, R26 represents a halogen atom or a hydrogen atom, R28 and R29 are the same or different, represents a C1-C6 chain hydrocarbon group that can be substituted by 1 or more halogen atoms, p and q are each independent and represent 0, 1 or 2]. [7] The compound or N-oxide thereof or salt thereof as described in [6], wherein R21 is a C1-C6 chain hydrocarbon group that can be substituted by 1 or more halogen atoms, or the halogen atom R22 is a halogen atom that can be substituted by 1 or more halogen atoms. A C1-C6 chain hydrocarbon group, halogen atom or hydrogen atom substituted by a halogen atom, R23, R25 and R27 are the same or different and are fluorine atoms or hydrogen atoms, R24 is a C1-C6 alkane that can be substituted by more than 1 halogen atom an oxygen group, or a fluorine atom, and R26 is a halogen atom or a hydrogen atom (hereinafter, the compound described in [7] or its N-oxide or its salt will be referred to as the compound A of the present invention). [8] A compound represented by formula (II-a) or its N-oxide or its salt (hereinafter, a compound represented by formula (II-a) or its N-oxide or its salt Recorded as compound A2) of the present invention, [in the formula, R21a represents a C1-C6 alkoxy group, a C3-C7 cycloalkyl group {the C1-C6 alkoxy group, and the C3-C7 cycloalkyl group, can be replaced by 1 or more Halogen atom substituted}, or S(O)rR28a, R22a represents C1-C6 alkoxy group, C3-C7 cycloalkyl {the C1-C6 alkoxy group, and the C3-C7 cycloalkyl group, can be replaced by 1 or more Halogen atom substitution}, S(O)sR29a or halogen atom, R23a, R25a and R27a are the same or different, representing a halogen atom or a hydrogen atom, R24a represents a C1-C6 chain hydrocarbon group that can be substituted by more than 1 halogen atom. C1-C6 alkoxy group substituted by more than 1 halogen atom, or halogen atom, R26a represents a C1-C6 chain hydrocarbon group, halogen atom or hydrogen atom that can be substituted by more than 1 halogen atom, R28a and R29a are the same or different , represents a C1-C6 chain hydrocarbon group that can be substituted by 1 or more halogen atoms, r and s are each independent, representing 0, 1 or 2]. [9] A compound represented by formula (III) or its N-oxide or these salts (hereinafter, the compound represented by formula (III) or its N-oxide or these salts is recorded as the present invention Compound B), [In the formula, the combination of R31, R32, R33, R34, R35, R36 and R37 means that R31 and R32 are chlorine atoms, R33, R35 and R37 are hydrogen atoms, and R34 can be substituted by more than 1 halogen atom C1-C6 alkoxy group, R36 is a combination of halogen atoms; or R31 is a C1-C6 chain hydrocarbon group or bromine atom that can be substituted by more than 1 halogen atom, R32 is a C1- that can be substituted by more than 1 halogen atom C6 chain hydrocarbon group, bromine atom or hydrogen atom. R33, R35 and R37 are the same or different and are fluorine atoms or hydrogen atoms. R34 is a C1-C6 chain hydrocarbon group which can be substituted by more than 1 halogen atom, and can be substituted by more than 1 halogen atom. A C1-C6 alkoxy group substituted by a halogen atom, or a halogen atom, R36 is a combination of a halogen atom or a hydrogen atom, R38 represents a C1-C6 chain hydrocarbon group that can be substituted by more than 1 halogen atom, or a hydrogen atom].

[10] A compound represented by formula (IV) or its N-oxide or these salts (hereinafter, the compound represented by formula (IV) or its N-oxide or these salts is recorded as the present invention Compound C), [In the formula, R41 represents a C1-C6 chain hydrocarbon group or halogen atom that can be substituted by more than 1 halogen atom, R42 represents a C1-C6 chain hydrocarbon group or halogen atom that can be substituted by more than 1 halogen atom or hydrogen atom, R43, R45 and R47 are the same or different, representing fluorine atom or hydrogen atom, R44 represents a C1-C6 chain hydrocarbon group that can be substituted by more than 1 halogen atom, C1-C6 that can be substituted by more than 1 halogen atom C6 alkoxy group, halogen atom or hydrogen atom, R46 represents halogen atom or hydrogen atom].

[11] A composition containing the compound described in any one of [6] to

[10] or its N-oxide or its salt and an inert carrier.

[12] A composition containing at least 1 component selected from the group consisting of group (a), group (b), group (c) and group (d), and, as [ Compounds described in any of 6 ] to

[10] or their N-oxides or salts thereof: Group (a): A group consisting of insecticidal active ingredients, acaricidal active ingredients and nematicidal active ingredients Group; Group (b): Bactericidal active ingredients; Group (c): Plant growth adjusting ingredients; Group (d): Avoidable ingredients.

[13] A method for controlling drug-resistant harmful arthropods, which is to use an effective amount of the compound described in any one of [6] to

[10] or its N-oxide or its salt, or as [ 12] The effective amount of the composition described is applied to drug-resistant harmful arthropods or the habitat of drug-resistant harmful arthropods.

[14] The method described in any one of [1] to [5] or

[13] , wherein the drug-resistant harmful arthropods are Hemiptera pests.

[15] The method described in any one of [1] to [5] or

[13] , wherein the resistant harmful arthropod is an Aphididae pest, a Delphacidae pest, or a mealybug pest. (Aleyrodidae) pests.

[16] A seed or vegetative reproductive organ that retains an effective amount of the compound described in any one of [6] to

[10] or its N-oxide or salt thereof, or retains an effective amount of The composition is as described in

[12] . [Effect of invention].

[0007] Through the present invention, drug-resistant harmful arthropods can be prevented.

Implementation

[0008] Description of the substituents in the present invention. The halogen atom means a fluorine atom, a chlorine atom, a bromine atom or an iodine atom. The substituent is a case where it is substituted by 2 or more halogen atoms or substituents. Each of these halogen atoms or substituents may be the same or different. The symbol "CX-CY" in this specification means that the number of carbon atoms is from X to Y. For example, the label "C1-C6" means that the number of carbon atoms is 1 to 6. The so-called chain hydrocarbon group means an alkyl group, an alkenyl group or an alkynyl group. Examples of the alkyl group include methyl, ethyl, propyl, isopropyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 1-ethylpropyl, butyl, sec-butyl, tert-butyl, pentyl and hexyl. Examples of the alkenyl group include vinyl, 1-propenyl, 2-propenyl, 1-methyl-1-propenyl, 1-methyl-2-propenyl, and 1,2-dimethyl-1- Pronyl, 1-ethyl-2-propenyl, 3-butenyl, 4-pentenyl and 5-hexenyl. Examples of the alkynyl group include ethynyl, 1-propynyl, 2-propynyl, 1-methyl-2-propynyl, 1,1-dimethyl-2-propynyl, and 1-ethynyl. -2-propynyl, 2-butynyl, 4-pentynyl and 5-hexynyl. Examples of the alkoxy group include methoxy, ethoxy, propoxy, isopropoxy, butoxy, tert-butoxy, pentyloxy and hexyloxy. Examples of the alkenyloxy group include 2-propenyloxy group, 2-butenyloxy group and 5-hexenyloxy group. Examples of the alkynyloxy group include 2-propynyloxy, 2-butynyloxy and 5-hexynyloxy. Examples of the alkylmercapto group include methylthio group, ethylmercapto group, isopropylmercapto group and hexylmercapto group. Examples of the alkylsulfinyl group include methylsulfinyl group, ethylsulfinyl group, isopropylsulfinyl group and hexylsulfinyl group. Examples of the alkylsulfonyl group include a methylsulfonyl group, an ethylsulfonyl group, an isopropylsulfonyl group and a hexylsulfonyl group.

[0009] Examples of the cycloalkyl group include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl and cycloheptyl. Examples of the cycloalkenyl group include cyclopropenyl, cyclobutenyl, cyclopentenyl, cyclohexenyl and cycloheptenyl.

[0010] Examples of the 3-7-membered non-aromatic heterocyclic group include aziridinyl, oxirane, thiiranyl, tetrahydroazepine, oxybutanyl, and thioheterocycles. Butyl, pyrrolidinyl, tetrahydrofuranyl, tetrahydrothienyl, piperidinyl, pyranyl, dihydropyranyl, tetrahydropyranyl, tetrahydrothiopyranyl, azepanyl, oxygen Heterocycloheptyl, thiazolinyl, pyrazolinyl, pyrazolinyl, imidazolinyl, imidazolidinyl, oxazolinyl, thiazolinyl, oxalidinyl, tetrahydrothiazolyl, isoxazole Phinyl, isoxazolidinyl, isothiazolinyl, isotetrahydrothiazolyl, dioxolyl (dioxolyl), dioxolanyl (dioxolanyl), dialkyl, morpholinyl, thiomorphyl linyl and piperyl. Examples of the 5- or 6-membered aromatic heterocyclic group include pyrrolyl, furyl, thienyl, pyrazolyl, imidazolyl, triazolyl, tetrazolyl, azolyl, isoxazolyl, thiazolyl, and isothiazolyl. base, diazolyl, thiadiazolyl, pyridyl, pyridyl, pyrimidinyl, pyridyl, tri- and tetra-yl.

[0011] Examples of the N-oxide of the compound represented by formula (I) include compounds represented by the following formula. [In the formula, the symbols represent the same meanings as mentioned above].

[0012] Compound AA of the present invention, compound A of the present invention, compound A2 of the present invention, compound B of the present invention and compound C of the present invention are recorded as compounds of the present invention. This compound (including the compound of the present invention) may have one or more stereoisomers. Examples of stereoisomers include enantiomers, diastereomers, geometric isomers, and the like. This compound contains each stereoisomer and a mixture of stereoisomers in any ratio.

[0013] The compound represented by formula (I) or its N-oxide may form an acid addition salt. Examples of acids that form acid addition salts include inorganic acids such as hydrogen chloride, phosphoric acid, and sulfuric acid, and organic acids such as acetic acid, trifluoroacetic acid, benzoic acid, and p-toluenesulfonic acid. Acid addition salts can be obtained by mixing the compound represented by formula (I) or its N-oxide with an acid.

[0014] Examples of the present compound N include the following compounds.

[0015] [Aspect 1] In this compound N, R1 is a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group, or a C3-C7 cycloalkyl group {the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group group, and the C3-C7 cycloalkyl group can be substituted by more than 1 halogen atom}, nitro group, S(O)mR10, or halogen atom, R2 is a C1-C6 chain hydrocarbon group, C1-C6 alkoxy group, C3-C7 cycloalkyl {the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, and the C3-C7 cycloalkyl group may be substituted by more than 1 halogen atom}, nitro group, S(O)nR10a , compounds of halogen atoms or hydrogen atoms. [Aspect 2] In this compound N, R1 is a halogen atom, and R2 is a compound in which a halogen atom or a hydrogen atom is used. [Aspect 3] In this compound N, a compound in which R1 and R2 are chlorine atoms. [Aspect 4] In this compound N, Q is a compound represented by a group represented by formula Q1 or a group represented by formula Q4. [Aspect 5] In this compound N, Q is a group represented by formula Q1 or a group represented by formula Q4, A1 and A3 are nitrogen atoms, A2 is an oxygen atom or NR12, and R12 is substituted by 1 or more halogen atoms. Compounds of C1-C6 chain hydrocarbon groups. [Aspect 6] In this compound N, Q is a group represented by formula Q1, A1 and A3 are nitrogen atoms, A2 is an oxygen atom or NR12, and R12 is a C1-C6 chain hydrocarbon group that can be substituted by 1 or more halogen atoms. of compounds. [Aspect 7] This compound N is a compound in which Q is a group represented by formula Q1, A1 and A3 are nitrogen atoms, and A2 is an oxygen atom. [Aspect 8] In this compound N, Q is a group represented by formula Q1, A1 and A3 are nitrogen atoms, A2 is NR12, and R12 is a C1-C6 chain hydrocarbon group that can be substituted by one or more halogen atoms. [Aspect 9] In aspect 1, Q is a compound of a group represented by formula Q1 or a group represented by formula Q4. [Aspect 10] In aspect 2, Q is a compound of a group represented by formula Q1 or a group represented by formula Q4. [Aspect 11] In aspect 3, Q is a compound of a group represented by formula Q1 or a group represented by formula Q4. [Aspect 12] In aspect 1, Q is a group represented by formula Q1 or a group represented by formula Q4, A1 and A3 are nitrogen atoms, A2 is an oxygen atom or NR12, and R12 is substituted by 1 or more halogen atoms. Compounds of C1-C6 chain hydrocarbon groups. [Aspect 13] In aspect 2, Q is a group represented by formula Q1 or a group represented by formula Q4, A1 and A3 are nitrogen atoms, A2 is an oxygen atom or NR12, and R12 is substituted by 1 or more halogen atoms. Compounds of C1-C6 chain hydrocarbon groups. [Aspect 14] In aspect 3, Q is a group represented by formula Q1 or a group represented by formula Q4, A1 and A3 are nitrogen atoms, A2 is an oxygen atom or NR12, and R12 is substituted by 1 or more halogen atoms. Compounds of C1-C6 chain hydrocarbon groups. [Aspect 15] In aspect 1, Q is a group represented by formula Q1, A1 and A3 are nitrogen atoms, A2 is an oxygen atom or NR12, and R12 is a C1-C6 chain hydrocarbon group that can be substituted by 1 or more halogen atoms. of compounds. [Aspect 16] In aspect 2, Q is a group represented by formula Q1, A1 and A3 are nitrogen atoms, A2 is an oxygen atom or NR12, and R12 is a C1-C6 chain hydrocarbon group that can be substituted by 1 or more halogen atoms. of compounds. [Aspect 17] In aspect 3, Q is a group represented by formula Q1, A1 and A3 are nitrogen atoms, A2 is an oxygen atom or NR12, and R12 is a C1-C6 chain hydrocarbon group that can be substituted by 1 or more halogen atoms. of compounds. [Aspect 18] In aspect 1, Q is a compound represented by formula Q1, A1 and A3 are nitrogen atoms, and A2 is an oxygen atom. [Aspect 19] In aspect 2, Q is a compound represented by formula Q1, A1 and A3 are nitrogen atoms, and A2 is an oxygen atom. [Aspect 20] In aspect 3, Q is a compound represented by formula Q1, A1 and A3 are nitrogen atoms, and A2 is an oxygen atom. [Aspect 21] In aspect 1, Q is a group represented by formula Q1, A1 and A3 are nitrogen atoms, A2 is NR12, and R12 is a compound of C1-C6 chain hydrocarbon group that can be substituted by one or more halogen atoms. [Aspect 22] In aspect 2, Q is a group represented by formula Q1, A1 and A3 are nitrogen atoms, A2 is NR12, and R12 is a compound of C1-C6 chain hydrocarbon group that can be substituted by 1 or more halogen atoms. [Aspect 23] In aspect 3, Q is a group represented by formula Q1, A1 and A3 are nitrogen atoms, A2 is NR12, and R12 is a compound of C1-C6 chain hydrocarbon group that can be substituted by 1 or more halogen atoms. [Aspect 24] In any one of aspects 1 to 23 or the present compound N, R3 and R7 are the same or different and are a compound of a halogen atom or a hydrogen atom. [Aspect 25] In any one of aspects 1 to 23 or compound N, R4 and R6 are the same or different, and are C1-C6 chain hydrocarbon group, C1-C6 alkoxy group, C3-C6 cycloalkane Base {the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, and the C3-C6 cycloalkyl group can be substituted by more than 1 halogen atom}, cyano group, nitro group, halogen atom or hydrogen atom, R5 It is one of C1-C6 chain hydrocarbon group, C1-C6 alkoxy group {the C1-C6 chain hydrocarbon group and the C1-C6 alkoxy group may be substituted by more than 1 halogen atom}, nitro group, halogen atom or hydrogen atom compound. [Aspect 26] In any one of aspects 1 to 23 or compound N, R3 and R7 are the same or different, and are halogen atoms or hydrogen atoms, and R4 and R6 are the same or different, and are C1-C6 chains. The formula hydrocarbon group, C1-C6 alkoxy group, C3-C6 cycloalkyl {the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, and the C3-C6 cycloalkyl group can be substituted by more than 1 halogen atom}, cyano group, nitro, halogen atom or hydrogen atom, R5 is a C1-C6 chain hydrocarbon group, C1-C6 alkoxy group {the C1-C6 chain hydrocarbon group and the C1-C6 alkoxy group can be 1 or more A compound in which a halogen atom is substituted}, a nitro group, a halogen atom or a hydrogen atom. [Aspect 27] In any one of aspects 1 to 23 or compound N, R3 and R7 are hydrogen atoms, R4 and R6 are the same or different, and are C1-C6 chain hydrocarbon groups or C1-C6 alkoxy group, C3-C6 cycloalkyl {the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, and the C3-C6 cycloalkyl group may be substituted by more than 1 halogen atom}, cyano group, nitro group, Halogen atom or hydrogen atom, R5 is a C1-C6 chain hydrocarbon group, C1-C6 alkoxy group {the C1-C6 chain hydrocarbon group and the C1-C6 alkoxy group can be substituted by more than 1 halogen atom}, nitro group , compounds of halogen atoms or hydrogen atoms. [Aspect 28] In any one of aspects 1 to 23 or compound N, R4, R5 and R6 are the same or different, and are C1-C6 chain hydrocarbon group or C1-C6 alkoxy group {the C1- C6 chain hydrocarbon group and the C1-C6 alkoxy group may be substituted by 1 or more halogen atoms, halogen atoms or hydrogen atoms. [Aspect 29] In any one of aspects 1 to 23 or compound N, R3 and R7 are the same or different and are halogen atoms or hydrogen atoms, and R4, R5 and R6 are the same or different and are C1- C6 chain hydrocarbon group, C1-C6 alkoxy group {the C1-C6 chain hydrocarbon group and the C1-C6 alkoxy group may be substituted by 1 or more halogen atoms}, halogen atom or hydrogen atom compound. [Aspect 30] In any one of aspects 1 to 23 or compound N, R3 and R7 are hydrogen atoms, R4, R5 and R6 are the same or different, and are C1-C6 chain hydrocarbon groups, C1-C6 Alkoxy group {the C1-C6 chain hydrocarbon group and the C1-C6 alkoxy group may be substituted by one or more halogen atoms}, a compound of a halogen atom or a hydrogen atom. [Aspect 31] In any one of aspects 1 to 23 or compound N, R4 and R6 are the same or different, and are a C1-C6 chain hydrocarbon group or a hydrogen atom that can be substituted by 1 or more halogen atoms, R5 is a compound of halogen atom or hydrogen atom. [Aspect 32] In any one of aspects 1 to 23 or the present compound N, R3 and R7 are the same or different, and are halogen atoms or hydrogen atoms, and R4 and R6 are the same or different, and can be 1 or more C1-C6 chain hydrocarbon group or hydrogen atom substituted by halogen atom, R5 is a compound of halogen atom or hydrogen atom. [Aspect 33] In any one of aspects 1 to 23 or the present compound N, R3 and R7 are hydrogen atoms, R4 and R6 are the same or different, and are C1-C6 which can be substituted by 1 or more halogen atoms. Chain hydrocarbon group or hydrogen atom, R5 is a compound of halogen atom or hydrogen atom. [Aspect 34] In any one of aspects 1 to 23 or compound N, R4 and R6 are the same or different, and are C1-C6 alkoxy groups that can be substituted by 1 or more halogen atoms, and R5 is halogen. Atom or compound of hydrogen atoms. [Aspect 35] In any one of aspects 1 to 23 or the present compound N, R3 and R7 are the same or different, and are halogen atoms or hydrogen atoms, and R4 and R6 are the same or different, and can be 1 or more C1-C6 alkoxy group substituted by halogen atom, R5 is a compound of halogen atom or hydrogen atom. [Aspect 36] In any one of aspects 1 to 23 or the compound N, R3 and R7 are hydrogen atoms, R4 and R6 are the same or different, and are C1-C6 which can be substituted by 1 or more halogen atoms. Alkoxy group, R5 is a compound of halogen atom or hydrogen atom. [Aspect 37] In any one of aspects 1 to 23 or the present compound N, R4, R5 and R6 are the same or different and are a compound of a halogen atom or a hydrogen atom. [Aspect 38] In any one of aspects 1 to 23 or compound N, R3 and R7 are the same or different and are halogen atoms or hydrogen atoms, and R4, R5 and R6 are the same or different and are halogen atoms. or compounds of hydrogen atoms. [Aspect 39] In any one of aspects 1 to 23 or this compound N, R3 and R7 are hydrogen atoms, and R4, R5 and R6 are the same or different and are a halogen atom or a compound of hydrogen atoms.

[0016] [Aspect N1] In this compound N, R1 is a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group, a C3-C7 cycloalkyl group {the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group base, and the C3-C7 cycloalkyl group can be substituted by more than 1 halogen atom}, S(O)mR10, or a halogen atom, R2 is a C1-C6 alkoxy group, C3-C7 cycloalkyl {the C1- The C6 chain hydrocarbon group, the C1-C6 alkoxy group, and the C3-C7 cycloalkyl group may be substituted by more than 1 halogen atom}, S(O)nR10a, a halogen atom or a hydrogen atom compound. [Aspect N2] In this compound N, R1 is a C1-C4 alkoxy group, cyclopropyl {the C1-C4 alkoxy group, and the cyclopropyl group may be substituted by more than 1 halogen atom}, S(O )mR10, or a halogen atom, R2 is a halogen atom or a hydrogen atom, and R10 is a C1-C4 chain hydrocarbon group compound that can be substituted by more than 1 halogen atom. [Aspect N3] In this compound N, R1 is a C1-C4 alkoxy group, a C1-C4 alkyl mercapto group {the C1-C4 alkoxy group, and the C1-C4 alkyl mercapto group can be replaced by more than 1 halogen atom Substituted}, or halogen atom, R2 is a compound of halogen atom or hydrogen atom. [Aspect N4] In this compound N, R1 is a C1-C4 alkoxy group, a C1-C4 alkyl mercapto group {the C1-C4 alkoxy group, and the C1-C4 alkyl mercapto group can be replaced by more than 1 halogen atom Substitute}, or a halogen atom, and R2 is a compound of a chlorine atom or a hydrogen atom. [Aspect N5] In this compound N, R1 is a C1-C4 alkoxy group, C1-C4 alkylmercapto group, or a chlorine atom, and R2 is a chlorine atom or a hydrogen atom. [Aspect N6] In this compound N, R1 is a C1-C4 alkoxy group, a C1-C4 alkylmercapto group, or a chlorine atom, and R2 is a chlorine atom. [Aspect N7] In this compound N, R1 is a C1-C4 alkoxy group or a chlorine atom, and R2 is a chlorine atom. [Aspect N8] In this compound N, Q is a group represented by formula Q1 or a group represented by formula Q4, A1 and A3 are nitrogen atoms, A2 is an oxygen atom or NR12, and R12 is substituted by 1 or more halogen atoms. methyl compound. [Aspect N9] In this compound N, Q is a group represented by formula Q1, A1 and A3 are nitrogen atoms, A2 is an oxygen atom or NR12, and R12 is a methyl group which may be substituted by one or more halogen atoms. [Aspect N10] In aspect N1, Q is a group represented by formula Q1 or a group represented by formula Q4, A1 and A3 are nitrogen atoms, A2 is an oxygen atom or NR12, and R12 is substituted by 1 or more halogen atoms. Compounds of methyl or hydrogen atoms. [Aspect N11] In aspect N2, Q is a group represented by formula Q1 or a group represented by formula Q4, A1 and A3 are nitrogen atoms, A2 is an oxygen atom or NR12, and R12 is substituted by 1 or more halogen atoms. Compounds of methyl or hydrogen atoms. [Aspect N12] In aspect N3, Q is a group represented by formula Q1 or a group represented by formula Q4, A1 and A3 are nitrogen atoms, A2 is an oxygen atom or NR12, and R12 is substituted by 1 or more halogen atoms. Compounds of methyl or hydrogen atoms. [Aspect N13] In aspect N4, Q is a group represented by formula Q1 or a group represented by formula Q4, A1 and A3 are nitrogen atoms, A2 is an oxygen atom or NR12, and R12 is substituted by 1 or more halogen atoms. Compounds of methyl or hydrogen atoms. [Aspect N14] In aspect N5, Q is a group represented by formula Q1 or a group represented by formula Q4, A1 and A3 are nitrogen atoms, A2 is an oxygen atom or NR12, and R12 is substituted by 1 or more halogen atoms. Compounds of methyl or hydrogen atoms. [Aspect N15] In aspect N6, Q is a group represented by formula Q1 or a group represented by formula Q4, A1 and A3 are nitrogen atoms, A2 is an oxygen atom or NR12, and R12 is substituted by 1 or more halogen atoms. Compounds of methyl or hydrogen atoms. [Aspect N16] In aspect N7, Q is a group represented by formula Q1 or a group represented by formula Q4, A1 and A3 are nitrogen atoms, A2 is an oxygen atom or NR12, and R12 is substituted by 1 or more halogen atoms. Compounds of methyl or hydrogen atoms. [Aspect N17] In aspect N1, Q is a group represented by formula Q1, A1 and A3 are nitrogen atoms, A2 is an oxygen atom or NR12, and R12 is a methyl group or hydrogen atom that can be substituted by 1 or more halogen atoms. compound. [Aspect N18] In aspect N2, Q is a group represented by formula Q1, A1 and A3 are nitrogen atoms, A2 is an oxygen atom or NR12, and R12 is a methyl group or hydrogen atom that can be substituted by 1 or more halogen atoms. compound. [Aspect N19] In aspect N3, Q is a group represented by formula Q1, A1 and A3 are nitrogen atoms, A2 is an oxygen atom or NR12, and R12 is a methyl group or hydrogen atom that can be substituted by 1 or more halogen atoms. compound. [Aspect N20] In aspect N4, Q is a group represented by formula Q1, A1 and A3 are nitrogen atoms, A2 is an oxygen atom or NR12, and R12 is a methyl group or hydrogen atom that can be substituted by 1 or more halogen atoms. compound. [Aspect N21] In aspect N5, Q is a group represented by formula Q1, A1 and A3 are nitrogen atoms, A2 is an oxygen atom or NR12, and R12 is a methyl group or hydrogen atom that can be substituted by 1 or more halogen atoms. compound. [Aspect N22] In aspect N6, Q is a group represented by formula Q1, A1 and A3 are nitrogen atoms, A2 is an oxygen atom or NR12, and R12 is a methyl group or hydrogen atom that can be substituted by 1 or more halogen atoms. compound. [Aspect N23] In aspect N7, Q is a group represented by formula Q1, A1 and A3 are nitrogen atoms, A2 is an oxygen atom or NR12, and R12 is a methyl group or hydrogen atom that can be substituted by 1 or more halogen atoms. compound. [Aspect N24] In aspect N1, Q is a compound represented by formula Q1, A1 and A3 are nitrogen atoms, and A2 is an oxygen atom. [Aspect N25] In aspect N2, Q is a compound represented by formula Q1, A1 and A3 are nitrogen atoms, and A2 is an oxygen atom. [Aspect N26] In aspect N3, Q is a compound represented by formula Q1, A1 and A3 are nitrogen atoms, and A2 is an oxygen atom. [Aspect N27] In aspect N4, Q is a compound represented by formula Q1, A1 and A3 are nitrogen atoms, and A2 is an oxygen atom. [Aspect N28] In aspect N5, Q is a compound represented by formula Q1, A1 and A3 are nitrogen atoms, and A2 is an oxygen atom. [Aspect N29] In aspect N6, Q is a compound represented by formula Q1, A1 and A3 are nitrogen atoms, and A2 is an oxygen atom. [Aspect N30] In aspect N7, Q is a compound represented by formula Q1, A1 and A3 are nitrogen atoms, and A2 is an oxygen atom. [Aspect N31] In any one of aspects 1 to 23, aspects N1 to N30, or this compound N, R3 and R7 are the same or different, and are a methyl group, a halogen atom or a hydrogen atom. . [Aspect N32] In any one of aspects 1 to 23, aspects N1 to N30, or this compound N, R3 is a methyl group, a chlorine atom or a hydrogen atom, and R7 is a hydrogen atom. [Aspect N33] A compound in which R3 and R7 are hydrogen atoms in any one of aspects 1 to 23, aspects N1 to N30, or this compound N. [Aspect N34] In any one of aspects 1 to 23, aspects N1 to N30, or the compound N, R4 and R6 are the same or different, and are C1-C6 chain hydrocarbon groups, C1-C6 Alkoxy group, C1-C6 alkyl mercapto group {the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, and the C1-C6 alkyl mercapto group may be substituted by more than 1 halogen atom}, cyano group, nitrogen group Compounds of radicals, halogen atoms or hydrogen atoms. [Aspect N35] In any one of aspects 1 to 23, aspects N1 to N30, or the compound N, R5 is a C1-C6 chain hydrocarbon group or a C1-C6 alkoxy group {the C1- The C6 chain hydrocarbon group and the C1-C6 alkoxy group may be substituted by more than 1 halogen atom, nitro group, halogen atom or hydrogen atom. [Aspect N36] In any one of aspects 1 to 23, aspects N1 to N30, or the compound N, R4 and R6 are the same or different, and are C1-C6 chain hydrocarbon groups, C1-C6 Alkoxy group, C1-C6 alkyl mercapto group {the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, and the C1-C6 alkyl mercapto group may be substituted by more than 1 halogen atom}, cyano group, nitrogen group group, halogen atom or hydrogen atom, R5 is a C1-C6 chain hydrocarbon group, C1-C6 alkoxy group {the C1-C6 chain hydrocarbon group and the C1-C6 alkoxy group can be substituted by more than 1 halogen atom}, Compounds of halogen atoms or hydrogen atoms. [Aspect N37] In any one of aspects 1 to 23, aspects N1 to N30, or this compound N, R4 and R6 are the same or different and are C1-C4 alkyl or C1-C4 alkoxy. group, C1-C4 alkyl mercapto group {the C1-C4 alkyl group, the C1-C4 alkoxy group, and the C1-C4 alkyl mercapto group may be substituted by more than 1 halogen atom}, cyano group, nitro group, halogen atom or hydrogen atom, R5 is a C1-C4 alkyl group, C1-C4 alkoxy group {the C1-C4 alkyl group and the C1-C4 alkoxy group may be substituted by more than 1 halogen atom}, a halogen atom or a hydrogen atom of compounds. [Aspect N38] In any one of aspects 1 to 23, aspects N1 to N30, or the compound N, R3 is a methyl group, a chlorine atom or a hydrogen atom, and R4 and R6 are the same or different, is a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group, and a C1-C6 alkyl mercapto group {the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, and the C1-C6 alkyl mercapto group can be 1 The above halogen atom is substituted with}, cyano group, nitro group, halogen atom or hydrogen atom, and R7 is a compound of hydrogen atom. [Aspect N39] In any one of aspects 1 to 23, aspects N1 to N30, or the compound N, R3 is a methyl group, a chlorine atom or a hydrogen atom, and R5 is a C1-C6 chain hydrocarbon group. , C1-C6 alkoxy group {the C1-C6 chain hydrocarbon group and the C1-C6 alkoxy group can be substituted by more than 1 halogen atom}, nitro group, halogen atom or hydrogen atom, a compound in which R7 is a hydrogen atom. [Aspect N40] In any one of aspects 1 to 23, aspects N1 to N30, or the compound N, R3 is a methyl group, a chlorine atom or a hydrogen atom, and R4 and R6 are the same or different, is a C1-C6 chain hydrocarbon group, a C1-C6 alkoxy group, and a C1-C6 alkyl mercapto group {the C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, and the C1-C6 alkyl mercapto group can be 1 The above halogen atoms are substituted}, cyano group, nitro group, halogen atom or hydrogen atom, R5 is a C1-C6 chain hydrocarbon group, C1-C6 alkoxy {the C1-C6 chain hydrocarbon group and the C1-C6 alkoxy group , can be substituted by more than 1 halogen atom}, a halogen atom or a hydrogen atom, a compound in which R7 is a hydrogen atom. [Aspect N41] In any one of aspects 1 to 23, aspects N1 to N30, or the compound N, R3 is a methyl group, a chlorine atom or a hydrogen atom, and R4 and R6 are the same or different. C1-C4 alkyl group, C1-C4 alkoxy group, C1-C4 alkyl mercapto group {the C1-C4 alkyl group, the C1-C4 alkoxy group, and the C1-C4 alkyl mercapto group can be replaced by more than 1 halogen Atom substitution}, cyano group, nitro group, halogen atom or hydrogen atom, R5 is C1-C4 alkyl group, C1-C4 alkoxy group {the C1-C4 alkyl group and the C1-C4 alkoxy group can be replaced by more than 1 A halogen atom substituted}, a halogen atom or a hydrogen atom, and R7 is a compound of hydrogen atom. [Aspect N42] In any one of aspects 1 to 23, N1 to N30, or this compound N, R3 and R7 are hydrogen atoms, R4 and R6 are the same or different, and are C1-C6 Chain hydrocarbon group, C1-C6 alkoxy group, C1-C6 alkyl mercapto group {The C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, and the C1-C6 alkyl mercapto group can be replaced by more than 1 halogen atom Compounds substituted for}, cyano group, nitro group, halogen atom or hydrogen atom. [Aspect N43] In any one of aspects 1 to 23, aspects N1 to N30, or the compound N, R3 and R7 are hydrogen atoms, and R5 is a C1-C6 chain hydrocarbon group, C1-C6 Alkoxy group {the C1-C6 chain hydrocarbon group and the C1-C6 alkoxy group may be substituted by one or more halogen atoms}, nitro group, halogen atom or hydrogen atom compound. [Aspect N44] In any one of aspects 1 to 23, N1 to N30, or this compound N, R3 and R7 are hydrogen atoms, R4 and R6 are the same or different, and are C1-C6 Chain hydrocarbon group, C1-C6 alkoxy group, C1-C6 alkyl mercapto group {The C1-C6 chain hydrocarbon group, the C1-C6 alkoxy group, and the C1-C6 alkyl mercapto group can be replaced by more than 1 halogen atom Substituted}, cyano group, nitro, halogen atom or hydrogen atom, R5 is a C1-C6 chain hydrocarbon group, C1-C6 alkoxy group {the C1-C6 chain hydrocarbon group and the C1-C6 alkoxy group can be replaced by 1 Compounds in which the above halogen atoms are substituted}, halogen atoms or hydrogen atoms.[Aspect N45] In any one of aspects 1 to 23, aspects N1 to N30, or this compound N, R3 and R7 are hydrogen atoms, and R4 and R6 are the same or different and are C1-C4 alkane. group, C1-C4 alkoxy group, C1-C4 alkyl mercapto group {the C1-C4 alkyl group, the C1-C4 alkoxy group, and the C1-C4 alkyl mercapto group can be substituted by more than 1 halogen atom}, Cyano group, nitro group, halogen atom or hydrogen atom, R5 is C1-C4 alkyl group, C1-C4 alkoxy group {the C1-C4 alkyl group and the C1-C4 alkoxy group can be substituted by more than 1 halogen atom}, compounds of halogen atoms or hydrogen atoms. [Aspect N46] In any one of aspects 1 to 23, aspects N1 to N30, or the compound N, R4, R5 and R6 are the same or different, and are C1-C4 alkyl, C1- C4 alkoxy group {the C1-C4 alkyl group and the C1-C4 alkoxy group may be substituted by 1 or more halogen atoms}, a compound of a halogen atom or a hydrogen atom. [Aspect N47] In any one of aspects 1 to 23, aspects N1 to N30, or the compound N, R3 is a methyl group, a chlorine atom or a hydrogen atom, and R4, R5 and R6 are the same or similar. is a C1-C4 alkyl group, a C1-C4 alkoxy group {the C1-C4 alkyl group and the C1-C4 alkoxy group may be substituted by more than 1 halogen atom}, a halogen atom or a hydrogen atom, R7 is a hydrogen atom of compounds. [Aspect N48] In any one of aspects 1 to 23, aspects N1 to N30, or this compound N, R3 and R7 are hydrogen atoms, and R4, R5 and R6 are the same or different, and are C1 -C4 alkyl, C1-C4 alkoxy {the C1-C4 alkyl and the C1-C4 alkoxy may be substituted by 1 or more halogen atoms}, halogen atom or hydrogen atom compound. [Aspect N49] In any one of aspects 1 to 23, aspects N1 to N30, or this compound N, R3 and R7 are hydrogen atoms, and R4, R5 and R6 are the same or different, which is C1 -C4 alkyl, C1-C4 alkoxy {the C1-C4 alkyl and the C1-C4 alkoxy may be substituted by 1 or more halogen atoms}, halogen atom or hydrogen atom compound. [Aspect N50] In any one of aspects 1 to 23, aspects N1 to N30, or this compound N, R3 and R7 are hydrogen atoms, and R4 and R5 are the same or different and are C1-C4 alkane base, C1-C4 alkoxy group {the C1-C4 alkyl group and the C1-C4 alkoxy group may be substituted by more than 1 halogen atom}, a halogen atom or a hydrogen atom, and R6 is a compound of a hydrogen atom. [Aspect N51] In any one of aspects 1 to 23, aspects N1 to N30, or the compound N, R3 and R7 are hydrogen atoms, and R4 is a C1-C4 alkyl group or a C1-C4 alkyl group. Oxygen group {the C1-C4 alkyl group and the C1-C4 alkoxy group may be substituted by more than 1 halogen atom}, a halogen atom or a hydrogen atom, R5 is a halogen atom or a hydrogen atom, and R6 is a compound of a hydrogen atom.

[0017] Examples of the compound AA of the present invention include the following compounds. [Aspect AA1] In compound AA of the present invention, R21 is a C1-C6 chain hydrocarbon group, C1-C6 alkoxy group, S(O)nR28, or a halogen atom, R22 is a chlorine atom or a hydrogen atom, and R28 is C1-C6 Chain hydrocarbon compounds. [Aspect AA2] In the compound AA of the present invention, R21 is a C1-C4 alkyl group, a C1-C4 alkoxy group, a C1-C4 alkylmercapto group, or a chlorine atom, and R22 is a chlorine atom or a hydrogen atom. [Aspect AA3] In the compound AA of the present invention, R23 and R27 are hydrogen atoms. [Aspect AA4] In aspect AA1, R23 and R27 are compounds of hydrogen atoms. [Aspect AA5] In aspect AA2, R23 and R27 are compounds of hydrogen atoms. [Aspect AA6] In any one of the aspects AA1 to AA5 or the compound AA of the present invention, R24 is a C1-C4 alkoxy group or a fluorine atom that can be substituted by 1 or more halogen atoms, and R25 is a fluorine atom or hydrogen Compounds of atoms. [Aspect AA7] In any of the aspects AA1 to AA5 or the compound AA of the present invention, R24 is a C1-C4 alkoxy group or a fluorine atom that can be substituted by 1 or more fluorine atoms, and R25 is a fluorine atom or hydrogen Compounds of atoms. [Aspect AA8] In any one of the aspects AA1 to AA5 or the compound AA of the present invention, R24 is a C1-C2 alkoxy group or a fluorine atom that can be substituted by 1 or more fluorine atoms, and R25 is a fluorine atom or hydrogen Compounds of atoms. [Aspect AA9] In any of the aspects AA1 to AA5 or the compound AA of the present invention, R24 is a methoxy group or a fluorine atom that can be substituted by 1 or more fluorine atoms, and R25 is a compound in which a fluorine atom or a hydrogen atom . [Aspect AA10] In any of the aspects AA1 to AA5 or the compound AA of the present invention, R24 is a methoxy group or a fluorine atom that may be substituted by 1 or more fluorine atoms, and R25 is a hydrogen atom.

[0018] Examples of the compound A2 of the present invention include the following compounds. [Aspect A2-1] In the compound A2 of the present invention, R21a is a C1-C4 alkoxy group or a C1-C4 alkyl mercapto group, R22a is a chlorine atom, R23a and R27a are hydrogen atoms, R24a is a C1-C4 alkyl group, C1 -C4 alkoxy {the C1-C4 alkyl and the C1-C4 alkoxy may be substituted by more than 1 halogen atom}, or a compound in which halogen atom and R25a is a fluorine atom or a hydrogen atom.

[0019] Examples of the compound B of the present invention include the following compounds. [Aspect B1] In the compound B of the present invention, R31 and R32 are chlorine atoms, R33, R35 and R37 are hydrogen atoms, R34 is a C1-C4 alkoxy group that can be substituted by 1 or more halogen atoms, and R36 is a halogen atom, R38 is a compound of methyl or hydrogen atom. [Aspect B2] In the compound B of the present invention, R31 and R32 are chlorine atoms, R33, R35 and R37 are hydrogen atoms, R34 is a C1-C4 alkoxy group that can be substituted by 1 or more fluorine atoms, and R36 is a fluorine atom, R38 is a compound of methyl or hydrogen atom.

[0020] Examples of the compound C of the present invention include the following compounds. [Aspect C1] In the compound C of the present invention, R41 and R42 are chlorine atoms, and R43 and R47 are hydrogen atoms. [Aspect C2] In aspect C1, R44 is a halogen atom or a hydrogen atom, R45 is a fluorine atom or a hydrogen atom, R46 is a halogen atom or a hydrogen atom, and R43 and R47 are hydrogen atoms.

[0021] Next, a method for producing the present compound (including the compound of the present invention) will be described.

[0022] Production method 1 The compound represented by the formula (I-1) (hereinafter, referred to as the compound (I-1)) can be made by adding the compound represented by the formula (M-1) in the presence of a base and a catalyst. It is produced by reacting a compound (hereinafter, referred to as compound (M-1)) with a compound represented by formula (M-2) (hereinafter, referred to as compound (M-2)). [In the formula, Q5 represents a group represented by formula Q1, a group represented by formula Q3 or a group represented by formula Q4, X1 represents a chlorine atom, a bromine atom or an iodine atom, and other symbols have the same meanings as above]. The reaction is carried out in a solvent or in the absence of a solvent. Examples of the solvent include tetrahydrofuran (hereinafter referred to as THF), 1,4-dioxane, 1,2-dimethoxyethane (hereinafter referred to as DME), methyl tert-butyl ether (hereinafter referred to as DME), and methyl tert-butyl ether (hereinafter referred to as DME). Ethers such as MTBE) and diethyl ether (hereinafter referred to as ethers); halogenated hydrocarbons such as methylene chloride and chloroform (hereinafter, halogenated hydrocarbons are referred to as hydrocarbons); hydrocarbons such as hexane, toluene and xylene (hereinafter referred to as ethers); , denoted as hydrocarbons); aprotic properties of N,N-dimethylformamide (hereinafter, denoted as DMF), N-methylpyrrolidone, dimethylstyrene (hereinafter, denoted as DMSO), etc. Polar solvents (hereinafter referred to as aprotic polar solvents); nitriles such as acetonitrile (hereinafter referred to as nitriles); water and mixtures thereof. Examples of the base used in the reaction include organic bases such as triethylamine, diisopropylethylamine, pyridine, and 4-(dimethylamino)pyridine (hereinafter referred to as organic bases); sodium carbonate, carbonic acid Alkali metal carbonates such as potassium (hereinafter referred to as alkali metal carbonates); alkali metal hydroxides such as sodium hydroxide and potassium hydroxide (hereinafter referred to as alkali metal hydroxides); sodium fluoride , alkali metal fluorides such as potassium fluoride and cesium fluoride; alkali metal phosphates such as tripotassium phosphate (hereinafter referred to as alkali metal phosphates). Examples of the catalyst used for the reaction include palladium(II) acetate, dichlorobis(triphenylphosphine)palladium(II), bis(diphenylphosphineferrocene)palladium(II) dichloride, and the like. In the reaction, relative to 1 mol of compound (M-1), compound (M-2) is usually in a ratio of 1 to 10 mol, and the base is usually in a ratio of 1 to 10 mol, usually 0.0001 to 1 mol. Ear ratio uses catalyst. During the reaction, ligands may also be used as needed. Examples of the ligand include triphenylphosphine, 4,5-bis(diphenylphosphino)-9,9-dimethyldibenzopyran (hereinafter referred to as Xantphos), and 2,2'-bis (Diphenylphosphino)-1,1'-binaphthyl, 1,1'-bis(diphenylphosphino)ferrocene, 2-dicyclohexylphosphino-2',4',6' -Triisopropylbiphenyl, 2-dicyclohexylphosphino-2',6'-dimethoxybiphenyl, 1,2-bis(diphenylphosphino)ethane, 2,2'-biphenyl Pyridine, 2-aminoethanol, 8-hydroxyquinoline, 1,10-phenanthroline, trans-1,2-cyclohexanediamine, trans-N,N'-dimethylcyclohexane-1,2 -Diamine, N,N'-dimethylethylenediamine, etc. When a ligand is used in the reaction, the ligand is usually used in a ratio of 0.01 to 0.5 mol relative to 1 mol of compound (M-1). The reaction temperature is usually in the range of 0°C to 150°C. The reaction time is usually in the range of 0.1 to 24 hours. After the reaction is completed, compound (I-1) can be obtained by performing post-processing operations such as adding water to the reaction mixture, extracting with an organic solvent, drying and concentrating the organic layer. Compound (M-2) is a commercially available compound or can be produced according to a known method.

[0023] Production method 2 The compound represented by formula (I-2) (hereinafter, referred to as compound (I-2)) can be prepared by making the compound represented by formula (M-3) (hereinafter referred to as compound (I-2)) in the presence of a base. , described as compound (M-3)) and a compound represented by formula (M-4) (hereinafter, described as compound (M-4)) are produced by reacting. [In the formula, X2 represents a fluorine atom or a chlorine atom, and other symbols have the same meanings as above]. The reaction is usually carried out in a solvent. Examples of the solvent include ethers, halogenated hydrocarbons, hydrocarbons, aprotic polar solvents, nitriles, and mixtures thereof. Examples of the base used in the reaction include organic bases, alkali metal carbonates, alkali metal hydroxides, and alkali metal phosphates. In the reaction, the base is usually used in a ratio of 1 to 10 moles of compound (M-4) relative to 1 mole of compound (M-3), usually in a ratio of 1 to 10 moles. During the reaction, a metal catalyst may be used if necessary. Examples of metal catalysts include copper (I) iodide, copper (I) bromide, copper (I) chloride, copper (I) oxide, copper (I) trifluoromethanesulfonate benzene complex, and acetonitrile. ) Copper catalysts such as copper (I) hexafluorophosphate, copper (I) 2-thiophene carboxylate, etc.; nickel catalysts such as bis(cyclooctadiene) nickel (0), nickel (II) chloride, etc.; palladium acetate ( II), 4 (triphenylphosphine) palladium (0), ginseng (dibenzylidene acetone) dipalladium (II) and other palladium catalysts, etc. When a metal catalyst is used in the reaction, the metal catalyst is usually used in a ratio of 0.01 to 0.5 mol relative to 1 mol of compound (M-3). During the reaction, ligands may also be used as needed. Examples of the ligand include triphenylphosphine, 4,5-bis(diphenylphosphino)-9,9-dimethyldibenzopyran (hereinafter referred to as Xantphos), and 2,2'-bis (Diphenylphosphino)-1,1'-binaphthyl, 1,1'-bis(diphenylphosphino)ferrocene, 2-dicyclohexylphosphino-2',4',6' -Triisopropylbiphenyl, 2-dicyclohexylphosphino-2',6'-dimethoxybiphenyl, 1,2-bis(diphenylphosphino)ethane, 2,2'-biphenyl Pyridine, 2-aminoethanol, 8-hydroxyquinoline, 1,10-phenanthroline, trans-1,2-cyclohexanediamine, trans-N,N'-dimethylcyclohexane-1,2 -Diamine, N,N'-dimethylethylenediamine, etc. When a ligand is used in the reaction, the ligand is usually used in a ratio of 0.01 to 0.5 mol relative to 1 mol of compound (M-3). The reaction temperature is usually in the range of 0°C to 150°C. The reaction time is usually in the range of 0.5 to 24 hours. After the reaction is completed, compound (I-2) can be obtained by performing post-processing operations such as adding water to the reaction mixture, extracting with an organic solvent, drying and concentrating the organic layer. Compound (M-3) and compound (M-4) are commercially available compounds or can be produced according to known methods.

[0024] Production method 3 The compound represented by the formula (I-3) (hereinafter, referred to as the compound (I-3)) can be prepared by making the compound represented by the formula (M-5) (hereinafter) in the presence of a base. , described as compound (M-5)) and a compound represented by formula (M-6) (hereinafter, described as compound (M-6)) are produced by reacting. [In the formula, the symbols represent the same meanings as mentioned above]. The reaction is usually carried out in a solvent. Examples of the solvent include ethers, halogenated hydrocarbons, hydrocarbons, aprotic polar solvents, nitriles, and mixtures thereof. Examples of the base used in the reaction include organic bases, alkali metal carbonates, alkali metal hydroxides, and alkali metal phosphates. In the reaction, the base is usually used in a ratio of 1 to 10 moles of compound (M-6) relative to 1 mole of compound (M-5), usually in a ratio of 1 to 10 moles. The reaction temperature is usually in the range of 0°C to 150°C. The reaction time is usually in the range of 0.5 to 24 hours. After the reaction is completed, compound (I-3) can be obtained by performing post-processing operations such as adding water to the reaction mixture, extracting with an organic solvent, drying and concentrating the organic layer. Compound (M-6) is a commercially available compound or can be produced according to a known method.

[0025] Production method 4 The compound represented by formula (I-4) (hereinafter, referred to as compound (I-4)) can be prepared by making the compound represented by formula (M-7) (hereinafter referred to as compound (I-4)) in the presence of an acid. , denoted as compound (M-7)), was produced by reacting. [In the formula, the symbols represent the same meanings as mentioned above]. The reaction is usually carried out in a solvent. Examples of the solvent include ethers, halogenated hydrocarbons, hydrocarbons, aprotic polar solvents, nitriles, and mixtures thereof. Examples of the acid used in the reaction include p-toluenesulfonyl group. In the reaction, the acid is usually used in a ratio of 0.1 to 10 moles based on 1 mole of compound (M-7). The reaction temperature is usually in the range of 0°C to 150°C. The reaction time is usually in the range of 0.5 to 24 hours. After the reaction is completed, compound (I-4) can be obtained by performing post-processing operations such as adding water to the reaction mixture, extracting with an organic solvent, drying and concentrating the organic layer.

[0026] Production method 5 The compound represented by the formula (I-5) (hereinafter, referred to as the compound (I-5)) can be prepared by making the compound represented by the formula (M-8) (hereinafter) in the presence of a base. , described as compound (M-8)) and a compound represented by formula (M-9) (hereinafter, described as compound (M-9)) are produced by reacting. [In the formula, the symbols represent the same meanings as mentioned above]. The reaction can be carried out according to Production Method 3 using compound (M-9) in place of compound (M-5) and compound (M-8) in place of compound (M-6). Compound (M-8) is a commercially available compound or can be produced according to a known method.

[0027] Production Method 6 The compound represented by the formula (I-6) (hereinafter, referred to as the compound (I-6)) can be produced by making the compound represented by the formula (M-10) (hereinafter, referred to as the compound ( M-10)) is produced by reacting with hydrazine. [In the formula, the symbols represent the same meanings as mentioned above]. The reaction is usually carried out in a solvent. Examples of the solvent include ethers, halogenated hydrocarbons, hydrocarbons, aprotic polar solvents, nitriles, and mixtures thereof. As hydrazine, hydrazine monohydrate or hydrazine acid addition salts such as hydrazine hydrochloride and hydrazine sulfate can also be used. In the reaction, hydrazine is usually used in a ratio of 0.5 to 10 moles based on 1 mole of compound (M-10). The reaction temperature is usually in the range of 0°C to 150°C. The reaction time is usually in the range of 0.5 to 24 hours. After the reaction is completed, compound (I-6) can be obtained by performing post-processing operations such as adding water to the reaction mixture, extracting with an organic solvent, drying and concentrating the organic layer. Compound (M-10) can be produced according to the method described in International Publication No. 2012 / 098416.

[0028] Production Method 7 The compound represented by the formula (I-7) (hereinafter, referred to as the compound (I-7)) can be prepared by reacting the compound (I-6) with the formula (M-11) in the presence of a base. ) (hereinafter referred to as compound (M-11)) is reacted to produce. [In the formula, the symbols represent the same meanings as mentioned above]. The reaction is usually carried out in a solvent. Examples of the solvent include ethers, halogenated hydrocarbons, hydrocarbons, aprotic polar solvents, nitriles, and mixtures thereof. Examples of the base used in the reaction include organic bases, alkali metal carbonates, alkali metal hydroxides, and alkali metal phosphates. In the reaction, the base is usually used in a ratio of 0.5 to 10 moles of compound (M-11) relative to 1 mole of compound (I-6), usually in a ratio of 0.5 to 10 moles. The reaction temperature is usually in the range of 0°C to 150°C. The reaction time is usually in the range of 0.5 to 24 hours. After the reaction is completed, compound (I-7) can be obtained by performing post-processing operations such as adding water to the reaction mixture, extracting with an organic solvent, drying and concentrating the organic layer. Compound (M-11) is a commercially available compound or can be produced according to a known method.

[0029] Production method 8 The N-oxide of the compound represented by formula (I) can be produced by reacting the compound represented by formula (I) with an oxidizing agent. The reaction can be carried out according to the method described in US Patent Application Publication No. 2018 / 0009778 or International Publication No. 2016 / 121970, for example.

[0030] Reference Production Method 1 Compound (M-5) can be produced by reacting a compound represented by formula (M-5S) (hereinafter, referred to as compound (M-5S)) and hydroxylamine. [In the formula, the symbols represent the same meanings as mentioned above]. The reaction is usually carried out in a solvent. Examples of the solvent include alcohols such as methanol and ethanol (hereinafter referred to as alcohols); ethers; halogenated hydrocarbons; hydrocarbons; aprotic polar solvents; nitriles; and mixtures thereof. As hydroxylamine, hydroxylamine acid addition salts such as hydrochloride and sulfate can also be used. In the reaction, hydroxylamine is usually used in a ratio of 0.5 to 10 moles based on 1 mole of compound (M-5S). During the reaction, acid may be used if necessary. Examples of the acid include inorganic acids such as hydrogen chloride, phosphoric acid, and sulfuric acid; and organic acids such as acetic acid, trifluoroacetic acid, benzoic acid, and p-toluenesulfonic acid. When an acid is used in the reaction, the acid is usually used in a ratio of 0.01 to 0.5 mol based on 1 mol of the compound (M-5S). The reaction temperature is usually in the range of 0°C to 150°C. The reaction time is usually in the range of 0.5 to 24 hours. After the reaction is completed, compound (M-5) can be obtained by performing post-processing operations such as adding water to the reaction mixture, extracting with an organic solvent, drying and concentrating the organic layer. Compound (M-5S) is a commercially available compound or can be produced according to a known method.

[0031] Reference Production Method 2 Compound (M-9) can be produced by reacting a compound represented by formula (M-9S) (hereinafter, referred to as compound (M-9S)) and hydroxylamine. [In the formula, the symbols represent the same meanings as mentioned above]. The reaction can be carried out according to Reference Production Method 1 using compound (M-9S) instead of compound (M-5S). Compound (M-9S) is a commercially available compound or can be produced according to a known method.

[0032] Refer to Production Method 3 Compound (M-7), the compound (M-8) and the compound represented by the formula (M-7S) (hereinafter, referred to as compound (M-7S)) can be prepared in the presence of a base. )) react to produce. The reaction is carried out in a solvent or in the absence of a solvent. Examples of the solvent include ethers, halogenated hydrocarbons, hydrocarbons, nitriles, nitrogen-containing aromatic compounds, aprotic polar solvents, and mixtures thereof. Examples of the base include organic bases; alkali metal carbonates; and alkali metal hydrides such as sodium hydride and potassium hydride. In the reaction, the base is usually used in a ratio of 0.5 to 1.5 mol of compound (M-7S), usually in a ratio of 1 to 3 mol, based on 1 mol of compound (M-8). The reaction temperature is usually in the range of -20°C to 150°C. The reaction time is usually in the range of 0.5 to 24 hours. After the reaction is completed, compound (M-7) can be obtained by performing post-processing operations such as adding water to the reaction mixture, extracting with an organic solvent, drying and concentrating the organic layer. Compound (M-7S) is a commercially available compound or can be produced using a known method.

[0033] The compound of the present invention may be combined with at least one component selected from the group consisting of the following group (a), group (b), group (c), and group (d) (hereinafter , recorded as this ingredient) are mixed or used together. The aforementioned mixing or combined use means that the compound of the present invention and the component are used at the same time, separately or at intervals of a certain period of time. When the compound of the present invention and this component are used simultaneously, the compound of the present invention and this component may be contained in separate preparations, or they may be contained in one preparation. One aspect of the present invention contains at least one component selected from the group consisting of group (a), group (b), group (c), and group (d) (that is, the component) , and the composition of the compound of the present invention (hereinafter, referred to as composition A).

[0034] Group (a) is acetylcholinesterase inhibitors (such as carbamate pesticides, organophosphorus pesticides), GABA-activated chloride channel blockers (such as phenylpyridine) Azole insecticides), sodium channel modulators (eg, pyrethroids), nicotinic acetylcholine receptor competitive modulators (eg, neonicotinoids) agents), ectopic modulators of nicotinic acetylcholine receptors, ectopic modulators of glutamate-gated chloride channels (e.g., macrolide insecticides), youth hormone analogs, multiple action sites Inhibitor, tuner TRPV channel modulator, mite fertility inhibitor, insect midgut lining disruptor derived from microorganisms, mitochondrial ATP synthesis enzyme inhibitor, oxidative phosphorylation unlinker, nicotinic acetylcholine Receptor channel blockers (e.g., Nereosin-based insecticides), chitin biosynthesis inhibitors, molt inhibitors, ecdysone receptor agonists, octopamine receptor agonists, mitochondrial electron transport system Inhibitors of complexes I, II, III and IV, potential-dependent sodium channel blockers, acetyl CoA carboxylase inhibitors, fish nicotine receptor modulators (e.g., diamide insecticides) , string tuner conditioners, microbial insecticides, and other groups consisting of insecticidal active ingredients, acaricidal active ingredients, and nematicidal active ingredients. These are classified and recorded based on the mechanism of action of IRAC.

[0035] Group (b) is nucleic acid synthesis inhibitors (for example, phenylamide-based bactericides, acylamino acid-based bactericides), cell division and cytoskeleton inhibitors (for example, MBC bactericides), respiratory Inhibitors (e.g., QoI bactericides, QiI bactericides), amino acid synthesis and protein synthesis inhibitors (e.g., anilinopyridine-based bactericides), message transmission inhibitors, lipid synthesis and membrane synthesis inhibitors, sterols Biosynthesis inhibitors (for example, triazole-based DMI fungicides), cell wall biosynthesis inhibitors, melanin synthesis inhibitors, plant defense inducers, multi-action point contact active fungicides, microbial fungicides, and other bactericidal active ingredients The group formed. These are classified and recorded based on the mechanism of action of FRAC.

[0036] Group (c) is a group of plant growth adjusting components (including mycorrhizal fungi and rhizogenes).

[0037] Group (d) is a group of avoidable ingredients.

[0038] Examples of combinations of the present component and the compound of the present invention are described below. For example, alanycarb+SX means the combination of alanycarb and SX. In addition, the abbreviation of SX means a compound of the present invention selected from any one of the compound groups SX1 to SX1397. In addition, the components described below are all well-known components and can be obtained from commercially available preparations or produced by known methods. When the component is a microorganism, it can also be obtained from a microorganism storage institution. In addition, the numbers in parentheses indicate CAS RN (registered trademark).

[0039] The combination of the present component of the above-mentioned group (a) and the compound of the present invention: abamectin+SX, acephate+SX, acequinocyl+SX, acephate+SX acetamiprid)+SX, acetoprole+SX, acrinathrin+SX, acynonapyr+SX, afidopyropen+SX, aflana( afoxolaner ) +SX, alanycarb + SX, aldicarb + SX, allethrin + SX, alpha-cypermethrin + SX, alpha- endosulfan +SX, aluminum phosphide +SX, amitraz +SX, azadirachtin +SX, azamethiphos +SX, azinphos-ethyl ) +SX, azinphos-methyl+SX, azocyclotin +SX, bark of Celastrus angulatus+SX, bendiocarb +SX, befunin (benfluthrin)+SX, benfuracarb+SX, bensultap+SX, benzoximate+SX, benzpyrimoxan+SX, beta- cyfluthrin) +SX, beta-cypermethrin +SX, bifenazate +SX, bifenthrin +SX, bioallethrin +SX, bioresmethrin )+SX, bistrifluron+SX, borax+SX, boric acid+SX, broflanilide+SX, bromopropylate+SX, bufungin( buprofezin)+SX, butocarboxim+SX, butoxycarboxim+SX, cadusafos+SX, calcium phosphide+SX, carbaryl+ SX , carbofuran + SX, carbosulfan butyl + SX, cartap hydrochloride + SX, cartap + SX, chinomethionat + SX, Chlorantraniliprole + SX, chlordane + SX, chlorethoxyfos + SX, chlorfenapyr + SX, chlorfenvinphos + SX, chlorfluazuron +SX, chlormephos+ SX, chloropicrin+SX, chlorpyrifos+ SX, chlorpyrifos-methyl+SX, chromafenozide+SX, chlorpyrifos clofentezine +SX, clothianidin +SX, concanamycin A +SX, coumaphos +SX, cryolite +SX, cyanophos )+SX, cyantraniliprole+SX, cyclaniliprole+SX, cyclobutrifluram+SX, cycloprothrin+SX, cycloprothrin( cycloxaprid)+SX, cyenopyrafen+SX, ethylfentrile+SX, cyflumetofen+SX, cyfluthrin+SX, cyhalodiamide+SX , cyhalothrin+SX, cyhexatin+SX, cypermethrin+SX, cyphenothrin+SX, cyproflanilide+SX, cypermethrin Cyromazine + SX, dazomet + SX, deltamethrin + SX, demeton-S-methyl + SX, diafenthiuron + SX, diazinon )+SX, dichlorvos+SX, dichloromezotiaz+SX, dicofol+SX, dicrotophos+SX, diflovidazin+SX, diflubenzuron+SX, dimefluthrin+SX, dimethoate+SX, dimethylvinphos+SX, dimpropyridaz+SX, up dinotefuran+SX, disodium octaborate+SX, disulfoton+SX, DNOC(2-methyl-4,6-dinitrophenol)+SX, multiple insecticides (doramectin)+SX, dried leaves of Dryopteris filix-mas+SX, emamectin-benzoate+SX, empenthrin+SX, endosulfan +SX, EPN (O-ethyl O-(4-nitrophenyl)phenylphosphonothioate) +SX, ε-metofluthrin (epsilon-metofluthrin) +SX, ε-metofluthrin (epsilon) -momfluorothrin)+SX, esfenvalerate +SX, etiofencarb+SX, ethiprole+SX, ethiprole+SX, ethoprophos+SX , etofenprox+SX, etoxazole+SX, extract of Artemisia absinthium+SX, extract of Azadirachta indica+SX, Cassia nigricans extract Extract of Cassia nigricans+SX, extract of clitoria ternatea+SX, extract of Symphytum officinale+SX, extracts or simulated blend of Chenopodium ambrosioides )+SX, extract of Tanacetum vulgare+SX, extract of Urtica dioica+SX, extract of Viscum album+SX, famphur )+SX, fenamiphos+SX, fenazaquin+SX, fenbutatin oxide+SX, fenitrothion+SX, fenmezoditiaz+SX, butylbutylmethane( fenobucarb)+SX, fenoxycarb+SX, fenpropathrin+SX, fenpyroximate+SX, fenthion+SX, fenvalerate+SX, fenpyroximate+SX fipronil+SX, flometoquin+SX, flonicamid+SX, fluacrypyrim+SX, fluazaindolizine+SX, fluazuron +SX, flubendiamide+SX, fluchlordiniliprole +SX, flucycloxuron+SX, flucythrinate+SX, fluensulfone+SX , flufenoprox + SX, flufenoxuron + SX, flufiprole + SX, flumethrin + SX, flupentiofenox + SX, flupyradifurone )+SX, flupyrimin+SX, fluralaner+SX, fluvalinate+SX, fluxametamide+SX, formetanate+SX, fluxametamide (fosthiazate)+SX, furamethrin+SX, furathiocarb+SX, gamma-cyhalothrin+SX, GS-omega / kappa HXTX-Hv1a peptide (GS -omega / kappa HXTX- Hv1a peptide)+SX, halfenprox+SX, halofenozide+SX, heptafluthrin+SX, heptenophos+SX, Hexaflumuron +SX, hexythiazox +SX, potassium salt of hop beta acid +SX, hydramethylnon +SX, hydroprene )+SX, imicyafos+SX, imidacloprid+SX, imidaclothiz+SX, imiprothrin+SX, indazapyroxamet+ SX, indoxacarb+ SX, isocycloseram+SX, isofenphos+SX, isoprocarb+SX, isopropyl O-(methoxyaminophosphorylthioate) salicylic acid Ester (isopropyl-O-(methoxyaminothiophosphoryl)salicylate)+SX, isoxathion+SX, ivermectin+SX, kadethrin+SX, kappa-tefluthrin )+SX, kappa-bifenthrin +SX, kinoprene +SX, lambda-cyhalothrin +SX,Lenoremycin + SX, lepimectin + SX, lime sulfur + SX, lotilaner + SX, lufenuron + SX, engine oil ( machine oil)+SX, malathion+SX, mecarbam+SX, meperfluthrin+SX, metaflumizone+SX, metam+ SX, methamidophos+SX, methidathion+SX, methiocarb+SX, methomyl+SX, methoprene+SX, methoxychlor ( methoxychlor)+SX, methoxyfenozide+SX, methyl bromide+SX, metofluthrin+SX, metolcarb+SX, metoxadiazone+SX, Mevinphos+SX, milbemectin+SX, milbemycin oxime+SX, momfluorothrin+SX, monocrotophos+SX, moxil moxidectin+SX, naled+SX, nicofluprole (nicofluprole)+SX, nicotine+SX, nicotine-sulfate+SX, nitenpyram +SX, novaluron +SX, novifluuron+SX, oil of the seeds of Chenopodium anthelminticum+SX, omethoate+SX, omethoate oxamyl)+SX, oxazosulfyl +SX, oxydemeton-methyl+SX, parathion-methyl+SX, parathion-methyl+SX, permethonine (permethrin) +SX, phenothrin + SX, phenthoate + SX, phorate + SX, phosalone + SX, phosmet + SX, Phosphamidon+SX, phosphine+SX, phoxim+SX, pirimicarb+SX, pirimiphos-methyl+SX, prallethrin ) +SX, profenofos+SX, profluthrin+SX, propargite+SX, propetamphos+SX, propoxur +SX, semen propylene glycol alginate+SX, prothiofos+SX, pyflubumide+SX, pymetrozine+SX, pyraclofos+SX, pyrethrins (pyrethrins)+SX, pyridaben+SX, pyridalyl +SX, pyridaphenthion+SX, pyrifluquinazone +SX, pyrimidifen + SX, pyriminostrobin + SX, pyriprole + SX, pyriproxyfen + SX, quinalphos + SX, resmethrin + SX, rotenone (rotenone)+SX, ryanodine+SX, sarolaner +SX, selamectin+SX, sigma-cypermethrin +SX, silicofen( silafluofen)+SX, sodium borate+SX, sodium metaborate+SX, spidoxamat(spidoxamat)+SX, spinetoram+SX, spinosad+SX, snail Spirobudifen+SX, spirodiclofen+SX, spiromesifen+SX, spiropidion+SX, spirotetramat+SX, sulfluramid ) +SX, sulfotep +SX, sulfoxaflor +SX, sulfur +SX, sulfuryl fluoride +SX, tartar emetic +SX, tau -tau-fluvalinate+SX, tebufenozide+SX, tebufenpyrad+SX, tebupirimfos+SX, teflubenzuron+SX, teflubenzuron Tefluthrin+SX, temephos+SX, terbufos+SX, terpene constituents of the extract of chenopodium ambrosioides near ambrosioides)+SX, four grams Tetrachlorantraniliprole + SX, tetrachlorvinphos + SX, tetradifon + SX, tetramethrin + SX, tetramethylfluthrin + SX, tetrafluorochloride Amine (tetraniliprole)+SX, theta-cypermethrin+SX, thiacloprid+SX, thiamethoxam+SX, thiocyclam+SX, thiocyclam (thiodicarb)+SX, thiofenox+SX, thiometon+SX, thiosultap-disodium+SX, thiosultap-monosodium+SX, thiocarb (tiorantraniliprole)+SX, tioxazafen+SX, tolfenpyrad+SX, tralomethrin+SX, transfluthrin+SX, triazamate+SX, triazamate( triazophos) +SX, trichlorfon+SX, trifluenfuronate +SX, triflumezopyrim +SX, triflumuron+ SX, trimethacarb+ SX, tyclopyrazoflor+SX, vamidothion+SX, wood extract of Quassia amara+SX, XMC (3,5-dimethylphenyl N-methylcarbamate)+ SX, xylylcarb+SX, zeta-cypermethrin+SX, zinc phosphide+SX, 4-[5-(3,5-dichlorophenyl)- 5-(Trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-2-methyl-N-(1-oxothiocyclobutan-3-yl)benzene Formamide (1241050-20-3)+SX, 3-methoxy-N-(5-{5-(trifluoromethyl)-5-[3-(trifluoromethyl)phenyl]-4 ,5-dihydro-1,2-oxazol-3-yl}inden-1-yl)propanamide (1118626-57-5)+SX, 2-({2-fluoro-4-methyl -5-[(2,2,2-trifluoroethyl)sulfinyl]phenyl}imino)-3-(2,2,2-trifluoroethyl)-1,3-thiazolidine -4-one(1445683-71-5)+SX, (2Z)-2-({2-fluoro-4-methyl-5-[(R)-(2,2,2-trifluoroethyl) Sulfenyl]phenyl}imino)-3-(2,2,2-trifluoroethyl)-1,3-thiazolidin-4-one (2377084-09-6)+SX, N- {4-Chloro-3-[(1-cyanocyclopropyl)aminoformyl]phenyl}-1-methyl-4-(methanesulfonyl)-3-(1,1,2,2 ,2-pentafluoroethyl)-1H-pyrazole-3-methamide (1400768-21-9)+SX, N-[3-chloro-1-(pyridin-3-yl)-1H-pyrazole -4-yl]-2-(methanesulfonyl)propionamide (2396747-83-2)+SX, 1,4-dimethyl-2-[2-(pyridin-3-yl)-2H- Indazol-5-yl]-1,2,4-triazolidine-3,5-dione (2171099-09-3)+SX, 2-isopropyl-5-[(3,4,4- Trifluoro-3-buten-1-yl)sulfonyl]-1,3,4-thiadiazole (2058052-95-0)+SX, N-({2-fluoro-4-[(2S, 3S) -2-Hydroxy-3-(3,4,5-trichlorophenyl)-3-(trifluoromethyl)pyrrolidin-1-yl]phenyl}methyl)cyclopropanecarboxamide + SX , 7-fluoro-N-[1-(methylhydrothio)-2-methylprop-2-yl]-2-(pyridin-3-yl)-2H-indazole-4-methamide+ SX, 7-fluoro-N-[1-(methanesulfenyl)-2-methylpropan-2-yl]-2-(pyridin-3-yl)-2H-indazole-4-methamide +SX, 7-fluoro-N-[1-(methanesulfonyl)-2-methylpropan-2-yl]-2-(pyridin-3-yl)-2H-indazole-4-methamide +SX, N-[1-(difluoromethyl)cyclopropyl]-2-(pyridin-3-yl)-2H-indazole-4-carboxamide+SX, 2,9-dihydro-9 -(methoxymethyl)-2-(pyridin-3-yl)-10H-pyrazolo[3,4-f]pyrido[2,3-b][1,4]oxazepine- 10-keto(2607927-97-7)+SX, BT crop protein Cry1Ab (BT crop protein Cry1Ab)+SX, BT crop protein Cry1Ac (BT crop protein Cry1Ac)+SX, BT crop protein Cry1Fa (BT crop protein Cry1Fa)+SX, BT crop protein Cry1A.105 (BT crop protein Cry1A.105)+SX, BT crop protein Cry2Ab (BT crop protein Cry2Ab)+SX, BT crop protein Vip3A (BT crop protein Vip3A)+SX , BT crop protein mCry3A (BT crop protein mCry3A)+SX, BT crop protein Cry3Ab (BT crop protein Cry3Ab)+SX,BT crop protein Cry3Bb (BT crop protein Cry3Bb)+SX, BT crop protein Cry34Ab1 / Cry35Ab1 (BT crop protein Cry34Ab1 / Cry35Ab1) +SX, Adoxophyes orana granulosis virus strain BV- 0001)+SX, Anticarsia gemmatalis mNPV+SX, Autographa californica mNPV+SX, Cydia pomonella GV strain V15)+SX, Cydia pomonella GV strain V22+SX, Cryptophlebia leucotreta GV+SX, Dendrolimus punctatus cypovirus)+SX, Helicoverpa armigera NPV strain BV-0003+SX, Helicoverpa zea NPV+SX, Gypsy moth nuclear polyhedrosis Viruses (Lymantria dispar NPV)+SX, Mamestra brassicae NPV+SX, Spodoptera exigua nuclear polyhedrosis virus (Mamestra configurata NPV)+SX, Spodoptera exigua nucleopolyhedrosis virus Neodiprion abietis NPV+SX, Neodiprion lecontei NPV+SX, Neodiprion sertifer NPV+SX, Locust microsporidia ( Nosema locustae )+SX, Orgyia pseudotsugata NPV+SX, Pieris rapae GV+SX, Plodia interpunctella GV+SX, Night Spodoptera exigua mNPV+SX, Spodoptera littoralis mNPV+SX, Spodoptera litura NPV+SX, finger-like Arthrobotrys dactyloides+SX, Bacillus firmus strain GB-126+SX, Bacillus firmus strain I-1582+SX, Bacillus firmus strain NCIM2637+SX, Bacillus megaterium +SX, Bacillus sp. Strain AQ175+SX, Bacillus sp. Strain AQ177+SX, Bacillus sp. Strain AQ178+SX, Bacillus sphaericus strain 2362 serotype H5a5b+SX, Bacillus thuringiensis strain ABTS1743+SX, Bacillus thuringiensis strain AQ52+SX, Bacillus thuringiensis strain BD#32+SX, Bacillus thuringiensis strain CR-371+SX, Bacillus thuringiensis strain (Bacillus thuringiensis strain) thuringiensis subsp. Aizawai strain) ABTS-1857+ SX, Aizawai strain AM65-52+SX, Aizawai strain GC-91+SX, Aizawai strain NB200+SX, Aizawai strain Bacillus thuringiensis subsp. Aizawai Serotype strain H-7+SX, Bacillus thuringiensis subsp. kurstaki strain ABTS351+SX, Bacillus thuringiensis subsp. kurstaki strain BMP123+ SX, Bacillus thuringiensis subsp. kurstaki strain strain CCT1306) +SX, T. custii strain EG2348+SX, T. custii strain EG7841+SX, T. custii strain EVB113-19+SX, T. custii strain F810+SX, library Thuliella cussii strain HD-1+SX, Thuliella cussii strain PB54+SX, Thurets cussii strain SA-11+SX, Thuliella cussii strain SA-12+SX, Thuliella cussii insecticidal Bacillus thuringiensis subsp. Tenebriosis strain NB176+SX, Bacillus thuringiensis subsp. Thuringiensis strain MPPL002+SX, Bacillus thuringiensis subsp. morrisoni )+SX, Bacillus thuringiensis var. colmeri+SX, Bacillus thuringiensis var. darmstadiensis strain 24-91+SX, thuringiensis pine caterpillar Bacillus thuringiensis var. dendrolimus+SX, Bacillus thuringiensis var. galleriae+SX, Bacillus thuringiensis var. israelensis strain BMP144+SX, Bacillus thuringiensis var. israelensis strain Bacillus thuringiensis var. israelensis serotype strain H-14+SX, Bacillus thuringiensis var. japonensis strain buibui (Bacillus thuringiensis var. japonensis strain buibui)+SX, Bacillus thuringiensis Santiago variant strain (Bacillus thuringiensis var. japonensis strain buibui) var. san diego strain)M-7+SX, Bacillus thuringiensis var. 7216+SX, Bacillus thuringiensis var. aegypti+SX, Bacillus thuringiensis var. aegypti)+SX, Bacillus thuringiensis var. 7216+SX, Bacillus thuringiensis var. Bacillus thuringiensis var. T36)+SX, Beauveria bassiana strain ANT-03+SX, Beauveria bassiana strain ATCC74040+SX, Beauveria bassiana strain GHA+SX, Beauveria bassiana strain Beauveria brongniartii+SX, Burkholderia rinojensis strain A396+SX, Chromobacterium subtsugae strain PRAA4-1T+SX, Dactyllela ellipsospora)+SX, Dectylaria thaumasia+SX, Hirsutella minnesotensis+SX, Hirsutella rhossiliensis+SX, Hirsutella thompsonii+SX, Large chainpot Lagenidium giganteum+SX, Lecanicillium lecanii strain KV01+SX, Lecanicillium lecanii conidia of strain DAOM198499 +SX, Lecanicillium lecanii conidia of strain DAOM198499 +SX, Lecanicillium lecanii conidia strain Spore strain DAOM216596+ SX, Lecanicillium muscarium strain Ve6+SX, Metarhizium anisopliae strain F52+SX, Metarhizium anisopliae var. acridum + SX, Metarhizium anisopliae var. acridum Metarhizium anisopliae var. anisopliae BIPESCO 5 / F52+SX, Metarhizium flavoviride +SX, Monacrosporium phymatopagum+SX, Paecilomyces rosacea strain ( Paecilomyces fumosoroseus Apopka strain) 97+SX, Paecilomyces lilacinus strain 251+SX, Paecilomyces tenuipes strain T1+SX, Paenibacillus popilliae +SX, Pasteuria nishizawae strain Pn1+SX, Pasteuria penetrans+SX, Pasteuria usgae+SX, Pasteuria penetrans+SX, Pasteuria penetrans+SX, Pasteuria penetrans Pasteuria thornei +SX, Serratia entomophila +SX, Verticillium chlamydosporium +SX, Verticillium lecani strain NCIM1312+ SX, Wolbachia pipientis +SX. ,

[0040] Combinations of the components of the above-mentioned group (b) and the compounds of the present invention: acibenzolar-S-methyl+SX, aldimorph+SX, ametoctradin+SX , aminopyrifen +SX, amisulbrom +SX, anilazine +SX, azaconazole +SX, azoxystrobin +SX, basic copper sulfate + SX, benalaxyl + SX, benalaxyl-M + SX, benodanil + SX, benomyl + SX, benthiavalicarb + SX , bentiavalicarb-isopropyl+SX, benzovindiflupyr+SX, binapacryl+SX, biphenyl+SX, biphenyltriazolol (bitertanol)+SX, bixafen+SX, blasticidin-S+SX, Bordeaux mixture+SX, boscalid+SX, bromyclofenil (bromothalonil)+SX, bromuconazole+SX, bupirimate+SX, captafol+SX, captan+SX, carbendazim+SX , carboxin +SX, carpropamid +SX, chinomethionat +SX, chitin +SX, chloroinconazide +SX, Dimao Chloroneb+SX, chlorothalonil +SX, chlozolinate+SX, colletochlorin B+SX, copper(II) acetate)+SX, copper hydroxide (II) (copper(II) hydroxide)+SX, alkaline copper oxychloride (copper oxychloride)+SX, copper(II) sulfate (copper(II) sulfate)+SX, coumoxystrobin (coumoxystrobin) +SX, race Cyazofamid + SX, cyflufenamid + SX, cymoxanil + SX, cyproconazole + SX, cyprodinil + SX, dichlobentiazox + SX, dichlofluanid )+SX, diclocymet+SX, diclomezine+SX, dicloran+SX, diethofencarb+SX, difenoconazole+SX, difluoride diflumetorim+SX, dimethachlone+SX, dimethirimol+SX, dimethomorph+SX, dimoxystrobin+SX, diniconazole+SX , diniconazole-M+SX, dipotassium hydrogenphosphite+SX, dipotassium hydrogenphosphite+SX, dipymetitrone+SX, dithianon+SX, dodecylbenzene dodecylbenzenesulphonic acid bisethylenediamine copper(II) salt+SX, dodemorph+SX, dodine+SX, edifenphos +SX, enoxastrobin +SX, epoxiconazole +SX, etaconazole + SX, ethaboxam +SX, ethirimol +SX, Etridiazole+SX, extract of Melaleuca alternifolia+SX, extract of Reynoutria sachalinensis+SX, extract of the cotyledons of lupine seedlings cotyledons of lupine plantlets ("BLAD")) + SX, garlic extract (extract of Allium sativum) + SX, extract of Equisetum arvense + SX, extract of Tropaeolum majus + SX , famoxadone +SX, fenamidone +SX, fenaminstrobin +SX, fenarimol +SX, fenbuconazole + SX, methfuran Amine (fenfuram) + SX, fenhexamid (fenhexamid) + SX, fenoxanil (fenoxanil) + SX, fenpiclonil (fenpiclonil) + SX, fenpicoxamid (fenpicoxamid) + SX, fenpropidin (fenpropidin) + SX, fen Fenpropimorph+SX, fenpyrazamine (fenpyrazamine) +SX, fentin acetate+SX, fentin chloride+SX, fentin hydroxide +SX, ferbam+SX, ferimzone+SX, florylpicoxamid +SX, fluazinam+SX, flubeneteram+SX, fludioxonil )+SX, flufenoxadiazam+SX, flufenoxystrobin+SX, fluindapyr+SX, flumetylsulforim+SX, flumorph+SX, fluopicolide+SX, fluopyram +SX, fluopimomide+SX, fluoroimide+SX, fluoxapiprolin+SX, fluoxastrobin+SX, fluoxytioconazole+SX, fluquinconazole+SX , flusilazole+SX, flusulfamide+SX, flutianil+SX, flutolanil+SX, flutriafol+SX, flutriafol Fluxapyroxad +SX, folpet + SX, fosetyl + SX, fosetyl-aluminum + SX, fuberidazole (fuberidazole) + SX, furosemide ( furalaxyl)+SX, furametpyr+SX, guazatine+SX, hexaconazole+SX, hymexazole+SX, imazalil+SX, Yi Imibenconazole+SX, iminoctadine+SX, iminoctadine triacetate+SX, inpyrfluxam(inpyrfluxam)+SX, iodocarb+ SX, ipconazole+SX, ipfentrifluconazole+SX, ipflufenoquin+SX, iprobenfos+SX, iprodione+SX, iprovalicarb +SX, isofetamid+SX, isoflucypram (isoflucypram)+SX, isoprothiolane+SX, isopyrazam+SX, isotianil+SX, Jiasi Kasugamycin +SX, kresoxim-methyl +SX, laminarin +SX, leaves and bark of Quercus +SX, mancozeb )+SX, mandestrobin(mandestrobin)+SX, mandipropamid(mandipropamid)+SX, maneb(maneb)+SX, mefentrifluconazole(mefentrifluconazole)+SX, mepanipyrim(mepanipyrim)+SX, mepanipyrim( mepronil)+SX, meptyldinocap+SX, metalaxyl+SX, metalaxyl-M+SX, metallpicoxamid+SX, metconazole+SX, sulfonate methasulfocarb + SX, metiram + SX, metominostrobin + SX, metrafenone + SX, metyltetraprole + SX, myclobutanil + SX, naftifen (naftifine) +SX, nuarimol +SX, octhilinone +SX, ofurace +SX, orysastrobin +SX, oxadixyl + SX , oxathiapiprolin + SX, oxolinic acid + SX, oxolinic acid + SX, oxpoconazole + SX, oxpoconazole fumarate + SX, Jiabaoxin (oxycarboxin)+SX, oxytetracycline+SX, pefurazoate+SX, penconazole+SX, pencycuron+SX, penflufen+SX, pyridine Penthiopyrad+SX, phenamacril+SX, phosphorous acid+SX, phthalide+SX, picarbutrazox+SX, picoxystrobin )+SX, piperalin+SX, polyoxins+SX,Potassium hydrogencarbonate+SX, potassium dihydrogenphosphite+SX, probenazole+SX, prochloraz+SX, procymidone+SX, diamidine Diphenoxypropane (propamidine) + SX, propamocarb + SX, propiconazole + SX, propineb + ​​SX, proquinazid + SX, sulfur bacteria Prothiocarb + SX, prothioconazole + SX, pydiflumetofen + SX, pyraclostrobin + SX, pyraclostrobin + SX, pyraclostrobin ( pyraoxystrobin + SX, pyrapropoyne + SX, pyraziflumid + SX, pyrazophos + SX, pyribencarb + SX, pyributicarb + SX, pyridachlometyl + SX , pyrifenox+SX, pyrimethanil+SX, pyrimorph+SX, pyriofenone+SX, pyrisoxazole+SX, 100 Pyroquilon + SX, Quillaja extract + SX, quinconazole + SX, quinofumelin + SX, quinoxyfen + SX, pentachloride Quintozene +SX, Saponins of Chenopodium quinoa +SX, seboctylamine +SX, sedaxane +SX, silthiofam +SX, simeconazole+SX, sodium hydrogencarbonate+SX, spiroxamine+SX, streptomycin+SX, sulfur+SX, tebuconazole +SX, tebufloquin+SX, teclofthalam+SX, tecnazene+SX, terbinafine+SX, tetraconazole+ SX, thiabendazole+SX, thifluzamide+SX, thiophanate+SX, thiophanate-methyl+SX, thiram+SX, Thymol+SX, tiadinil+SX, tolclofos-methyl+SX, tolfenpyrad+SX, tolprocarb+SX, methyl tolylfluanid + SX, triadimefon + SX, triadimenol + SX, triazoxide + SX, triclopyricarb + SX, tricyclazole +SX, tridemorph+SX, trifloxystrobin+SX, triflumizole+SX, triforine+SX, triticonazole+SX, Vitil Validamycin + SX, valifenalate + SX, vinclozolin + SX, yellow mustard powder + SX, zinc thiazole + SX, zineb + ​​SX , ziram+SX, zoxamide+SX, N'-[4-({3-[(4-chlorophenyl)methyl]-1,2,4-thiadiazole- 5-yl}oxy)-2,5-dimethylphenyl]-N-ethyl-N-methylformamidine (1202781-91-6)+SX, N'-{4-[(4,5 -Dichlorothiazol-2-yl)oxy]-2,5-dimethylphenyl}-N-ethyl-N-methylformamidine (929908-57-6)+SX, N'-(2 ,5-dimethyl-4-phenoxyphenyl)-N-ethyl-N-methylformamidine (1052688-31-9)+SX, N'-[5-chloro-4-(2- Fluorophenoxy)-2-methylphenyl]-N-ethyl-N-methylformamidine (2055589-28-9)+SX, N'-[2-chloro-4-(2-fluorobenzene Oxy)-5-methylphenyl]-N-ethyl-N-methylformamidine (2055756-21-1)+SX, N'-(2-chloro-4-phenoxy-5-methyl ylphenyl)-N-ethyl-N-methylformamidine (2062599-39-5)+SX, N'-[4-(1-hydroxy-1-phenyl-2,2,2-trifluoro Ethyl)-2-methyl-5-methoxyphenyl]-N-isopropyl-N-methylformamidine (2101814-55-3)+SX, N'-[5-bromo-6- (1-Methyl-2-propoxyethoxy)-2-methylpyridin-3-yl]-N-ethyl-N-methylformamidine (1817828-69-5)+SX, 4- (2-Bromo-4-fluorophenyl)-N-(2-chloro-6-fluorophenyl)-1,3-dimethyl-1H-pyrazole-5-amine (1362477-26-6)+ SX, 2-[6-(3-fluoro-4-methoxyphenyl)-5-methylpyridin-2-yl]quinazoline (1257056-97-5)+SX, ethyl (2Z)- 3-Amino-2-cyano-3-phenyl acrylate (39491-78-6)+SX, N-[(2-chlorothiazol-5-yl)methyl]-N-ethyl-6-methyl Oxy-3-nitropyridin-2-amine (1446247-98-8)+SX, 5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(1H- 1,2, 4-triazol-1-ylmethyl)cyclopentan-1-ol (1394057-11-4)+SX, (1R, 2S, 5S)-5-(4-chlorobenzyl)- 2-(Chloromethyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol (1801930-06-2)+SX, (1S, 2R, 5R)-5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl )Cyclopentan-1-ol (1801930-07-3)+SX, 2-(chloromethyl)-5-(4-fluorobenzyl)-2-methyl-1-(1H-1,2, 4-Triazol-1-ylmethyl)cyclopentan-1-ol (1394057-13-6)+SX, (1R, 2S, 5S)-2-(chloromethyl)-5-(4-fluoro Benzyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol (1801930-08-4)+SX, (1S, 2R , 5R)-2-(chloromethyl)-5-(4-fluorobenzyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentane -1-ol(1801930-09-5)+SX, methyl 3-[(4-chlorophenyl)methyl]-2-hydroxy-1-methyl-2-(1H-1,2,4- Triazol-1-ylmethyl)cyclopentane-1-carboxylate (1791398-02-1)+SX, 1-(2,4-difluorophenyl)-2-(1H-1,2, 4-Triazol-1-yl)-1-[1-(4-bromo-2,6-difluorophenoxy)cyclopropyl]ethanol (2019215-86-0)+SX, 1-(2, 4-Difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)-1-[1-(4-chloro-2,6-difluorophenoxy)cyclopropyl ]Ethanol (2019215 -84-8)+SX, 1-[2-(1-chlorocyclopropyl)-3-(2-fluorophenyl)-2-hydroxypropyl]-1H-imidazole-5-carbonitrile (2018316-13 -5)+SX, 1-[2-(1-chlorocyclopropyl)-3-(2,3-difluorophenyl)-2-hydroxypropyl]-1H-imidazole-5- Nitrile (2018317- 25-2)+SX, 2-[6-(4-bromophenoxy)-2-(trifluoromethyl)pyridin-3-yl]-1-(1H-1,2,4 -Triazol-1-yl)propan-2-ol (2082661-43-4)+SX, 2-[6-(4-chlorophenoxy)-2-(trifluoromethyl)pyridin-3-yl ]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol (2082660-27-1)+SX, methyl ({2-methyl-5-[1-( 4-Methoxy-2-methylphenyl)-1H-pyrazol-3-yl]phenyl}methyl)carbamate (1605879-98-8)+SX, 2-(difluoromethyl )-N-[1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]pyridine-3-methamide (1616239-21-4)+SX, 2-( Difluoromethyl)-N-[3-ethyl-1,1-dimethyl-2,3-dihydro-1H-inden-4-yl]pyridine-3-methamide (1847460-02-9 )+SX, 2-(difluoromethyl)-N-[3-propyl-1,1-dimethyl-2,3-dihydro-1H-inden-4-yl]pyridine-3-methane Amine (1847460- 05-2)+SX, (2E,3Z)-5-{[1-(4-chlorophenyl)-1H-pyrazol-3-yl]oxy}-2-(methoxy Imino)-N,3-dimethylpent-3-enamide (1445331-27-0)+SX, (2E,3Z)-5-{[1-(2,4-dichlorophenyl )-1H-pyrazol-3-yl]oxy}-2-(methoxyimino)-N,3-dimethylpent-3-enamide (1445331-54-3)+SX, 5-Chloro-4-({2-[6-(4-chlorophenoxy)pyridin-3-yl]ethyl}amino)-6-methylpyrimidine (1605340-92-8)+SX, N -(1-benzyl-1,3-dimethylbutyl)-8-fluoroquinoline-3-carboxamide (2132414-04-9)+SX, N-(1-benzyl-3,3 ,3-trifluoro-1-methylpropyl)-8-fluoroquinoline-3-methamide (2132414-00-5)+SX, 4,4-dimethyl-2-({4-[ 5-(Trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)isoxazolidin-3-one (2098918-25-1)+SX, 5,5 -Dimethyl-2-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)isoxazolidin-3-one ( 2098918-26- 2)+SX, N-ethyl-2-methyl-N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzene methyl)propylamine+SX, N,2-dimethoxy-N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl] Phenyl}methyl)propanamide+SX, N-methoxy-N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}Methyl)cyclopropanemethamide+SX, N-methoxy-N'-methyl-N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazole- 3-yl]phenyl}methyl)urea+SX, N'-ethyl-N-methoxy-N-({4-[5-(trifluoromethyl)-1,2,4-oxadis Azol-3-yl]phenyl}methyl)urea+SX, N,N'-dimethoxy-N-({4-[5-(trifluoromethyl)-1,2,4-oxadis Azol-3-yl]phenyl}methyl)urea+SX, N-acetyl-2-(ethylsulfonyl)-N-[2-(methoxycarbonyl)-4-(trifluoromethoxy )phenyl]-4-(trifluoromethyl)benzamide (2043675-28-9)+SX,3-(4-Bromo-7-fluoroindol-1-yl)butan-2-yl N-[(3-hydroxy-4-methoxypyridin-2-yl)carbonyl]-L-alanine ester+ SX, 3-(7-bromoindol-1-yl)but-2-yl N-[(3-hydroxy-4-methoxypyridin-2-yl)carbonyl]-L-alanine ester + SX, 3-(7-Bromo-4-fluoroindol-1-yl)butan-2-yl N-[(3-hydroxy-4-methoxypyridin-2-yl)carbonyl]-L-alanine+ SX, 3-(3,5-dichloropyridin-2-yl)butan-2-yl N-[(3-hydroxy-4-methoxypyridin-2-yl)carbonyl]-L-alanine ester+ SX, 3-(3,5-dichloropyridin-2-yl)butan-2-yl N-{[3-(acetyloxymethoxy)-4-methoxypyridin-2-yl]carbonyl}-L-Alanine ester+SX, (1S)-1-[1-(naphth-1-yl)cyclopropyl]ethyl N-[(3-hydroxy-4-methoxypyridin-2-yl) )carbonyl]-L-alanine+SX, (1S)-1-[1-(naphthyl-1-yl)cyclopropyl]ethyl N-[(3-ethyloxy-4-methoxy) Pyridin-2-yl)carbonyl]-L-alanine+SX, (1S)-1-[1-(naphth-1-yl)cyclopropyl]ethyl N-{[3-(ethyloxy) Methoxy)-4-methoxypyridin-2-yl]carbonyl}-L-alanine+SX, N-({4-[5-(trifluoromethyl)-1,2,4-ox Diazol-3-yl]phenyl}methyl)cyclopropanecarboxamide + SX, N-allyl-N-({4-[5-(trifluoromethyl)-1,2,4-ox Diazol-3-yl]phenyl}methyl)acetamide+SX, N-allyl-N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazole -3-yl]phenyl}methyl)propanamide+SX, N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl} Methyl)propylamide+SX, 3,3,3-trifluoro-N-({2-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazole-3- base]phenyl}methyl)propanamide+SX, 3,3,3-trifluoro-N-({3-fluoro-4-[5-(trifluoromethyl)-1,2,4-ox Diazol-3-yl]phenyl}methyl)propanamide+SX, 3,3,3-trifluoro-N-({2,3-difluoro-4-[5-(trifluoromethyl)) -1,2,4-oxadiazol-3-yl]phenyl}methyl)propanamide+SX, N-({2,3-difluoro-4-[5-(trifluoromethyl)- 1,2,4-oxadiazol-3-yl]phenyl}methyl)butanamide+SX, N-methoxy-N-methyl-N'-({4-[5-(trifluoro Methyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)urea+SX, N,N-diethyl-N'-({4-[5-(trifluoromethyl base)-1,2,4-oxadiazol-3-yl]phenyl}methyl)urea+SX, N-methyl-N'-({4-[5-(trifluoromethyl)-1 ,2,4-oxadiazol-3-yl]phenyl}methyl)urea+SX, 1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazole-3 -yl]phenyl}methyl)pyrrolidin-2-one+SX, 1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}Methyl)piperidin-2-one+SX, 4-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)? Phin-3-one+SX, 2-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)isoxazolidine-3 -Ketone+SX, 3,3-dimethyl-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)piper Din-2-one+SX, 2-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)-1,2-oxa Azinan-3-one+SX, 1-({3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl) acridine -2-one+SX, 4,4-dimethyl-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl )pyrrolidin-2-one+SX, 5-methyl-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl )pyrrolidin-2-one+SX, ethyl 1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)-1H -Pyrazole-4-carboxylate+SX, N-methyl-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl} Methyl)-1H-pyrazole-4-carboxamide+SX, N-propyl-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazole-3- [base]phenyl}methyl)-1H-pyrazole-4-carboxamide+SX, N-methoxy-1-({4-[5-(trifluoromethyl)-1,2,4- Oxadiazol-3-yl]phenyl}methyl)-1H-pyrazole-4-carboxamide+SX, N-methoxy-N-methyl-1-({4-[5-(tri Fluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)-1H-pyrazole-4-carboxamide+SX, N,N-dimethyl-1-( {4-[5-(Trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)-1H-1,2,4-triazol-3-amine+SX , N-Methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide+SX, Methyl 2-[2-chloro-4- (4-Chlorophenoxy)phenyl]-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propionate+SX, ethyl 2-[2-chloro-4 -(4-chlorophenoxy)phenyl]-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propionate+SX, methyl 2-[2-(tri Fluoromethyl)-4-(4-chlorophenoxy)phenyl]-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propionate+SX, 1-( 2,3-dimethylpyridin-5-yl)-4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinoline+SX, 1-[2-(difluoromethyl base)-3-methylpyridin-5-yl]-4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinoline+SX, 2,2-difluoro-N- [6-({[1-(1-methyl-1H-tetrazol-5-yl)benzimidazol-2-yl]oxy}methyl)pyridin-2-yl]-2-phenoxyethane Amide+SX, 1-[2-(1-chlorocyclopropyl)-3-(3-chloro-2-fluorophenyl)-2-hydroxypropyl]-1H-imidazole-5-carbonitrile+SX, Ethyl 1-[(4-{[2-(trifluoromethyl)-1,3-dioxolane-2-yl]methoxy}phenyl)methyl]-1H-pyrazole-4- Carboxylate + SX, ethyl 1-[(4-{[(1Z)-2-ethoxy-3,3,3-trifluoro-1-propen-1-yl]oxy}phenyl)methyl base]-1H-pyrazole-4-carboxylate+SX, 6-chloro-3-(3-cyclopropyl-2-fluorophenoxy)-N-[2-(2,4-dimethyl Phenyl)-2,2-difluoroethyl]-5-methylpyridazine-4-methamide+SX, 6-chloro-3-(3-cyclopropyl-2-fluorophenoxy)- N-[2-(3,4-dimethylphenyl)-2,2-difluoroethyl]-5-methylpyridazine-4-methamide+SX, 6-chloro-N-[2 -(2-Chloro-4-methylphenyl)-2,2-difluoroethyl]-3-(3-cyclopropyl-2-fluorophenoxy)-5-methylpyridazine-4- Formamide+SX, 2-[cyano(2,6-difluoropyridin-4-yl)amino]-N-(2,2-dimethylcyclobutyl)-5-methylthiazole-4 -Formamide+SX, 2-[cyano(2,6-difluoropyridin-4-yl)amino]-N-(spiro[3.4]oct-1-yl)-5-methylthiazole-4 -Formamide+SX,2-[cyano(2,6-difluoropyridin-4-yl)amino]-N-hexyl-5-methylthiazole-4-formamide+SX,2-[ Acetyl(2,6-difluoropyridin-4-yl)amino]-N-(2,2-dimethylcyclobutyl)-5-methylthiazole-4-carboxamide+SX, 2 -[(2-Methoxyethyl) (2,6-difluoropyridin-4-yl)amino]-N-(2,2-dimethylcyclobutyl)-5-methylthiazole- 4-Formamide+SX, 2-[(2-methylpropyl)(2,6-difluoropyridin-4-yl)amino]-N-(2,2-dimethylcyclobutyl )-5-methylthiazole-4-carboxamide+SX, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[1-(2 -Fluorophenyl)ethyl]pyrimidin-2-amine+SX, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[1-(2 ,6-Difluorophenyl)ethyl]pyrimidin-2-amine+SX, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[1 -(3,5-Difluorophenyl)ethyl]pyrimidin-2-amine+SX, 5-[5-(difluorophenyl)-1,3,4-oxadiazol-2-yl]-N -[1-(6-chloropyridin-3-yl)ethyl]pyrimidin-2-amine+SX, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl ]-N-[1-(2-fluorophenyl)cyclopropyl]pyrimidin-2-amine+SX, 5-[5-(difluoromethyl)-1,3,4-oxadiazole-2- base]-N-[1-(2,6-difluorophenyl)cyclopropyl]pyrimidin-2-amine+SX, 5-[5-(difluoromethyl)-1,3,4-oxadis Azol-2-yl]-N-[1-(2-fluoro-3-methoxyphenyl)cyclopropyl]pyrimidin-2-amine+SX, 5-[5-(difluoromethyl)-1 ,3,4-oxadiazol-2-yl]-2-{[1-(2,6-difluorophenyl)cyclopropyl]oxy}pyrimidine+SX, 3-[3-(3-cyclo Propyl-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-[(2,4-dimethylphenyl)methyl]-5,6-dihydro-4H- 1,2,4-oxadiazine+SX, (5S)-3-[3-(3-cyclopropyl-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5- [(2,4-dimethylphenyl)methyl]-5,6-dihydro-4H-1,2,4-oxadiazine+SX, 3-[3-(3-chloro-2-fluoro Phenoxy)-6-methylpyridazin-4-yl]-5-[(4-bromo-2-methylphenyl)methyl]-5,6-dihydro-4H-1,2,4 -oxadiazine+SX, 3-[3-(3-chloro-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-[(2-chloro-4-methylbenzene base)methyl]-5,6-dihydro-4H-1,2,4-oxadiazine+SX, (5S)-3-[3-(3-chloro-2-fluorophenoxy)-6 -Methylpyridazin-4-yl]-5-[(2-chloro-4-methylphenyl)methyl]-5,6-dihydro-4H-1,2,4-oxadiazine+SX , (5R)-3-[3-(3-chloro-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-[(2-chloro-4-methylphenyl) Methyl]-5,6-dihydro-4H-1,2,4-oxadiazine+SX, Agrobacterium radiobactor strain K1026+SX, Agrobacterium radiobactor strain K84+ SX, liquefied amylosporus Bacillus amyloliquefaciens strain PTA-4838 (Aveo (trademark) EZ Nematicide)+SX, Bacillus amyloliquefaciens strain AT332+SX, Bacillus amyloliquefaciens strain B3+SX, Bacillus amyloliquefaciens strain D747+SX, liquefied starch Bacillus amyloides strain DB101+SX, Bacillus amyloliquefaciens strain DB102+SX, Bacillus amyloliquefaciens strain GB03+SX, Bacillus amyloliquefaciens strain FZB24+SX, Bacillus amyloliquefaciens strain FZB42+SX, Bacillus amyloliquefaciens strain IN937a+ SX , Bacillus amyloliquefaciens strain MBI600 +SX, Bacillus amyloliquefaciens strain QST713+SX, Bacillus amyloliquefaciens isolate strain B246+SX, Bacillus amyloliquefaciens strain F727+SX, Bacillus amyloliquefaciens subsp. plantarum strain (Bacillus amyloliquefaciens subsp. plantarum strain) D747+SX, Bacillus licheniformis strain (Bacillus licheniformis strain) HB-2+SX, Bacillus licheniformis strain SB3086+SX, Bacillus pumilus strain (Bacillus pumilus strain) AQ717+SX, Bacillus pumilus strain BUF-33+SX, Bacillus pumilus strain GB34+SX, Bacillus pumilus strain QST2808 +SX,Bacillus simplex strain CGF2856 +SX, Bacillus subtilis strain AQ153+SX, Bacillus subtilis strain AQ743+SX, Bacillus subtilis strain BU1814+SX, Bacillus subtilis strain D747+SX, Bacillus subtilis strain DB101 +SX, Bacillus subtilis strain FZB24+SX, Bacillus subtilis strain GB03+SX, Bacillus subtilis strain HAI0404+SX, Bacillus subtilis strain IAB / BS03+SX, Bacillus subtilis strain MBI600+SX, Bacillus subtilis strain QST30002 / AQ30002 +SX, Bacillus subtilis strain Bacillus strain QST30004 / AQ30004+SX, Bacillus subtilis strain QST713+SX, Bacillus subtilis strain QST714+SX, Bacillus subtilis var. Amyloliquefaciens strain FZB24+SX, Bacillus subtilis strain Y1336+SX, Bacillus cepacia Burkholderia cepacian+SX, Burkholderia cepacia type Wisconsin strain J82+SX, Burkholderia cepacia type Wisconsin strain M54+SX, Candida oleophila strain O +SX, Candida saitoana+SX, Chaetomium cupreum +SX, Clonostachys rosea+SX, Coniothyrium minitans strain CGMCC8325+ SX, shield mold strain CON / M / 91-8+SX, cryptococcus albidus +SX, Erwinia carotovora subsp. carotovora strain CGE234M403 +SX , Fusarium oxysporum strain Fo47+SX, Gliocladium catenulatum strain J1446+SX, Paenibacillus polymyxa strain AC-1+SX, Paenibacillus polymyxa Strain BS-0105+SX, Pantoea agglomerans strain E325+SX, Phlebiopsis gigantea strain VRA1992+SX, Pseudomonas aureofaciens strain TX-1 +SX, Pseudomonas chlororaphis strain 63-28+SX, Pseudomonas chlororaphis strain AFS009+SX, Pseudomonas chlororaphis strain MA342+SX, Pseudomonas fluorescens strain)1629RS +SX, Pseudomonas fluorescens strain A506+SX, Pseudomonas fluorescens strain CL145A+SX, Pseudomonas fluorescens strain G7090+SX, Pseudomonas sp. Strain CAB-02 +SX, Pseudomonas syringae strain 742RS+SX, Pseudomonas syringae strain MA-4+SX, Pseudozyma flocculosa strain PF-A22UL+SX, Roche Pseudomonas rhodesiae strain HAI-0804+SX, Pythium oligandrum strain DV74+SX, Pythium oligandrum strain M1+SX, Streptomyces griseoviridis strain K61 +SX, Streptomyces lydicus strain WYCD108US+SX, Streptomyces lydicus strain WYEC108+SX, Talaromyces flavus strain SAY-Y-94-01+SX, Talaromyces flavus strain Strain V117b+ SX, Trichoderma asperellum strain ICC012+SX, Trichoderma asperellum SKT-1+SX, Trichoderma asperellum strain T25+SX, Trichoderma asperellum strain T34+SX, Trichoderma atroviride strain TV1+SX, Trichoderma atroviride strain CNCM 1-1237+SX, Trichoderma atroviride strain LC52+SX, Trichoderma atroviride strain IMI 206040+SX, Trichoderma atroviride strain SC1+ SX, Trichoderma harzana strain SKT-1+SX, Trichoderma harzianum strain T11+SX, Trichoderma gamsii strain ICC080+SX, Trichoderma harzianum strain 21+ SX, Trichoderma harvei strain DB104+SX, Trichoderma harvei strain DSM 14944+SX, Trichoderma harvei strain ESALQ-1303+SX, Trichoderma harvei strain ESALQ-1306+SX, Trichoderma harvei strain IIHR- Th -2+SX, Trichoderma harveyi strain ITEM908+SX, Trichoderma harveyi strain kd+SX, Trichoderma harveyi strain MO1+SX, Trichoderma harveyi strain SF+SX, Trichoderma harveyi strain T22 +SX , Trichoderma harveyi strain T39+SX, Trichoderma harveyi strain T78+ SX, Trichoderma harveyi strain TH35+SX, Trichoderma polysporum strain IMI206039+SX, Trichoderma stromaticum + SX, Trichoderma virens strain G-41+ SX, Trichoderma viride strain GL-21+SX, Trichoderma viride+SX, Variovorax paradoxus strain CGF4526+ SX, Harpin protein + SX. ,

[0041] The combination of the component of the above-mentioned group (c) and the compound of the present invention: 1-methylcyclopropene (1-metylcyclopropene)+SX, 1,3-diphenylurea (1,3-diphenylurea)+SX, 2,3,5-triiodobenzoic acid (2,3,5-triiodobenzoic acid)+SX, IAA ((1H-indol-3-yl)acetic acid)+SX, IBA (4-(1H-indol- 3-yl)butyric acid)+SX, MCPA (2-(4-chloro-2-methylphenoxy)acetic acid)+SX, MCPB (4-(4-chloro-2-methylphenoxy)butanic acid) acid)+SX, 4-CPA (4-chlorophenoxyacetic acid)+SX, 5-aminoacetyl propionate hydrochloride (5-aminolevulinic acid hydrochloride)+SX, 6-benzylaminopurine (6 -benzylaminopurine)+SX, abscisic acid+SX, aminoethoxyvinylglycine+SX, anisiflupurin+SX, ancymidol+SX, butralin+SX, calcium carbonate+SX, calcium chloride+SX, calcium formate+SX, calcium peroxide+SX, calcium polysulfide (calcium polysulfide)+SX, calcium sulfate(calcium sulfate)+SX, chlormequat-chloride+SX, chlorpropham+SX, choline chloride(choline chloride)+SX, fruit acid( cloprop)+SX, cyanamide+SX, cyclanilide+SX, daminozide+SX, decan-1-ol+SX, dichlorprop (dichlorprop)+SX, dikegulac+SX, dimethipin+SX, diquat+SX, ethephon+SX, ethychlozate +SX, flumetralin +SX, flurprimidol +SX, forchlorfenuron +SX, formononetin +SX, Gibberellin A +SX , Gibberellin A3+SX, inabenfide+SX, Kinetin+SX, lipochitin oligosaccharide SP104+SX, maleic hydrazide+SX , mefluidide + SX, mepiquat-chloride + SX, oxidized glutathione + SX, paclobutrazol + SX, pendimethalin + SX, Prohexadione-calcium +SX, prohydrojasmon +SX, pyraflufen-ethyl +SX, sintofen +SX, sodium 1-naphthalene acetate 1 -naphthaleneacetate)+SX, sodium cyanate +SX, thidiazuron+SX, triapenthenol+SX, tribufos+SX, trinexapac- ethyl)+SX, uniconazole-P+SX, 2-(naphthyl-1-yl)acetamide (2-(naphthyl-1-yl)acetamide)+SX, [4-side oxygen Base-4-(2-phenylethyl)amino]butyric acid+SX, 5-(trifluoromethyl)benzo[b]thiophene-2-carboxylic acid methyl+SX, 3-[(6-chloro - 4-Phenylquinazolin-2-yl)amino]propan-1-ol+SX, Claroideoglomus etunicatum+SX, Claroideoglomus claroideum+SX, Moses stem Funneliformis mosseae + SX, Gigaspora margarita + SX, Gigaspora rosea + SX, Glomus aggregatum + SX, Glomus deserticola )+SX, Glomus monosporum+SX, Paraglomus brasillianum+SX, Rhizophagus clarus+SX, RTI-801 ( Rhizophagus intraradices RTI-801)+SX, Rhizophagus irregularis DAOM 197198+SX, Azorhizobium caulinodans+SX, Azospirillum amazonense +SX, Brazilian nitrogen fixation Spirillella Azospirillum irakense+SX, Azospirillum lipoferum+SX, Bradyrhizobium elkanii SEMIA 587 (Bradyrhizobium elkanii SEMIA 587)+SX, Bradyrhizobium elkanii SEMIA 587 SEMIA 5019 (Bradyrhizobium elkanii SEMIA 5019) + SX, Bradyrhizobium japonicum TA-11 (Bradyrhizobium japonicum TA-11) + SX, Bradyrhizobium japonicum USDA 110 (Bradyrhizobium japonicum USDA 110) + SX, Bradyrhizobium japonicum USDA 110 + SX, Bradyrhizobium japonicum USDA 110 Bradyrhizobium liaoningense+SX, Bradyrhizobium lupini+SX, Delftia acidovorans RAY209+SX, Mesorhizobium cicero+SX, Huagui Mesorhizobium huakii+SX, Mesorhizobium loti+SX, etli Rhizobium (Rhizobium etli)+SX, galegae Rhizobium (Rhizobium galegae)+SX, Rhizobium leguminosarum ) bv. Phaseoli+SX, Rhizobium leguminosarum bv. Trifolii+SX, Rhizobium leguminosarum bv. Viciae+SX, Rhizobium trifolii+SX, tropic Rhizobium (Rhizobium tropici)+SX, Sinorhizobium fredii+SX, Sinorhizobium meliloti+SX, Zucchini Yellow Mosaik Virus weak strain+SX.

[0042] The combination of the component of the above group (d) and the compound of the present invention: anthraquinone + SX, deet (deet) + SX, icaridin (icaridin) + SX.

[0043] Although the ratio of the compound of the present invention to the component is not particularly limited, for example, the weight ratio (compound of the present invention: component) is 1000:1~1:1000, 500:1~1:500, 100: 1~1:100, 50:1, 20:1, 10:1, 9:1, 8:1, 7:1, 6:1, 5:1, 4:1, 3:1, 2:1, 1:1, 1:2, 1:3, 1:4, 1:5, 1:6, 1:7, 1:8, 1:9, 1:10, 1:20, 1:50, etc.

[0044] The present compound or the compound of the present invention, for harmful arthropods (in this specification, Marked as resistant harmful arthropods), harmful molluscs and harmful nematodes show efficacy. Examples of the insecticide, the acaricide, the molluscicide and the nematicide include group a1 to group a26. Group a1: Acetylcholinesterase inhibitors are group 1A carbamate compounds and group 1B organophosphorus compounds classified according to the role of IRAC, such as alanycarb, aldicarb, bentiocarb, benfuracarb, butocarboxim, butoxycarboxim, carbaryl: NAC, carbofuran, butylcarboxim carbosulfan), ethiofencarb, fenobucarb (BPMC), formetanate, furathiocarb, isoprocarb (MIPC), methiocarb, sodium Methomyl, methoxychlor, metolcarb, oxamyl, pirimicarb, promecarb, propoxur (PHC), sulfur Thiodicarb, thiofanox, triazamate, trimethacarb, xylylcarb; acephate, azamethiphos, ethyl Azinphos-ethyl, azinphos-methyl, cadusafos, chlorethoxyfos, chlorfenvinphos, chlormephos, chlorpyrifos, Chlorpyrifos-methyl, coumaphos, cyanophos (CYAP), demeton, demeton-S-methyl, cyanophos (diazinon), dichlorvos: DDVP, dicrotophos, dimethoate, dimethylvinphos, disulfoton, EPN, ethion, Ethoprophos, famphur, fenamiphos, fenchlorphos, fenitrothion: MEP, fenthion: MPP, fosthiazate ), heptenophos, imicyafos, isofenphos, isopropyl-O-(methoxyaminothiophosphoryl) salicylate), isoxathion, malathion, mecarbam, methamidophos, methidathion (DMTP), mevinphos, monocrotophos, etc. Naled: BRP, omethoate, oxydemeton-methyl, parathion, parathion-methyl, phenthoate: PAP , phorate, phosalone, phosmet (PMP), phosphamidon, phoxim, pirimiphos-methyl, phosphatide ( profenofos), propetamphos, prothiofos, pyraclofos, pyrazophos, pyridaphenthion, quinalphos, sulfotep, sulfur Sulprofos, tebupirimfos, temephos, terbufos, tetrachlorvinphos, thiometon, toxaphene, trepanate A group consisting of triazophos, trichlorfon (DEP) and vamidothion. Group a2: GABA-activated chloride channel blockers are group 2A cyclic diene organochlorines and group 2B phenylpyrazole compounds classified according to the role of IRAC, such as chlordane, The group consisting of endosulfan, dieldrin, ethiprole, fipronil, flufiprole and pyriprole. Group a3: Sodium channel modulators are group 3A pyrethroids and group 3B compounds classified according to the role of IRAC, for example, acrinathrin, allethrin, bifenthrin ), kappa-bifenthrin, bioallethrin, bioresmethrin, cycloprothrin, cyfluthrin, beta- cyfluthrin), cyhalothrin, gamma-cyhalothrin, lambda-cyhalothrin, cypermethrin, alpha-cypermethrin, β-cypermethrin Beta-cypermethrin, theta-cypermethrin, zeta-cypermethrin, sigma-cypermethrin, cyphenothrin, cypermethrin deltamethrin, empenthrin, esfenvalerate, etofenprox, fenpropathrin, fenvalerate, flucythrinate, fenvalerate flumethrin), fluvalinate, tau-fluvalinate, halfenprox, heptafluthrin, imiprothrin, kadethrin , meperfluthrin, momfluorothrin, permethrin, phenothrin, prallethrin, pyrethrins, resmethrin , silafluofen, tefluthrin, kappa-tefluthrin, tetramethrin, tetramethylfluthrin, tralomethrin, ginseng transfluthrin, benfluthrin, flufenoprox, flumethrin, furamethrin, metofluthrin, profluthrin ), a group consisting of dimefluthrin and DDT. Group a4: Competitive modulators of nicotinic acetylcholine receptors classified according to the action of IRAC: 4A neonicotinoids (neonicotinoids), 4B nicotine, 4C sulfonimine, 4D crotonide Esters and 4E neutral ions, for example, acetamiprid, clothianidin, dinotefuran, imidacloprid, nitenpyram, sagope ( thiacloprid), thiamethoxam, flupyradifurone, sulfoxaflor, cycloxaprid, triflumezopyrim, dichloromezotiaz and flurbifen The group formed. Group a5: nicotinic acetylcholine receptor ectopic modulators Group 5 spinosyns classified according to the action of IRAC, such as spinosad and spinetoram The group formed. Group a6: Glutamic acid-gated chloride channel ectopic modulators are classified according to the role of IRAC in group 6 abatin series and milbemycin series, for example, abamectin, emamectin -benzoate), lepimectin, milbemectin, dimadectin, doramectin, eprinomectin, ivermectin ), latidectin, selamectin, milbemycin D, moxidectin and nemadectin. Group a7: Youth hormone analogues classified according to their action by IRAC: Group 7A youth hormone analogues, Group 7B Fennox and 7C Prefenac, for example, hydroprene, methoprene The group consisting of (kinoprene), metoprene, fenoxycarb and pyriproxyfen. Group a8: Tuner TRPV channel modulators Group 9 pyridine imine derivatives classified according to the role of IRAC, such as Pymetrozine and Pyrifluquinazon.Group a9: Insect midgut lining-destroying agents derived from microorganisms classified according to the action of IRAC Group 11A Bacillus thuringiensis, Group 11B Bacillus sphaericus, for example, Bacillus sphaericus), Bacillus thuringiensis strain BD#32, Bacillus thuringiensis strain AQ52, acillus thuringiensis subsp. Aizawai strain ABTS - 1857), Bacillus thuringiensis subsp. kurstaki strain HD-1, Bacillus thuringiensis subsp. kurstaki strain BMP123, Bacillus thuringiensis subsp. kurstaki strain BMP123, Bacillus thuringiensis subsp. kurstaki strain BMP123 Bacillus thuringiensis subsp. Tenebriosis strain NB176, Bacillus thuringiensis var. israelensis, Bacillus thuringiensis var. aegypti, Bacillus thuringiensis var. aegypti, Bacillus thuringiensis var. (Bacillus thuringiensis var. colmeri), Bacillus thuringiensis var. darmstadiensis, Bacillus thuringiensis var. dendrolimus, Bacillus thuringiensis var. dendrolimus, Bacillus thuringiensis var. dendrolimus var. galleriae), Bacillus thuringiensis var. japonensis, Bacillus thuringiensis subsp. morrisoni, Bacillus thuringiensis var. san diego, Bacillus thuringiensis subsp. Thuringiensis strain MPPL002, Bacillus thuringiensis var. 7216, Bacillus thuringiensis var. T36, Bacillus thuringiensis var. δ-endotoxins that are resistant to insects (for example, Cry1A, Cry1Ab, modified Cry1Ab (Cry1Ab with a partial deletion), Cry1Ac, Cry1Ab-Ac (hybrid protein fused to Cry1Ab and Cry1Ac), Cry1C, Cry1F, Cry1Fa2 ( Modified cry1F), moCry1F (modified Cry1F), Cry1A.105 (hybrid protein fused from Cry1Ab, Cry1Ac, Cry1F), Cry2Ab2, Cry2Ae, Cry9C, Vip3A, Vip3Aa20), which confer resistance to Coleopteran insects A group consisting of δ-endotoxins (such as Cry3A, mCry3A (modified Cry3A), Cry3Bb1, Cry34Ab1, Cry35Ab1), and δ-endotoxins (such as Cry1A, Cry4A, Cry4B, Cry11A) with insecticidal activity against Culicidae Group. Group a10: Oxidative phosphorylation unlinkers that interfere with proton gradients Group 13 compounds classified according to their effects on IRAC, for example, the group consisting of chlorfenapyr and sulfluramid. Group a11: Nicotinic acetylcholine receptor channel blockers Group 14 Nereitoxin analogues classified according to the action of IRAC, for example, bensultap, cartap, bedan hydrochloride The group consisting of (cartap hydrochloride), thiocyclam, thiosultap-disodium, and thiosultap-monosodium. Group a12: Chitin biosynthesis inhibitors of group 15 benzyl urea and group 16 bufungin classified according to the action of IRAC, for example, bistrifluron, chlorfluazuron, chlorfluazuron diflubenzuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron, defulon The group consisting of teflubenzuron, triflumuron and buprofezin. Group a13: Sloughing Inhibitors Group 17 compounds classified according to their action by IRAC, for example, the group consisting of Cyromazine. Group a14: Ecdysone (ecdysone) receptor agonists are group 18 dihydroxyhydramines classified according to their action by IRAC, for example, chromafenozide, halofenozide, methoxyphene The group consisting of methoxyfenozide and tebufenozide. Group a15: Potential-dependent sodium channel blockers are group 22A oxadiazine and group 22B semicarbazone based on the action classification of IRAC, for example, indoxacarb and flumeflufenamid ( metaflumizone) group. Group a16: Acetyl CoA carboxylase inhibitors group 23 classified according to the action of IRAC Tetronic acid, tetramine derivatives, such as spirodiclofen, spiromesifen ) and the group formed by spiritotetramat. Group a17: Group 28 diamide series of fish nicotine receptor modulators classified according to the role of IRAC, for example, chlorantraniliprole, cyantraniliprole, cycloniliprole , a group consisting of flubendiamide, tetraniliprole, cyhalodiamide and tetrachlorantraniliprole. Group a18: Tuner modulators Group 29 compounds classified according to their effects by IRAC, for example, the group consisting of flonicamid. Group a19: Mite Growth Inhibitors Group 10 compounds classified according to their effects by IRAC, for example, the group consisting of etoxozole, clofentezine, and hexythiazox. Group a20: Octopamine receptor agonists Group 19 compounds classified according to their effects on IRAC, for example, the group consisting of amitraz. Group a21: Mitochondrial electron transport system complex IV inhibitors Group 24 compounds classified according to the action of IRAC, for example, a group consisting of phosphine. Group a22: a group of isoxazoline compounds, such as afoxolaner, fluralaner, sarolaner, and lotilaner. Group a23: Mitochondrial ATP synthesis enzyme inhibitors Group 12 compounds classified according to their effects on IRAC, for example, the group consisting of diafenthiuron. Group a24: Mitochondrial electron transport system complex III inhibitors Group 20 compounds classified according to their effects on IRAC, for example, the group consisting of acequinocyl and bifenazate. Group a25: Mitochondrial electron transport complex I inhibitors (METI) Group 21 compounds classified according to their effects on IRAC, for example, the group consisting of pyridaben and fenpyroximate. Group a26: the group consisting of azadiractin and pyridalyl.

[0045] As the main factors that reduce sensitivity, examples include [1] amino acid substitution of target protein, [2] reduction of target protein, [3] metabolic enhancement, [4] reduction of skin permeability, [ 5] Increased excretion function caused by membrane transport proteins. In [1], the target protein can have one or multiple amino acid substitutions. The so-called metabolic enhancement in [3] means, for example, metabolic enzymes called cytochrome P450 (cytochrome P450), carboxylesterase (carboxylesterase), and glutathion-S-transferase (also known as The activity of detoxifying enzymes is increased. In addition, the main factors for reducing sensitivity include [1] amino acid substitution of the target protein, [2] reduction of the target protein, [3] metabolic enhancement, [4] reduction of skin permeability, [5] ] Any one or more of the enhancement of excretion function caused by membrane transport proteins.

[0046] Examples of harmful arthropods, harmful molluscs, and harmful nematodes such as harmful insects and harmful mites with reduced sensitivity are as follows. Hemiptera with reduced sensitivity to one or more compounds selected from group a2; Hemiptera with reduced sensitivity to one or more compounds selected from group a4; Hemiptera with reduced sensitivity to one or more compounds selected from group a8; Hemiptera with reduced sensitivity to one or more compounds selected from group a12; Hemiptera with reduced sensitivity to one or more compounds selected from group a12; Hemiptera with reduced sensitivity to one or more compounds selected from group a2 Hemiptera with reduced sensitivity to compounds and one or more compounds selected from group a4; to one or more compounds selected from group a2 and one or more compounds selected from group a8 Hemiptera with reduced sensitivity; Hemiptera with reduced sensitivity to more than one compound selected from group a2 and bufungin belonging to group a12; To one compound selected from group a4 Hemiptera with reduced sensitivity to the above compounds and one or more compounds selected from group a8; Sensitivity to one or more compounds selected from group a4 and bufungin belonging to group a12 Hemiptera with reduced susceptibility to one or more compounds selected from group a8 and to bufungin belonging to group a12; Hemiptera with reduced susceptibility to one or more compounds selected from group a2 , Hemiptera with reduced sensitivity to one or more compounds selected from group a4 and one or more compounds selected from group a8; To one or more compounds selected from group a2, select Hemiptera with reduced susceptibility to one or more compounds from group a4 and to bufungin belonging to group a12; To one or more compounds selected from group a2, to one or more compounds selected from group a8 Hemiptera with reduced sensitivity to more than one compound and to bufungin belonging to group a12; To more than one compound selected from group a4, to more than one compound selected from group a8 and Hemiptera with reduced susceptibility to bufungin belonging to group a12; to one or more compounds selected from group a2, to one or more compounds selected from group a4, to one or more compounds selected from group a8 Hemiptera with reduced susceptibility to more than one compound selected from group a12 and bufungin belonging to group a12; Hemiptera with reduced susceptibility to more than one compound selected from group a2; Rice lice with reduced susceptibility to one or more compounds in group a4; Rice lice with reduced susceptibility to one or more compounds selected from group a8; To 1 compound selected from group a12 Rice lice that have reduced sensitivity to the above compounds; Rice lice that have reduced sensitivity to one or more compounds selected from group a2 and one or more compounds selected from group a4; Rice lice with reduced susceptibility to one or more compounds in group a2 and bufenzin belonging to group a8; To one or more compounds selected from group a2 and bufungin belonging to group a12 Rice lice with reduced susceptibility; Rice lice with reduced susceptibility to more than one compound selected from group a4 and paclitaxel belonging to group a8; To 1 compound selected from group a4 Rice lice with reduced susceptibility to the above compounds and bufungin belonging to group a12; To more than one compound selected from group a2, to more than one compound selected from group a4 and belonging to group a12 Rice lice with reduced susceptibility to pyridoxin of group a8; to one or more compounds selected from group a2, one or more compounds selected from group a4 and bufungin belonging to group a12 Rice lice with reduced susceptibility; Rice lice with reduced susceptibility to one or more compounds selected from group a2, permethrin belonging to group a8 and bufungin belonging to group a12; Rice lice with reduced susceptibility to one or more compounds selected from group a4, permethrin belonging to group a8 and bufungin belonging to group a12; to one or more compounds selected from group a2 Compounds of the family Rice lice, one or more compounds selected from group a4, paclitaxel belonging to group a8 and bufungin belonging to group a12; to compounds selected from group a2 Nilaparvata lugens, Sogatella furcifera or Laodelphax striatellus with reduced sensitivity to one or more compounds; reduced sensitivity to one or more compounds selected from group a4 Brown planthopper, white-backed planthopper or spotted planthopper; Brown planthopper, white-backed planthopper or spotted planthopper with reduced sensitivity to one or more compounds selected from group a8; To one selected from group a12 Brown planthopper, white-backed planthopper or spotted planthopper with reduced susceptibility to more than one compound; sensitivity to one or more compounds selected from group a2, and one or more compounds selected from group a4 Brown planthoppers, white-backed planthoppers or spotted planthoppers; Brown planthoppers, white-backed planthoppers or spotted planthoppers with reduced susceptibility to one or more compounds selected from group a2 and paclitaxel belonging to group a8 ; Brown planthopper, white-backed planthopper or spotted planthopper with reduced sensitivity to one or more compounds selected from group a2 and bufungin belonging to group a12; To one or more compounds selected from group a4 Brown planthoppers, white-backed planthoppers or spotted planthoppers with reduced susceptibility to compounds and bufengin belonging to group a8; To more than one compound selected from group a4 and bufungin belonging to group a12 Brown planthoppers, white-backed planthoppers or spotted planthoppers with reduced susceptibility; To more than one compound selected from group a2, to more than one compound selected from group a4 and pyridine belonging to group a8 Brown planthoppers, white-backed planthoppers or spotted planthoppers with reduced susceptibility; to one or more compounds selected from group a2, one or more compounds selected from group a4 and ibufen belonging to group a12 Nilaparvata planthoppers, white-backed planthoppers or spotted planthoppers with reduced susceptibility; sensitive to one or more compounds selected from group a2, paclitaxel belonging to group a8 and bufungin belonging to group a12 Brown planthopper, white-backed planthopper or spotted planthopper with reduced sensitivity; reduced susceptibility to one or more compounds selected from group a4, permethrin belonging to group a8 and bufungin belonging to group a12 Brown planthopper, white-backed planthopper or spotted planthopper; to more than one compound selected from group a2, to more than one compound selected from group a4, to paclitaxel belonging to group a8 and to group a8 Brown planthoppers, white-backed planthoppers or spotted planthoppers with reduced susceptibility to bufungin of a12; Aphididae with reduced susceptibility to one or more compounds selected from group a3; For those selected from group a8 The family Aphididae has reduced sensitivity to one or more compounds selected from group a3; The family Aphididae has reduced sensitivity to one or more compounds selected from group a3 and one or more compounds selected from group a4; Aphididae with reduced sensitivity to one or more compounds selected from group a3 and one or more compounds selected from group a8; To one or more compounds selected from group a4 and selected Aphididae with reduced susceptibility to one or more compounds from group a8; to one or more compounds selected from group a3, one or more compounds selected from group a4, and one or more compounds selected from group a4 Aphidae with reduced susceptibility to one or more compounds in group a8; Myzus persicae with reduced susceptibility to one or more compounds selected from group a1; Myzus persicae with reduced susceptibility to one or more compounds selected from group a1; Cotton aphid (Aphis gossypii) or Myzus aphid with reduced sensitivity to one or more compounds selected from group a4; Cotton aphid or Myzus aphid with reduced sensitivity to one or more compounds selected from group a4; A cotton aphid or green peach aphid with reduced sensitivity to one or more compounds selected from group a8; A reduced sensitivity to one or more compounds selected from group a3 and one or more compounds selected from group a4 Cotton aphid or green peach aphid; Cotton aphid or green peach aphid with reduced sensitivity to one or more compounds selected from group a3 and one or more compounds selected from group a8; Cotton aphid or green peach aphid with reduced sensitivity to one or more compounds selected from group a4; cotton aphid or green leaf aphid with reduced sensitivity to one or more compounds selected from group a8 and one or more compounds selected from group a8; to one or more compounds selected from group a3, selected from group a4 Cotton aphid or green leaf aphid with reduced susceptibility to one or more compounds selected from group a8 and one or more compounds selected from group a8; Tobacco powder with reduced susceptibility to one or more compounds selected from group a3 Bemisia tabaci; tobacco whitefly with reduced sensitivity to one or more compounds selected from group a4; green peach aphid with reduced sensitivity to one or more compounds selected from group a1; Cotton aphids with reduced sensitivity to carbamate compounds selected from group a1 and / or organophosphorus compounds selected from group a1; to Marathon pine, Taos pine, Dali pine, butyl chloride, plus Baofu, Aidibai, Fenpunil, Fipronil, Efenin, Datnam, Yidamide, Nitenpyram, Susulfide, Segope, Sessoan, Pafenac and Brown planthoppers with reduced susceptibility to / or bufungin; White-backed planthoppers with reduced susceptibility to methamphetamine, taosin, idamid and / or bufungin; Two-spotted green leafhoppers (Amrasca biguttula biguttula) with reduced susceptibility to Segpyre, canidine and / or dartnam; Comparatively reduced susceptibility to plus and / or organophosphorus compounds selected from group a1 Cotton aphids; Myzus aphid with reduced sensitivity to Trimethon, Bigap, Endosulfan, Dimethonine, Lambda Xeronine, DDT and / or Iridamide; Compared to Bigap, Nanide, Sulfate Lettuce aphid (Nasonovia ribisnigri) with reduced susceptibility to pine, detriline and / or endosulfane; Sitobion avenae with reduced susceptibility to lambda xeronine; To those selected from group a4 Greenhouse whiteflies (Trialeurodes vaporariorum) with reduced susceptibility to more than one compound, bifenin and / or fenfenin; To pyronium, pine buphyrax, endosulfane, fenpronil, λxeronine, Tobacco mealybugs with reduced susceptibility to Bifenin, subfenin, Pedan, Bufungin, Cifenin, Trifenin, Trifenon and / or Azadirachtin; Citrus psyllid (Diaphorina citri) with reduced susceptibility to methionine, submethonium, idamid, cysosan, nitenpyram and / or clofenpyr; to suberin, damasone, and methionine Euschistus heros with reduced sensitivity to endosulfane, betasulfonine and / or idamid; Lepidoptera with reduced sensitivity to one or more compounds selected from group a14 ; Lepidoptera with reduced sensitivity to one or more compounds selected from group a15; Lepidoptera with reduced sensitivity to one or more compounds selected from group a17; Lepidoptera with reduced sensitivity to one or more compounds selected from group a17; Lepidoptera with reduced sensitivity to one or more compounds selected from group a14, and one or more compounds selected from group a17; Diamondbacks with reduced sensitivity to one or more compounds selected from group a15 Moth (Plutella xylostella); Diamondback moth with reduced sensitivity to one or more compounds selected from group a17; Rice leaf curler with reduced sensitivity to one or more compounds selected from group a14 Cnaphalocrocis medinalis; Rice leafroller with reduced sensitivity to one or more compounds selected from group a17; To one or more compounds selected from group a14, and selected from group a14 Heliothis virescens, which has reduced sensitivity to one or more compounds in group a17; Heliothis virescens, which has reduced sensitivity to one or more compounds selected from group a3; Helicoverpa armigera with reduced susceptibility to one or more compounds selected from group a9; Helicoverpa zea with reduced susceptibility to one or more compounds selected from group a9; Homona magnanima with reduced sensitivity to one or more compounds selected from group a14; Homona magnanima with reduced sensitivity to one or more compounds selected from group a17; Homona magnanima with reduced sensitivity to one or more compounds selected from group a17; Adoxophyes honmai with reduced sensitivity to one or more compounds in group a14; Adoxophyes honmai with reduced sensitivity to one or more compounds selected from group a17; selected from group a14 The tea leaf roller moth has reduced sensitivity to one or more compounds selected from group a17; The diamondback moth has reduced sensitivity to one or more compounds selected from group a3; Tomato locust moth (Tuta absoluta) with reduced susceptibility to one or more compounds selected from group a17; Stem borer (Tuta absoluta) with reduced susceptibility to endosulfane, fipronil and / or insecticides Chilo suppressalis); European millet borer (Ostrinia nubilalis) with reduced susceptibility to dimethonine and / or lambda xeronine; Sugarcane straw borer (Diatraea) with reduced susceptibility to Cry1Ab and / or Cry1Ac of delta-endotoxins saccharalis);Leucinodes orbonalis with reduced susceptibility to pine pine, garbaoli, taos pine, endosulfane, dimethonine and / or fenclid; Trinac, nanide, sulfonate, endosulfane, fenpronil, sulfenin, dimethonin, beta-sulfonin, sinosal, apatin, inmetin, lufenlong, Spodoptera litura with reduced susceptibility to difuron, methoxyfenac and / or index; to taosin, dimethonin, sulfenin, sinosal, apatin, immetin, lufenon, Spodoptera exigua with reduced susceptibility to Cry1Ab, Cry1Ac, Cry2Ab2, Cry2Ae and / or Cry1F of delta-endotoxins (Mamestra brassicae) ); parathionate, bufenac, subsulin, methylbarazon, sulfonate, nanide, toxaphene, endosulfane, sulfamethrin, dimethonine, DDT and / or Spodoptera exigua with reduced susceptibility to noclosin; Toasulin, taosin, bufeidin, nanide, thionic, toxaphene, endosulfane, phenyl, dimethonin, xymenin Spodoptera armigera with reduced susceptibility to , DDT, Index and / or Crombo; Spodoptera armigera with reduced susceptibility to methylbarazone, sulfamethonine, endosulfane and / or DDT; to lambda The codling moth (Cydia pomonella) with reduced susceptibility to Xeronine, Secopyr and / or Methofenox; The European grape moth (Lobesia botrana) with reduced susceptibility to Dimethonine and / or Index; Nanide, Diterin, Permethonin, Fenpunil, Sinoxa, Abatin, Inmetin, δ-endotoxin Cry1C, Lufenon, Indek, Ke'anbo, Fluoride and / or Diamondback moths with reduced susceptibility to Tyfenon; Trichoptera with reduced susceptibility to one or more compounds selected from group a2; Susceptible to one or more compounds selected from group a3 Totaloptera with reduced sensitivity to one or more compounds selected from group a4; Totaloptera with reduced sensitivity to one or more compounds selected from group a9 ; Thrips tabaci with reduced susceptibility to one or more compounds selected from group a17; Thrips tabaci with reduced susceptibility to one or more compounds selected from group a3; Onion thrips with reduced susceptibility to Buffy pine, Toss pine, dimethonine and / or lambda xeronine; Onion thrips with reduced susceptibility to Buffy pine, Toss pine, Toss pine, Toss pine, Marathon, Toss pine, Talisman pine , damasone, methamphetamine, dicloxazone, cloxazone, methamphetamine, toxaphene, endosulfane, fenpronil, ananin, subfenin, bifenin, dimethonine, yihua Sulfate, permethonine, tau-flufenin, sulfonin, fenflufenin, sulfonin, iodamide, sinosulfide, sinosulfate, abutin, sulfamethoxazole and / or cyanoprofen Western flower thrips (Frankliniella occidentalis) with reduced sensitivity to amines; Diptera with reduced sensitivity to one or more compounds selected from group a2; To one or more compounds selected from group a3 Diptera with reduced sensitivity to one or more compounds selected from group a4; Diptera with reduced sensitivity to one or more compounds selected from group a9 Ptera; Diptera with reduced susceptibility to one or more compounds selected from group a17; Liriomyza sativae with reduced susceptibility to permethonine and / or fenclid; Decreased susceptibility to tangerine, methylparazone, leucopine, methamphetamine, taosin, triclopid, permethanine, sulfamethrin, DDT, cynosal, apatin and / or sulfamethoxazole Liriomyza trifolii; Coleoptera with reduced susceptibility to one or more compounds selected from group a2; Elytra with reduced susceptibility to one or more compounds selected from group a3 order; Coleoptera with reduced sensitivity to one or more compounds selected from group a4; Coleoptera with reduced sensitivity to one or more compounds selected from group a9; Coleoptera with reduced sensitivity to one or more compounds selected from group a17 Coleoptera with reduced sensitivity to one or more compounds selected from group a2; Coleoptera with reduced sensitivity to one or more compounds selected from group a2, and one or more compounds selected from group a4; Chrysomelidae that have reduced sensitivity to one or more compounds selected from group a2; Chrysomelidae that have reduced sensitivity to one or more compounds selected from group a3; Chrysophyllidae with reduced susceptibility to one or more compounds selected from group a4; Chrysanthemumidae with reduced susceptibility to one or more compounds selected from group a9; Aphrodisiacae that have reduced sensitivity to one or more compounds in group a17; those that have reduced sensitivity to one or more compounds selected from group a2, and one or more compounds selected from group a4 Oulema oryzae; Oulema oryzae with reduced susceptibility to one or more compounds selected from group a2; Oulema oryzae with reduced susceptibility to one or more compounds selected from group a4 Rice mudworm; rice mudworm with reduced sensitivity to one or more compounds selected from group a2 and one or more compounds selected from group a4; rice mudworm with reduced sensitivity to one or more compounds selected from group a2 Diabrotica spp. with reduced sensitivity to one or more compounds selected from group a3; Diabrotica spp. with reduced sensitivity to one or more compounds selected from group a3; Diabrotica spp. with reduced sensitivity to one or more compounds selected from group a3; A genus that has reduced sensitivity to one or more compounds in group a4; a genus that has reduced sensitivity to one or more compounds selected from group a9; a genus that has reduced sensitivity to one or more compounds selected from group a17; Diabrotica virgifera virgifera with reduced susceptibility to more than one compound selected from group a2; Western corn rootworm (Diabrotica virgifera virgifera) with reduced susceptibility to more than one compound selected from group a2; Western corn rootworms with reduced susceptibility to one or more compounds in group a3; Western corn rootworms with reduced susceptibility to one or more compounds selected from group a4; Western corn rootworms with reduced susceptibility to one or more compounds selected from group a9; Western corn rootworms with reduced susceptibility to more than one compound selected from group a17; Western corn rootworms with reduced susceptibility to one or more compounds selected from group a17; Western corn rootworms with reduced susceptibility to one or more compounds selected from group a2 Southern corn root cutter (Diabrotica undecimpunctata howardi) with reduced susceptibility; Southern corn root cutter with reduced susceptibility to one or more compounds selected from group a3; To one compound selected from group a4 Southern corn root-cutting insects with reduced sensitivity to the above compounds; Southern corn root-cutting insects with reduced sensitivity to one or more compounds selected from group a9; Southern corn root-cutting insects with reduced sensitivity to one or more compounds selected from group a17 Southern corn rootworm with reduced susceptibility to compounds; Northern corn rootworm (Diabrotica barberi) with reduced susceptibility to one or more compounds selected from group a2; To one or more compounds selected from group a3 Northern corn rootworms with reduced susceptibility to compounds selected from group a4; Northern corn rootworms with reduced susceptibility to one or more compounds selected from group a4; Susceptible to one or more compounds selected from group a9 Northern corn rootworm with reduced sensitivity; Northern corn rootworm with reduced sensitivity to one or more compounds selected from group a17; South American corn rootworm with reduced sensitivity to one or more compounds selected from group a2 Diabrotica speciosa; South American leaf beetle with reduced sensitivity to one or more compounds selected from group a3; South American leaf beetle with reduced sensitivity to one or more compounds selected from group a4 ; South American leaf beetle with reduced sensitivity to one or more compounds selected from group a9; South American leaf beetle with reduced sensitivity to one or more compounds selected from group a17; South American leaf beetle with reduced sensitivity to one or more compounds selected from group a17; Potato beetles (Leptinotarsa ​​decemlineata) with reduced sensitivity to one or more compounds selected from group a2; Potato beetles with reduced sensitivity to one or more compounds selected from group a3; To one selected from group a4 Potato beetles with reduced sensitivity to more than one compound selected from group a11; Potato beetles with reduced sensitivity to one or more compounds selected from group a11; Potato beetles with reduced sensitivity to one or more compounds selected from group a17 Potato beetles; Phyllotreta striolata with reduced susceptibility to one or more compounds selected from group a3; Phyllotreta striolata with reduced susceptibility to one or more compounds selected from group a4 striped leaf flea; yellow striped leaf flea with reduced susceptibility to one or more compounds selected from group a17; black mustard flea beetle with reduced susceptibility to one or more compounds selected from group a3 ( Phyllotreta cruciferae); A black mustard flea beetle with reduced sensitivity to one or more compounds selected from group a4; A black mustard flea beetle with reduced sensitivity to one or more compounds selected from group a17; Phyllotreta pusilla with reduced sensitivity to one or more compounds selected from group a3; Phyllotreta pusilla with reduced sensitivity to one or more compounds selected from group a4; Western black flea beetle with reduced sensitivity to one or more compounds selected from group a17; Psylliodes chrysocephala with reduced sensitivity to one or more compounds selected from group a3; The rapeseed blue flea beetle has reduced sensitivity to one or more compounds selected from group a4; The rapeseed blue flea beetle has reduced sensitivity to one or more compounds selected from group a17; Psylliodes punctulata with reduced sensitivity to one or more compounds in group a3; Psylliodes punctulata with reduced sensitivity to one or more compounds selected from group a4; Flea beetles with reduced susceptibility to one or more compounds selected from group a17; Curculionidae with reduced susceptibility to one or more compounds selected from group a2; Curculionidae with reduced sensitivity to one or more compounds selected from group a2; Weevils with reduced sensitivity to one or more compounds selected from group a2 and one or more compounds selected from group a4 Family; Rice water weevil (Lissorhoptrus oryzophilus) with reduced sensitivity to one or more compounds selected from group a2; Rice water weevil with reduced sensitivity to one or more compounds selected from group a4 Weevils; rice water weevils with reduced sensitivity to one or more compounds selected from group a2 and one or more compounds selected from group a4; The family Knockonidae has reduced sensitivity to one or more compounds selected from group a3; The family Knockonidae has reduced susceptibility to one or more compounds selected from group a3; The family has reduced sensitivity to one or more compounds selected from group a4 Melanotus okinawensis with reduced sensitivity to one or more compounds selected from group a2; Melanotus okinawensis with reduced sensitivity to one or more compounds selected from group a3 Okinawa wireworm with reduced susceptibility to one or more compounds selected from group a4; Okinawa wireworm with reduced susceptibility to one or more compounds selected from group a2 (Agriotes fuscicollis); A leptothoracic wireworm with reduced sensitivity to one or more compounds selected from group a3; A leptothoracic wireworm with reduced sensitivity to one or more compounds selected from group a4 ; Melanotus legatus with reduced sensitivity to one or more compounds selected from group a2; Melanotus legatus with reduced sensitivity to one or more compounds selected from group a3; Anchastus spp. with reduced susceptibility to one or more compounds selected from group a4; Anchastus spp. with reduced susceptibility to one or more compounds selected from group a2; The genus Anchastus has reduced sensitivity to one or more compounds selected from group a3; The genus Anchastus has reduced sensitivity to one or more compounds selected from group a4; The genus Anchastus has reduced sensitivity to one or more compounds selected from group a2 Conoderus spp. with reduced sensitivity to compounds selected from group a3; Conoderus spp. with reduced sensitivity to one or more compounds selected from group a3; Conoderus spp. with reduced sensitivity to compounds selected from group a4 Ctenicera spp., which has reduced sensitivity to more than one compound selected from group a2; Ctenicera spp., which has reduced sensitivity to more than one compound selected from group a2;A species of the genus Triton that has reduced sensitivity to one or more compounds selected from group a3; a genus that has reduced sensitivity to one or more compounds selected from group a4; Limonius spp. with reduced sensitivity to one or more compounds selected from group a2; Limonius spp. with reduced sensitivity to one or more compounds selected from group a3; Limonius spp. with reduced sensitivity to one or more compounds selected from group a3; Limonius spp. which has reduced sensitivity to one or more compounds selected from group a4; Aeolus spp. which has reduced sensitivity to one or more compounds selected from group a2; Aeolus spp. which has reduced sensitivity to one or more compounds selected from group a3 The genus Aeolus has reduced sensitivity to one or more compounds selected from group a4; The genus Aeolus has reduced sensitivity to one or more compounds selected from group a4; The rapeseed blue flea beetle has reduced sensitivity to lambda xeronine ; Butyl Jiabaofu, Jiabaofu, Yubison, Taosong, Gusupine, Xeronine, Lambda Xeronine, Dimenin, Permethonine, Idamide, Datnam, Canidine , potato beetles with reduced susceptibility to Segope, Sessoan and / or Nitenpyram; , pollen beetles (Brassicogethes aeneus) with reduced susceptibility to β-sulfonin, dimethonin, tau-flufenin, and / or submethonine; to one or more species selected from group a2 An order of mites with reduced sensitivity to compounds; An order of mites with reduced sensitivity to one or more compounds selected from group a3; An order of mites with reduced sensitivity to one or more compounds selected from group a4 ; Acarids with reduced sensitivity to one or more compounds selected from group a9; Acarids with reduced sensitivity to one or more compounds selected from group a17; Acarids with reduced sensitivity to one or more compounds selected from group a19 Two-spotted spider mites (Tetranychus urticae) with reduced susceptibility to more than one compound, bifenin, abutin, minmetin, subquinone and / or bifenside; European spider mites (Panonymchus ulmi) with reduced susceptibility to Cfennella mites, Hecedo, Pydaben and / or Pimple mites; Bedbugs with reduced susceptibility to one or more compounds selected from group a1 ( Cimex lectularius); bed bugs with reduced sensitivity to one or more compounds selected from group a2; bed bugs with reduced sensitivity to one or more compounds selected from group a3; bed bugs with reduced sensitivity to one or more compounds selected from group a4 Bed bugs with reduced susceptibility to one or more compounds selected from group a5; Bed bugs with reduced susceptibility to one or more compounds selected from group a5; Bed bugs with reduced susceptibility to one or more compounds selected from group a10 Bedbugs; against diclofenac, diclosan, permethonine, butylpyridoxine, marathon, andan, diterin, fenpunil, alenin, bifenin, sefenin, β -Serfenin, λxeronine, sulfenin, subfenin, dimethonin, effenim, efenin, permethonin, phentenine, pyrethrin, termethrin, DDT, subfenthrin Bed bugs with reduced susceptibility to , datnam, idatamide, cysoxan, sinosal and / or crofenpa; tropical bed bugs with reduced susceptibility to one or more compounds selected from group a1 (Cimex hemipterus); Tropical bed bugs with reduced susceptibility to one or more compounds selected from group a2; Tropical bed bugs with reduced susceptibility to one or more compounds selected from group a3; Tropical bed bugs with reduced susceptibility to one or more compounds selected from group a4; Tropical bed bugs with reduced susceptibility to one or more compounds selected from group a10; Permethrin, Butylbutylin, Marathon, Andan, Deterin, Fenpunil, Yarenin, Bifenin, Saifenin, Lambda Xeronine, Saimenin, Yamenin, Dimenin Tropical bed bugs with reduced susceptibility to , Yifali, Efenin, Permethonin, DDT, Idamide and / or Kefanpai; Reduced susceptibility to one or more compounds selected from group a1 A housefly (Musca domestica); a housefly with reduced sensitivity to one or more compounds selected from group a2; a housefly with reduced sensitivity to one or more compounds selected from group a3; House flies with reduced sensitivity to one or more compounds selected from group a4; House flies with reduced sensitivity to one or more compounds selected from group a5; House flies with reduced sensitivity to one or more compounds selected from group a6 House flies with reduced susceptibility to one or more compounds selected from group a7; House flies with reduced susceptibility to one or more compounds selected from group a7; Susceptibility to one or more compounds selected from group a11 House flies with reduced susceptibility to one or more compounds selected from group a12; House flies with reduced susceptibility to one or more compounds selected from group a13; House flies with reduced susceptibility to one or more compounds selected from group a13; House flies with reduced susceptibility to one or more compounds in group a14; house flies with reduced susceptibility to one or more compounds selected from group a15; Taosone methyl, Dalipine, Dicloxazone, Dicloxazone, Lexazone, Permethasone, Nanide, Methoxychloride, Nalisone, Methylbarasone, Barxazone, Buffason, Andan , tetraclosone, triclosan, triclosone, diterin, endosulfane, fenpronil, bifenin, saifonine, β-sefonine, λxonine, safenin, β- Cyperfenin, Cyfenfenin, Dimethrin, Yihuali, Phentenine, Pyrethrin, Dimethonine, DDT, Dimethonium, Dartenam, Idamidamide, Nitenpyram, Cyssoan, Cinusal, Apatin, Inmetin, Medipin, Bailipfen, Pedan, Erfulon, Lufenlong, Salfenuron, Cymetin, Methoxyfenac and / or Indekezhi House flies with reduced sensitivity; Simulium damnosum with reduced sensitivity to one or more compounds selected from group a1; Simulium damnosum with reduced sensitivity to one or more compounds selected from group a3 Culex pipiens pallens; Culex pipiens pallens with reduced susceptibility to one or more compounds selected from group a2; Culex pipiens pallens with reduced susceptibility to one or more compounds selected from group a3 Mosquitoes; Trichomonas mosquitoes with reduced susceptibility to bifenin, β-thiefonin, lambda xyronin, thyperfenin, dimethonin, perfenin and / or refenin; To mosquitoes selected from group a3 Culex pipiens f. molestus with reduced susceptibility to one or more of the compounds contained in Culex pipiens f. molestus; Culex pipiens f. molestus with reduced susceptibility to dimethonine, efenin, permethonine and / or phentenine; Tropical house mosquitoes (Culex quinquefasciatus) that have reduced susceptibility to one or more compounds selected from group a1; Tropical house mosquitoes that have reduced susceptibility to one or more compounds selected from group a3; Tropical domestic mosquitoes with reduced susceptibility to personin, bifenin, β-thiefonin, lambda xyronin, thimemonin, dimethonin, perfenin and / or refenin; for those selected from group a1 aegypti mosquitoes with reduced susceptibility to one or more compounds selected from group a3; Aedes aegypti mosquitoes with reduced susceptibility to one or more compounds selected from group a3; Aedes aegypti mosquitoes with reduced susceptibility to one or more compounds selected from group a9; Aedes aegypti mosquitoes with reduced susceptibility to one or more compounds selected from group a9; Marathon, Atsonin, Andan, Yapersonin, Yalenin, Bifenin, Saifenin, Lambda Xeronine, Saimenin, Yamenin, Dimenin, Efenin, Permenin, Aedes aegypti mosquitoes with reduced susceptibility to phenterine, DDT and / or methipin; Aedes aegypti mosquitoes with reduced susceptibility to Cry4A and Cry4B of δ-endotoxins; To one or more species selected from group a1 Anopheles gambiae with reduced sensitivity to compounds; Anopheles gambiae with reduced sensitivity to one or more compounds selected from group a2; Anopheles gambiae with reduced sensitivity to one or more compounds selected from group a3 Anopheles gambiae mosquitoes with reduced susceptibility to the above compounds; reduced susceptibility to ampicillin, permethonine, atasone, deterin, λxeronine, dimethonine, permethonine and / or DDT Anopheles gambiae mosquito; Anopheles coluzzii with reduced susceptibility to one or more compounds selected from group a1; Anopheles coluzzii that is sensitive to one or more compounds selected from group a2 Anopheles kuruzi mosquitoes with reduced susceptibility to one or more compounds selected from group a3; Anopheles kuruzi mosquitoes with reduced susceptibility to one or more compounds selected from group a3; Toxicon, permethonine, diterin, lambda xeronine, Anopheles kuruzi mosquitoes with reduced susceptibility to dimethonine, permethonine and / or DDT; Anopheles arabiensis mosquitoes with reduced susceptibility to one or more compounds selected from group a1; Anopheles arabiensis mosquitoes with reduced susceptibility to one or more compounds selected from group a2; Anopheles arabiensis mosquitoes with reduced susceptibility to one or more compounds selected from group a3; Anopheles arabiensis mosquitoes with reduced susceptibility to trane, lambda xeronine, dimethonine, permethonine and / or DDT; Anopheles arabiensis mosquitoes with reduced susceptibility to one or more compounds selected from group a2 ( Anopheles funestus); Anopheles anopheles mosquitoes with reduced susceptibility to one or more compounds selected from group a3; reduced susceptibility to deterin, λxeronine, dimethonine, permethonine and / or DDT Anopheles malaria mosquito; Tribolium castaneum with reduced susceptibility to one or more compounds selected from group a1; Tribolium castaneum with reduced susceptibility to one or more compounds selected from group a3 Tribolium castaneum; Tribolium castaneum with reduced susceptibility to one or more compounds selected from group a5; Red Tribolium castaneum with reduced susceptibility to one or more compounds selected from group a21 ; Garbaly, Taosong, methyl Taosong, cyanasone, Dalipine, dicloxazone, permethasone, marathon, bassason, atasone, promethacone, Andan, subason, tetracloxazone, must. Tribolium castaneum with reduced susceptibility to Xerin, Xerfenin, Xeronine, Xerfenin, Dimethonin, Permethanine, Phentenine, Pyrethrin, DDT, Cynosal and / or Phosphate; Blattella germanica with reduced sensitivity to one or more compounds selected from group a1; Blattella germanica with reduced sensitivity to one or more compounds selected from group a2; Blattella germanica with reduced sensitivity to one or more compounds selected from group a2; Blattella germanica with reduced sensitivity to one or more compounds in group a3; Blattella germanica with reduced sensitivity to one or more compounds selected from group a4; Blattella germanica with reduced sensitivity to one or more compounds selected from group a6; Blattella germanica has reduced susceptibility to more than one type of compound; to taosin, marathon, andandan, fenpronil, beta-sulfonin, safenin, dimethonin, permethrin, pyrethrin, DDT, Yida Blattella germanica with reduced susceptibility to amines and / or abutin; Cat fleas (Ctenocephalides felis) with reduced susceptibility to one or more compounds selected from group a1; To one selected from group a2 Cat fleas with reduced sensitivity to more than one compound selected from group a3; Cat fleas with reduced sensitivity to more than one compound selected from group a3; Cat fleas with reduced sensitivity to one or more compounds selected from group a4 cat fleas; cat fleas with reduced susceptibility to one or more compounds selected from group a5; cat fleas with reduced susceptibility to 1 or more compounds selected from group a5; to flea, garbalifer, clofenacone, taosin, dalipine, fenclofenac, subfensone, Cat fleas with reduced susceptibility to prodanzone, endanil, marathon, fenpronil, sulfonin, sulfonin, fentanil, permethrin, pyrethrins, idamidide and / or serozolin; Dermacentor variabilis with reduced susceptibility to one or more compounds selected from group a3; Dermacentor variabilis with reduced susceptibility to DDT; Dermacentor variabilis with one compound selected from group a1 Rhipicephalus microplus with reduced sensitivity to the above compounds; Rhipicephalus microplus with reduced sensitivity to one or more compounds selected from group a2; Rhipicephalus microplus with reduced sensitivity to one or more compounds selected from group a3 R. minuta ticks with reduced sensitivity to the above compounds; R. minuta ticks with reduced sensitivity to one or more compounds selected from group a6; R. minuta ticks sensitive to one or more compounds selected from group a20 Rhipicephalus microscopic ticks with reduced sex; for garbazolin, taosin, muscarin, fenpronil, birepro, sulfenin, dimethonin, vomethonin, permethonin, ivermectin and / or sanya Rhipicephalus sanguineus with reduced sensitivity to one or more compounds selected from group a1; Rhipicephalus sanguineus with reduced sensitivity to one or more compounds selected from group a3; Rhipicephalus sanguineus with reduced sensitivity to one or more compounds selected from group a3 R. sanguineus ticks with reduced susceptibility to compounds; R. sanguineus ticks with reduced susceptibility to one or more compounds selected from group a20; R. sanguineus ticks with reduced susceptibility to permethonine and / or sanyapan tick;

[0047] Examples of harmful arthropods, harmful molluscs, and harmful nematodes such as harmful insects and harmful mites whose sensitivity is reduced by substitution of one or more amino acids of the target protein include the following. The cotton aphid with an amino acid substitution of R81T in the beta subunit of the nicotinic acetylcholine receptor; the green peach aphid with an amino acid substitution of R81T in the beta subunit of the nicotinic acetylcholine receptor; Diamondback moth with G4946E amino acid substitution in the fish nicotin receptor; Diamondback moth with F1845Y or V1848I amino acid substitution in the sodium channel; A2'N amino acid substitution in the GABA-activated chloride channel The white-backed planthopper; the cotton aphid with amino acid substitutions of S431F and / or A302S in acetylcholinesterase; the tobacco whitefly with amino acid substitutions of L925I and / or T929V in the potential-dependent sodium channel; Myzus aphid with amino acid substitution of S431F in acetylcholinesterase; Myzus aphid with amino acid substitutions of L1014F, M918T and / or TL932F in potential-dependent sodium channel; Myzus aphid with amino acid substitution in GABA-operated chloride channel Myzus peach aphid with amino acid substitutions of A302S and / or A302G; Western flower thrips with amino acid substitutions of L1014F and / or M918T in potential-dependent sodium channels; α6 times in nicotinic acetylcholine receptors The western flower thrips unit has the amino acid substitution of G275E; The armigera has the amino acid substitution of L1029H, V421M, V421A, V421G and / or I951V in the potential-dependent sodium channel; The potential-dependent sodium channel has L1029H, Spodoptera exigua with amino acid substitutions of D1561V, E1565G and / or V421M; Potato beetles with amino acid substitutions of R30K, S291G and / or I392T in acetylcholinesterase; L1014F in potential-dependent sodium channels Potato beetles with amino acid substitutions; White-backed planthoppers with amino acid substitutions of S298P in acetylcholinesterase type 1; Two amino acid substitutions with G323D in the GluCl1 subunit of glutamate receptors Spider mites; Two-spotted spider mites with the amino acid substitution G326E in the GluCl3 subunit of the glutamate receptor; amino acid substitutions with M918T, M918L, T929I, V1010A and / or L1014F in the potential-dependent sodium channel Onion thrips; Greenhouse whitefly with amino acid substitutions of L925I and / or T929I in the potential-dependent sodium channel; Tomato with amino acid substitutions of G4903V, G4903E, I4746T and / or I4746M in the nicotine receptor Lycorotor moth; Brown planthopper with A301S amino acid substitution in the GABA-activated chloride channel; Brown planthopper with Y151S amino acid substitution in the α1 and α3 subunits of the nicotinic acetylcholine receptor; In potential European milletworm with L1014F amino acid substitution in the potential-dependent sodium channel; European spider mite with F1538I amino acid substitution in the potential-dependent sodium channel; Brassica napus with L1014F amino acid substitution in the potential-dependent sodium channel Flea beetles; Aphids with L1014F amino acid substitutions in potential-dependent sodium channels; Diamondback moths with amino acid substitutions of A282S, A282G and / or A302S in GABA-active chloride channels; Potential-dependent Diamondback moths with amino acid substitutions of M918I, T929I and / or L1014F in the potential-dependent sodium channel; Bedbugs with amino acid substitutions of V419L, L925I and / or I936F in the α subunit of the potential-dependent sodium channel; In acetylcholine Alkaline esterase has amino acid substitutions of V180L, V260L, G262A, G262V, G342A, G342V, G365A, F327Y, F407Y and / or G445A in house flies; the alpha subunit of the potential-dependent sodium channel has M918T, L1014F and / or or L1014H amino acid substitution of house flies; house flies with A302S amino acid substitution of GABA-active chloride channels; house flies with L1014F and / or L1014S amino acid substitution of potential-dependent sodium channels Mosquitoes; Trichoderma mosquitoes with A302S amino acid substitution in GABA-activated chloride channels; Subterranean house mosquitoes with L1014F and / or L1014S amino acid substitutions in potential-dependent sodium channels; Potential-dependent sodium channels Tropical house mosquitoes with amino acid substitutions of L1014F and / or L1014S; Tropical house mosquitoes with amino acid substitutions of G119S in acetylcholinesterase; V410L, G923V, L982W, S989P, Aedes aegypti mosquitoes with amino acid substitutions of I1011M, I1011V, V1016I, V1016G, T1520I, F1534C and / or D1763Y; Anopheles gambiae mosquitoes with amino acid substitutions of L1014S and / or N1575Y in potential-dependent sodium channels; Anopheles gambiae mosquitoes with amino acid substitutions of G119S in acetylcholinesterase; Anopheles kuruzei mosquitoes with amino acid substitutions of L1014F and / or N1575Y in potential-dependent sodium channels; In potential-dependent sodium channels Anopheles arabiensis mosquitoes with amino acid substitutions of L1014F; Anopheles malaria mosquitoes with amino acid substitutions of A296S and / or V327I in GABA-activated chloride channels; Amino acid substitutions of A302S in GABA-activated chloride channels Substituted Tribolium castaneum; Blattella germanica with amino acid substitutions of D58G, E434K, C764R, L933F and / or P1880L in the potential-dependent sodium channel; Amino acid substitution of A302S in the GABA-acting chloride channel Blattella germanica; Cat fleas with amino acid substitutions of T929V and / or L1014F in potential-dependent sodium channels; Cat fleas with amino acid substitutions of A302S in GABA-active chloride channels; Cat fleas with amino acid substitutions of A302S in potential-dependent sodium channels The channel has amino acid substitutions of C190A and / or F1550I.

[0048] Examples of harmful arthropods, harmful molluscs, and harmful nematodes such as harmful insects and harmful mites whose sensitivity is reduced by the reduction of the target protein include the following. The expression of α2 subunit of nicotinic acetylcholine receptor is reduced in house flies.

[0049] As the main factors that increase the activity of metabolic enzymes, examples include excessive expression of metabolic enzyme genes (also known as quantitative variation), and increased affinity with pharmaceuticals due to amino acid substitution of metabolic enzymes. (Also known as qualitative variation). There may be one or a plurality of main factors that increase the activity of these metabolic enzymes. Examples of harmful arthropods, harmful molluscs, and harmful nematodes such as harmful insects and harmful mites that increase the activity of metabolic enzymes due to excessive expression of metabolic enzyme genes are as follows. CYP6ER1 (one of the cytochrome P450 genes) is overexpressed in the brown planthopper; Glutathione S-transferase gene is overexpressed in the two-spotted green leafhopper; Cytochrome P450 monooxygenase gene is overexpressed in the cotton aphid; CYP6CM1 (cytochrome Tobacco whitefly with overexpression of P450-dependent monooxygenase gene); tobacco whitefly with overexpression of cytochrome P450-dependent monooxygenase gene; carboxylesterase gene and / or microsomal-O-demethylation The enzyme (microsomal-O-demethylase) gene is overexpressed in the borer borer; the glutathione S-transferase gene and / or the cytochrome P450 monooxygenase gene is overexpressed in the codling moth; 3 types of aminopeptidase N ( Sugarcane straw borer with reduced expression of aminopeptidases N) genes (DsAPN1, DsAPN2, and DsAPN3) and / or DsCAD1 (a type of cadherin gene); African leafminer with overexpression of cytochrome P450 genes; Cells Pollen beetles with overexpression of pigment P450 genes; Myzu aphid with overexpression of CYP6CY3 (a type of cytochrome P450 gene); E4 gene of one type of carboxylesterases (carboxylesterases) and / or one of carboxylesterases (carboxylesterases) The peach aphid with an overexpressed FE4 gene; the lettuce aphid with overexpressed esterase gene; the lettuce aphid with overexpressed glutathione S-transferases gene; the hero with overexpressed esterase gene American stink bug; The heroic stink bug whose EST-2 gene, one type of cholinesterase, and / or the EST-4 gene, one type of cholinesterase, is overexpressed; The western flower whose esterase gene is overexpressed Thrips; Western flower thrips, which overexpresses the cytochrome P450 monooxygenase gene; Western flower thrips, which overexpresses the glutathione S-transferases gene; expresses CYP337B3 (a type of cytochrome P450 gene) ) in Spodoptera armigera; Spodoptera armigera in which the cytochrome P450 monooxygenase gene is overexpressed; Spodoptera armigera in which the glutathione S-transferases gene is overexpressed; esterase gene is overexpressed in Spodoptera armigera Helicoverpa armigera; Spodoptera exigua with overexpression of glutathione S-transferase gene; Spodoptera exigua with overexpression of esterase gene; Spodoptera exigua with overexpression of cytochrome P450 gene; Glutathione S - Potato beetles with over-expressed transferase genes; Potato beetles with over-expressed esterase genes; Potato beetles with over-expressed cytochrome P450 genes; Two-spotted leaves with over-expressed TuGSTd14 (one type of glutathione S-transferase gene) Mites; Greenhouse whiteflies with overexpression of CYP6CM1 (one type of cytochrome P450 gene); Tribolium castaneum with overexpression of cytochrome P450 gene; Brown planthopper with reduced expression of CYP6AY1 (one type of cytochrome P450 gene); Carboxylesterase (carboxylesterases) gene is overexpressed in brown planthoppers; brown planthoppers are overexpressed in Nl-EST1 gene, a type of carboxylesterases; brown planthoppers are overexpressed in CYP6ER1, CYP6AY1 and / or CYP6FU1 (a type of cytochrome P450 gene) ; European milletworm with overexpression of cytochrome P450 monooxygenase gene; European milletworm with overexpression of glutathione S-transferase gene; European spider mite with overexpression of cytochrome P450-dependent monooxygenase gene; Cytochrome P450 Brassica flea beetles with over-expressed genes; bed bugs with over-expressed CYP397A1, CYP398A1, CYP6DN1, CYP4CM1 and / or CYP400A1 (all 1 type of cytochrome P450 genes); CE3959 and / or CE21331 (all carboxylesterases) ) gene) overexpressing bed bugs; S1 (glutathione S-transferase gene 1) overexpressing bed bugs; CYP6A1, CYP6A5v1, CYP6A5v2, CYP6A36, CYP6A40, CYP6D1, CYP6D1v1, CYP6D3, CYP6D8, CYP6G2 and / or CYP6G4 (all 1 type of cytochrome P450 genes) in house flies; tropical house mosquitoes with overexpression of CYP9M10, CYP6AA7 and / or CYP4H34 (all 1 type of cytochrome P450 genes); esterase gene overexpression aegypti mosquito; Aedes aegypti mosquito that overexpresses the glutathione S-transferase gene; Egypt that overexpresses CYP4D24, CYP6BB2, CYP6F3, CYP6M11, CYP6N12 and / or CYP9M6 (all are 1 type of cytochrome P450 gene) Aedes mosquitoes; Aedes aegypti mosquitoes with overexpression of carboxylesterase genes; Anopheles gambiae mosquitoes with overexpression of CYP4P16, CYP4P17, CYP6P3, CYP6Z1, CYP12F1 and / or CYP325A3 (all of which are a type of cytochrome P450 genes); GSTE2 ( Anopheles gambiae mosquitoes with overexpression of glutathione S-transferase gene); Anopheles gambiae mosquitoes with overexpression of PX13A and / or PX13B (both 1 type of peroxidase gene); Overexpression of esterase genes Anopheles gambiae; Anopheles arabiensis with overexpression of CYP6P4 (a type of cytochrome P450 gene); Anopheles arabiensis with overexpression of carboxylesterase genes; Anopheles arabiensis with overexpression of beta-esterases genes; CYP6P4 and / Or CYP6P9 (both a type of cytochrome P450 gene) is overexpressed in Anopheles mosquitoes; CYP6BQ9 (a type of cytochrome P450 gene) is overexpressed in Tribolium castaneum; Glutathione S-transferase gene is overexpressed. Tribolium castaneum; Epsilon (one type of glutathione S-transferase gene) is overexpressed in Tribolium castaneum; CYP4G19 (one type of cytochrome P450 gene) is overexpressed in Blattella germanica.

[0051] Harmful arthropods, harmful molluscs, and harmful nematodes such as harmful insects, harmful mites, etc. that increase the activity of the metabolic enzyme by increasing the affinity with the drug due to amino acid substitution of the metabolic enzyme, Examples include the following. Brown planthoppers containing CYP6ER1vA (a variant of CYP6ER1) with amino acid substitutions of T318S, A375δ and A376G; Brown planthoppers containing CYP6ER1vB (a variant of CYP6ER1) with amino acid substitutions of T318S and A377δ; House flies containing amino acid substituted carboxyesterase with W251L and / or W251S; containing amino acid substituted dihydrolipoamide dehydrogenase with P45S and / or G131S The red imitates the grain robber.

[0052] Harmful arthropods, harmful molluscs, and harmful nematodes such as harmful insects and harmful mites, which are major factors that increase the activity of multiple metabolic enzymes, can be exemplified by excessive expression of CYP6ER1, and by having CYP6ER1vA and CYP6ER1vB reduce the sensitivity of brown planthoppers to idamidine.

[0053] Examples of harmful arthropods, harmful molluscs, and harmful nematodes such as harmful insects and harmful mites whose sensitivity is reduced by reducing the permeability of the skin are as follows. Spodoptera armigera has reduced sensitivity to pyrethroids (such as pyrethroids, etc.) due to reduced cuticular penetration in the epidermis; C2, C10 and / or C13 (Both are 1 type of putative epidermal protein gene) Bed bugs with reduced sensitivity to pyrethroids (β-sulfonin, etc.) due to excessive expression.

[0054] Examples of harmful arthropods, harmful molluscs, and harmful nematodes such as harmful insects and harmful mites whose sensitivity is reduced due to increased excretion function due to membrane transport proteins include the following. Bugs with overexpression of the ABC transporter genes Abc8, Abc9, Abc10 and / or Abc11.

[0055] Examples of Aphididae pests include cotton aphids, green peach aphids, and lettuce aphids. Examples of rice planthoppers include brown planthopper, white-backed planthopper, and spotted planthopper. Examples of the pests of the family Ameliidae include tobacco whiteflies and greenhouse whiteflies.

[0056] As the harmful arthropod control method of the present invention, an effective amount of the present compound, the compound of the present invention or composition A can be directly applied to harmful arthropods and / or the habitat of harmful arthropods (plants, soil , house, animals, etc.) to carry out. Examples of the method for controlling harmful arthropods of the present invention include stem and leaf treatment, soil treatment, root treatment, shower treatment, fumigation treatment, water surface treatment and seed treatment.

[0057] This compound, the compound of the present invention or composition A is usually prepared by mixing an inert carrier such as a solid carrier, a liquid carrier, a gaseous carrier, and a surfactant, and optionally adding a binder, a dispersant, a stabilizer, etc. Auxiliary agent, formulated into aqueous suspension preparations, oily suspension preparations, oil preparations, emulsions, emulsion preparations, microemulsion preparations, microcapsule preparations, hydrating agents, granular hydrating agents, powders, granules, tablets, aerosols, resin preparations, etc. It is not limited to these preparations, and can also be formulated into Manual on development and use of FAO and WHO Specifications for pesticides, FAO Plant Production and Protection Papers-271~276, prepared by the FAO / WHO Joint Meeting on Pesticide Specifications, 2016, ISSN :Use the dosage form described in 0259-2517. In these preparations, the present compound, the compound of the present invention or composition A usually contains 0.0001 to 99% by weight.

[0058] Examples of the solid support include clay (pyrophyllite clay, kaolin clay, etc.), talc, calcium carbonate, diatomaceous earth, zeolite, bentonite, acid clay, sepiolite, white carbon, and ammonium sulfate. , vermiculite, perlite, pumice, silica sand, fine powders and granules of chemical fertilizers (ammonium sulfate, ammonium phosphate, ammonium nitrate, urea, ammonium chloride, etc.), and resins (polypropylene, polyester, polyamine methyl formate, polyamide, polyvinyl chloride, etc.).

[0059] Examples of the liquid carrier include water, alcohols (ethanol, cyclohexanol, benzyl alcohol, propylene glycol, polyethylene glycol, etc.), ketones (acetone, cyclohexanone, etc.), aromatic hydrocarbons (xylene , phenylxylyylethane, methylnaphthalene, etc.), aliphatic hydrocarbons (hexane, cyclohexane, etc.), esters (ethyl acetate, methyl oleate, propylene carbonate, etc.), nitriles ( Acetonitrile, etc.), ethers (ethylene glycol dimethyl ether, etc.), amides (N,N-dimethylformamide, N,N-dimethyloctanamide, etc.), styrenes ( dimethyl styrene, etc.), lactams (N-methylpyrrolidone, N-octylpyrrolidone, etc.), fatty acids (oleic acid, etc.), vegetable oils (soybean oil, etc.).

[0060] Examples of the gaseous carrier include fluorocarbon, butane gas, LPG (liquefied petroleum gas), dimethyl ether, nitrogen, and carbon dioxide gas.

[0061] Examples of surfactants include nonionic surfactants (polyoxyethylene alkyl ethers, polyoxyethylene alkyl aryl ethers, polyethylene glycol fatty acid esters, etc.) and anionic surfactants (alkyl Sulfonates, alkyl aryl sulfonates, alkyl sulfates, etc.). Specific examples include Nimbus (registered trademark), Assist (registered trademark), Aureo (registered trademark), Iharol (registered trademark), Silwet L-77 (registered trademark), BreakThru (registered trademark), and SundanceII (registered trademark). , Induce (registered trademark), Penetrator (registered trademark), AgriDex (registered trademark), Lutensol A8 (registered trademark), NP-7 (registered trademark), Triton (registered trademark), Nufilm (registered trademark), Emulgator NP7 (registered trademark) Trademark), Emulad (Registered Trademark), TRITON .

[0062] Examples of other preparation auxiliaries include binding agents, dispersants, colorants, stabilizers, etc. Specific examples include polysaccharides (starch, gum arabic, cellulose derivatives, alginic acid, etc.), Lignin derivatives, synthetic water-soluble polymers (polyvinyl alcohol, polyvinylpyrrolidone, polyacrylic acids, etc.), acidic isopropyl phosphate, and dibutylhydroxytoluene.

[0063] In the present invention, examples of plants include the entire plant, stems and leaves, flowers, ears, fruits, trunks, branches, crowns, seeds, vegetative reproductive organs, and seedlings.

[0064] The so-called vegetative reproductive organs refer to those parts of the roots, stems, leaves, etc. of plants that have the ability to grow when the parts are cut off from the main body and placed in the soil. Examples of vegetative reproductive organs include tuberous roots, creeping roots, bulbs, corms or solid bulbs, tubers, rhizomes, and stolons. , rhizophore, cane cuttings, propagule and vine cuttings. In addition, stolons are also called runners, and propagules are also called bulbils, which are divided into broad buds and bulbils. The so-called vine refers to the slender shoots (general name of leaves and stems, shoot) of sweet potatoes or Japanese yam. Bulbs, corms, tubers, rhizomes, stem segments, rhizome or tubers are also collectively referred to as bulbs. The cultivation of potatoes begins by planting tubers in the soil, and the tubers used are generally called seed potatoes.

[0065] As a method for applying an effective amount of the compound of the present invention or composition A to soil to control harmful arthropods, for example, applying the compound, the compound of the present invention or the composition to the soil before or after planting plants Method for determining the effective amount of substance A. More specifically, examples include planting hole treatment (planting hole spreading, planting hole treatment soil mixing), plant bottom treatment (plant bottom spreading, plant bottom soil mixing, plant bottom filling, plant bottom treatment in the second half of the seedling period), plant bottom treatment Furrow treatment (planting row spreading, planting ditch soil mixing), planting row treatment (planting row spreading, planting row soil mixing, planting row spreading during growth period), planting row treatment during sowing (planting row spreading, planting row soil mixing) Mixing), comprehensive treatment (comprehensive soil spreading, comprehensive soil mixing), edge row treatment, water surface treatment (water surface application, water surface application after soaking), other soil spreading treatments (granule foliage spreading during the growth period, spreading under the canopy or around the trunk , soil surface spreading, soil surface mixing, seeding hole spreading, furrow surface spreading, inter-plant spreading), other irrigation treatments (soil irrigation, seedling irrigation, liquid injection treatment, grounding part irrigation, liquid drip irrigation, chemical Irrigation), seedling box treatment (seedling box spreading, seedling box perfusion, seedling box liquid immersion), seedling tray treatment (seedling tray spreading, seedling tray perfusion, seedling tray liquid immersion), seedbed treatment (seedbed spreading, seedbed perfusion, Water seedlings are used for seedbed spreading, seedling dipping), bed soil mixing treatments (bed soil mixing, bed soil mixing before sowing, spreading before covering with soil during sowing, spreading after covering with soil during sowing, and covering soil mixing), and other treatments (soil mixing, plowing, digging, Topsoil mixing, drip soil mixing, planting location treatment, granular calyx spreading, paste fertilizer mixing).

[0066] Examples of seed treatment include treatment of seeds or vegetative reproductive organs with the present compound, the compound of the present invention, or composition A. Specifically, examples include suspension of the present compound, the compound of the present invention, or composition A. Spraying treatment in which liquid is sprayed in a mist form onto the surface of seeds or vegetative reproductive organs; coating treatment in which the compound, the compound of the present invention or composition A is applied to seeds or vegetative reproductive organs; immersing seeds in this compound, this compound Dip treatment for a certain period of time in the medicinal solution of the compound of the invention or composition A; method of coating seeds or vegetative reproductive organs with a carrier containing the compound, the compound of the invention or composition A (film coating treatment, particle coating treatment, etc.). As the above-mentioned vegetative reproductive organs, seed potatoes can be particularly exemplified. When using composition A to treat seeds or vegetative reproductive organs, composition A can be made into one preparation to treat the seeds or vegetative reproductive organs, or composition A can be made into different preparations and divided into multiple times to treat the seeds. Or nourish the reproductive organs for processing. An example of a method of preparing composition A into a plurality of different preparations and treating them several times is, for example, using a preparation containing only the present compound or the compound of the present invention as an active ingredient, and then drying the seeds or vegetative reproductive organs. A method of processing a preparation containing this ingredient; and processing a preparation containing this compound or a compound of the present invention and this ingredient as an active ingredient, and then drying the seeds or vegetative reproductive organs, and then using a preparation containing this ingredient other than the treated ingredient. Methods for processing preparations. The term "seeds or vegetative reproductive organs holding the compound of the present invention, the compound of the present invention, or composition A in the present invention" means a state in which the compound, the compound of the present invention, or composition A is attached to the surface of the seed or vegetative reproductive organ. . The seeds or vegetative reproductive organs holding the above-mentioned compound of the present invention, the compound of the present invention or the composition A may also have the present compound, Materials other than the compound or composition A of the present invention. Moreover, when the composition A is attached to the surface of a seed or a vegetative reproductive organ to form a layer, the layer may be composed of one layer or a plurality of layers. Moreover, when it is composed of a plurality of layers, each layer may be a layer containing one or more active ingredients, or may be composed of a layer containing one or more active ingredients and a layer containing no active ingredient. The seeds or vegetative reproductive organs holding the compound of the present invention or the compound of the present invention or composition A can be, for example, applied to the seeds or vegetative organs by applying a preparation containing the compound of the present invention or the compound of the present invention or composition A to the seeds or nutrients through the aforementioned seed treatment method. Reproductive organs are obtained.

[0067] When the present compound, the compound of the present invention or the composition A is used to control harmful arthropods in the agricultural field, the application amount is usually 1 to 10000g per 10000m2 of the compound or the compound of the present invention. When treating seeds or vegetative reproductive organs, the amount of the compound or the compound of the present invention is usually applied in the range of 0.001 to 100g per 1 kg of seeds or vegetative reproductive organs. When the present compound, the compound of the present invention or Composition A is formulated into an emulsion, hydration agent, suspension, etc., it is usually diluted with water so that the concentration of the active ingredient becomes 0.01 to 10000 ppm and administered. Granules, powders, etc. are usually administered directly.

[0068] Alternatively, the resin preparation processed into a sheet or rope shape can be wound around the crop, spread near the crop, and covered with the soil at the base of the plant.

[0069] When the present compound, the compound of the present invention or the composition A is used to control harmful arthropods that inhabit the house, the application amount shall be the amount of the compound or the present invention per 1 m2 of treatment area when the surface is treated. The amount of the compound is usually 0.01 to 1000 mg. When the treatment is performed in a space, the amount of the compound or the compound of the present invention per 1 m3 of treatment space is usually 0.01 to 500 mg. When this compound, the compound of the present invention or composition A is formulated into an emulsion, hydration agent, suspension, etc., it is usually diluted with water so that the concentration of the active ingredient becomes 0.1 to 10000 ppm. Oils, aerosols, fumigants, Poison baits, etc. are applied directly.

[0070] When the present compound, the compound of the present invention or composition A is used for the prevention of external parasites in livestock such as cattle, horses, pigs, sheep, goats, chickens, etc., and small animals such as dogs, cats, rats, mice, etc., In veterinary medicine, it can still be used on animals using well-known methods. As a specific method of use, when the purpose is systemic suppression, for example, it can be administered by tablets, mixed with feed, suppositories, injections (intramuscular, subcutaneous, intravenous, intraperitoneal, etc.). When the purpose is not systemic suppression, for example, by administration It can be used by spraying oil or water-based liquid, pouring or dotting, washing the animal with a scouring preparation, or attaching the resin preparation to the animal as a collar or ear tag. The amount of the compound, the compound of the present invention, or composition A when administered to an animal is usually in the range of 0.1 to 1000 mg per 1 kg of the animal's body weight.

[0071] The present compound, the compound of the present invention or composition A can be used as a control agent for harmful arthropods in agricultural lands such as fields, paddy fields, lawns, orchards, etc. Examples of plants include the following.

[0072] Corn (maize, hard-grained, soft-grained, bursting, waxy, sweet, feed corn), rice (long-grained, short-grained, medium-grained, japonica, tropical japonica) Seeds, indica rice, Javanese rice, rice, upland rice, floating rice, direct seeding, transplantation, glutinous rice), wheat (bread wheat (hard, soft, medium, red wheat, white wheat), durum wheat, Sri Lankan wheat) Pelted wheat, dense wheat, respective winter wheat types, spring wheat types), barley (two-row barley (= malting barley), six-row barley, highland barley, waxy wheat, respective winter barley type, spring barley type), rye ( Winter rye type, spring rye type), triticale (winter triticale type, spring triticale type) oats (winter oat type, spring oat type), sorghum, cotton (highland type, Pima type), soybeans (fully mature Seed harvest varieties, edamame varieties, green cut varieties, respective unlimited growth types, limited growth types, semi-limited growth types), peanuts, buckwheat, sugar beets (for sugar production, feed, root vegetables, leaf vegetables, fuel), rapeseed (Winter rapeseed type, spring rapeseed type), canola (winter canola type, spring canola type) sunflower (for oil extraction, edible, ornamental use), sugar cane, tobacco, tea tree, mulberry, solanaceous vegetables (eggplant , tomatoes, green peppers, hot peppers, potatoes, etc.), cucurbitaceous vegetables (cucumber, pumpkin, zucchini, watermelon, cantaloupe, etc.), cruciferous vegetables (radish, turnip, horseradish, kohlrabi, cabbage, cabbage, mustard greens) , broccoli, cauliflower, etc.), Asteraceae vegetables (burdock, chrysanthemums, artichokes, lettuce, etc.), Liliaceae vegetables (scallions, onions, garlic, asparagus, etc.), Umbelliferae vegetables (carrots, parsley, celery, American parsnips, etc.), Chenopodiaceae vegetables (spinach, red cabbage, etc.), Labiatae vegetables (perilla, mint, basil, etc.), strawberries, sweet potatoes, Japanese yam, taro, pome fruits (apples, pears, Japanese Pears, Chinese pears, quince, quinces, etc.), stone fruits (peaches, plums, nectarines, plums, cherries, apricots, dates, etc.), citrus (Wenzhou mandarins, oranges, lemons, limes, grapefruits, etc. ), nuts (chestnuts, walnuts, hazelnuts, almonds, pistachios, cashews, macadamia nuts, etc.), berries (blueberries, cranberries, blackberries, raspberries, etc.), grapes, persimmons, figs, olives, loquats, bananas , coffee, dates, coconuts, ornamental plants, forest plants, grasses, and pastures.

[0073] The above-mentioned plants are not particularly limited as long as they are commonly cultivated varieties. The above-mentioned plants also include plants that can be produced by natural mating, plants that can be produced by mutation, F1 hybrid plants, and genetically recombinant crops. Examples of genetically recombinant crops include HPPD (4-hydroxyphenylpyruvate dioxygenase) inhibitors such as isoxaflutole, imazethapyr, and thifensulfuron-methyl. Such as ALS (acetyl lactate synthase) inhibitor, EPSP (5-enolpyruvylshikimate-3-phosphate synthase) inhibitor, glutamine synthetase inhibitor, PPO (protoporphyrin oxidase) inhibitor Plants that are resistant to herbicides such as herbicides such as bromoxynil or dicamba; plants that can synthesize known selective toxins in Bacillus genus such as Bacillus thuringiensis; plants that are synthesized and derived from Gene fragments that are partially identical to the intrinsic genes of harmful insects, etc., are plants that confer specific insecticidal activity by inducing gene silencing (RNAi; RNA interference) in the target harmful insects. [Example]

[0074] Hereinafter, although the present invention will be further described in detail through production examples, preparation examples, test examples, etc., the present invention is not limited to these examples. In this specification, Me represents methyl, Et represents ethyl, Pr represents propyl, i-Pr represents isopropyl, t-Bu represents tert-butyl, c-Pr represents cyclopropyl, and c-Bu represents cyclobutyl. Base, c-Pen represents cyclopentyl, c-Hex represents cyclohexyl, CF3 represents trifluoromethyl, OCF3 represents trifluoromethoxy, OEt represents ethoxy, OPr represents propoxy, O(i-Pr) represents isopropoxy group, Ph represents phenyl group, Py2 represents 2-pyridyl group, Py3 represents 3-pyridyl group, Py4 represents 4-pyridyl group, and Bn represents benzyl group. When c-Pr, c-Bu, c-Pen, c-Hex, Ph, Py2, Py3 and Py4 have a substituent, the substitution position is stated before the symbol. For example, 1-CN-c-Pr represents 1-cyanocyclopropyl, 3,4-F2-Ph represents 3,4-difluorophenyl, and 4-CF3-Py2 represents 4-(trifluoromethyl)- 2-pyridyl, 5-OCH2CF2CF3-Py2 represents 5-(2,2,3,3,3-pentafluoropropoxy)-2-pyridyl.

[0075] First, a production example of the present compound (including the compound of the present invention) is shown.

[0076] When measuring the physical property values ​​of a compound by liquid chromatography / mass analysis (hereinafter, referred to as LCMS), the measured molecular ion value [M+H]+ or [M-H]- and the retention time (hereinafter, referred to as RT) are recorded. . The conditions for liquid chromatography analysis (hereinafter, referred to as LC) are as follows.

[0077] [LC conditions] Column: L-column2 ODS, inner diameter 4.6 mm, length 30 mm, particle size 3 μm (General Incorporated Research Institute for Chemical Substances Evaluation) UV measurement wavelength: 254nm Mobile phase: Liquid A: 0.1% Formic acid aqueous solution, B solution: 0.1% formic acid acetonitrile Flow rate: 2.0 mL / min Pump: LC-20AD (manufactured by Shimadzu Corporation) 2 units (high-pressure gradient) Gradient conditions: Deliver the solution with the concentration gradient described in [Table LC1].

[0078]

[0079] [MS conditions] Detector: LCMS-2020 (manufactured by Shimadzu Corporation) Ionization method: DUIS

[0080] Production Example 1 To a mixture of 0.20 g of 3-chloro-N'-hydroxypyridine-4-carboxyliminamide and 5 mL of DMF produced by the method described in Japanese Patent Application Laid-Open No. 2002-114783, benzene was added under ice-cooling. After adding 0.18 g of formyl chloride, 0.13 g of triethylamine was added dropwise under ice cooling, and the mixture was stirred at 140° C. for 6 hours. After cooling to room temperature, a saturated aqueous sodium bicarbonate solution was added to the resulting mixture, and the mixture was extracted with ethyl acetate. The obtained organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography (ethyl acetate:hexane=30:70) to obtain 0.31 g of this compound 1 represented by the following formula. Compound 1: 1H-NMR (CDCl3) δ: 8.81 (1H, s), 8.67 (1H, d), 8.22 (2H, d), 8.01 (1H, d), 7.65-7.55 (3H, m).

[0081] Production Example 1-1 The compound produced according to Production Example 1 and its physical property values ​​are shown below. Among the compounds represented by formula (B-1), the combination of R1, R2, R3, R4, R5, R6 and R7 is a compound of any combination described in [Table B-1] and [Table B-2].

[0082]

[0083] This compound 2: 1H-NMR (CDCl3) δ: 8.82 (1H, s), 8.67 (1H, d), 8.28-8.22 (2H, m), 7.99 (1H, d), 7.30-7.24 (2H , m). This compound 3: 1H-NMR (CDCl3) δ: 8.83 (1H, s), 8.68 (1H, d), 8.24-8.18 (1H, m), 8.01 (1H, d), 7.13-7.07 ( 2H, m), 2.80 (3H, s). This compound 4: 1H-NMR (CDCl3) δ: 8.67 (2H, s), 8.21 (2H, dd), 7.64-7.54 (3H, m). This compound 5 : 1H-NMR (CDCl3) δ: 8.60 (2H, s), 8.10 (1H, dd), 7.55-7.35 (3H, m). This compound 6: 1H-NMR (CDCl3) δ: 8.69 (2H, s) , 8.21 (1H, s), 8.11 (1H, d), 7.62 (1H, d), 7.53 (1H, t) Compound 7: 1H-NMR (CDCl3) δ: 8.68 (2H, s), 8.16 (2H , d), 7.57 (2H, d). Compound 8: 1H-NMR (CDCl3) δ: 8.59 (2H, s), 8.09 (1H, d), 7.42 (1H, t), 7.29 (2H, d) , 2.68 (3H, s). Compound 9: 1H-NMR (CDCl3) δ: 8.68 (2H, s), 8.04 (1H, br s), 8.04-8.00 (1H, m), 7.46 (2H, d) , 2.47 (3H, s). This compound 10: 1H-NMR (CDCl3) δ: 8.68 (2H, s), 8.10 (2H, d), 7.38 (2H, d), 2.47 (3H, s). This compound 11: 1H-NMR (CDCl3) δ: 8.68 (2H, s), 8.26-8.23 (2H, m), 7.31-7.24 (2H, m). Compound 12: 1H-NMR (CDCl3) δ: 8.60 (2H , s), 8.08 (1H, d), 7.57 (1H, s), 7.39 (1H, d). Compound 13: 1H-NMR (CDCl3) δ: 8.69 (2H, s), 8.14 (1H, d) , 7.40 (1H, s), 7.38 (1H, d), 2.75 (3H, s). Compound 14: 1H-NMR (CDCl3) δ: 8.69 (2H, s), 8.32 (1H, s), 8.05 ( 1H, d), 7.68 (1H, d). This compound 15: 1H-NMR (CDCl3) δ: 8.69 (2H, s), 8.11 (2H, s), 7.64 (1H, s). This compound 16: 1H -NMR (CDCl3) δ: 8.70 (2H, s), 8.52 (1H, br s), 8.45 (1H, dd), 7.94 (1H, dd), 7.75 (1H, t). Compound 17: 1H-NMR (CDCl3) δ: 9.08 (1H, br s), 8.70 (2H, s), 8.55 (2H, dt), 7.85 (1H, dt). Compound 18: 1H-NMR (CDCl3) δ: 8.59 (2H, s), 7.72 (1H, dd), 7.61 (1H, t), 7.38 (1H, t), 7.08 (1H, dd), 3.81 (3H, s). Compound 19 of the present invention: 1H-NMR (CDCl3) δ : 8.69 (2H, s), 8.09-8.01 (2H, m), 7.45-7.36 (1H, m). Compound 20 of the present invention: 1H-NMR (CDCl3) δ: 8.72 (2H, s), 7.79-7.78 ( 2H, m), 7.15-7.13 (1H, m). Compound 21: 1H-NMR (CDCl3) δ: 8.70 (2H, s), 8.51 (1H, br s), 8.42 (1H, d), 7.92 ( 1H, d), 7.76 (1H, t). Compound 22 of the present invention: 1H-NMR (CDCl3) δ: 8.69 (2H, s), 8.17 (1H, d), 8.08 (1H, s), 7.66-7.64 ( 1H, m), 7.51 (1H, d). Compound 23 of the present invention: 1H-NMR (CDCl3) δ: 8.96 (2H, s), 8.17-8.15 (1H, m), 8.04 (1H, s), 7.93 ( 1H, d). Compound 36 of the present invention: 1H-NMR (CDCl3) δ: 8.84 (1H, s), 8.70 (1H, d), 8.19 (1H, d), 8.10 (1H, s), 8.01 (1H, d), 7.66 (1H, t), 7.52 (1H, d). Compound 37: 1H-NMR (CDCl3) δ: 8.84 (1H, s), 8.70 (1H, d), 8.54 (1H, s), 8.36 (1H, d), 8.02 (1H, d), 7.95 (1H, d), 7.69 (1H, t). Compound 38: 1H-NMR (CDCl3) δ: 8.85 (1H, s), 8.71 (1H , d), 8.25-8.23 (1H, m), 8.13 (1H, d), 8.04-8.01 (1H, m), 7.66-7.62 (1H, m), 7.57-7.52 (1H, m). Compounds of the present invention 39: 1H-NMR (CDCl3) δ: 8.85 (1H, s), 8.71 (1H, d), 8.06-8.05 (1H, m), 8.00 (1H, d), 7.87-7.83 (1H, m), 7.41 -7.38 (1H, m). This compound 40: 1H-NMR (CDCl3) δ: 8.70 (2H, s), 8.40-8.39 (1H, m), 8.17 (1H, d), 7.80 (1H, d), 7.48 (1H, t). Compound 41: 1H-NMR (CDCl3) δ: 8.70 (2H, s), 8.60-8.58 (1H, m), 8.22-8.18 (1H, m), 8.01-7.98 (1H, m), 7.34 (1H, t). Compound 42: 1H-NMR (CDCl3) δ: 8.68 (2H, s), 8.24 (1H, s), 8.04 (1H, d), 7.69 (1H, d), 7.52 (1H, t), 1.40 (9H, s). Compound 43 of the present invention: 1H-NMR (CDCl3) δ: 8.70 (2H, s), 8.10 (1H, d), 8.00-7.98 (1H, m), 7.61 (1H, t), 7.46-7.43 (1H, m), 6.63 (1H, t). Compound 44: 1H-NMR (CDCl3) δ: 8.68 (2H, s), 7.85 (2H, s), 7.29 (1H, s), 2.43 (6H, s). This compound 45: 1H-NMR (CDCl3) δ: 8.69 (2H, s), 8.34-8.30 (1H, m), 8.16-8.11 (1H, m), 7.37 (1H, t). Compound 46 of the present invention: 1H-NMR (CDCl3) δ: 8.70 (2H, s), 8.06-8.04 (1H, m), 7.84 (1H, d), 7.40 (1H, d). Compound 47 of the present invention: 1H-NMR (CDCl3) δ: 8.69 (2H, s), 8.49-8.46 (1H, m), 8.20-8.16 (1H, m), 7.34 (1H, t). Compound 48 of the present invention: 1H -NMR (CDCl3) δ: 8.70 (2H, s), 8.20-8.19 (1H, m), 7.90-7.86 (1H, m), 7.57-7.53 (1H, m). This compound 49: 1H-NMR (CDCl3 ) δ: 8.84 (2H, s), 8.52 (1H, s), 8.43 (1H, d), 7.93 (1H, d), 7.76 (1H, t). Compound 56 of the present invention: 1H-NMR (CDCl3) δ : 8.70 (2H, s), 8.06-8.02 (1H, m), 7.96-7.91 (1H, m), 7.61-7.55 (1H, m), 7.40-7.34 (1H, m).

[0084] Production Example 2: 3,5-dichloro-N-hydroxyisonicotinimidoyl chloride produced by the method described in International Publication No. 2002 / 081482 To a mixture of 0.40 g and 20 mL of tetrahydrofuran, add 0.24 mL of 4-ethynyl-1,2-difluorobenzene under ice-cooling, add 0.55 mL of triethylamine dropwise under ice-cooling, and stir at room temperature for 20 hours. Water was added to the obtained mixture, and the mixture was extracted with ethyl acetate. The obtained organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography (ethyl acetate:hexane=25:75) to obtain 0.30 g of this compound 24 represented by the following formula. Compound 24: 1H-NMR (CDCl3) δ: 8.66 (2H, s), 7.73-7.57 (2H, m), 7.37-7.28 (1H, m), 6.65 (1H, s).

[0085] Production Example 3 To a mixture of 0.73 g of 3,5-dichloropyridine-4-carboxylic acid and 10 mL of toluene, 0.33 mL of thionyl chloride was added at room temperature, and the mixture was stirred under reflux for 3 hours. After cooling to room temperature, toluene was distilled off, and 5 mL of DMF and 0.72 g of 3,4-difluorobenzohydrazine were added to the resulting residue, and the mixture was stirred under reflux for 8 hours. 50 mL of saturated sodium bicarbonate aqueous solution was added to the resulting mixture, and extraction was performed with ethyl acetate. The obtained organic layer was dried over anhydrous magnesium sulfate and concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography (ethyl acetate: hexane = 1:1) to obtain 3,5-dichloro-N'-(3,4-difluorobenzoyl). )pyridine-4-carbohydrazide (carbohydrazide) 0.21g. To the obtained mixture of 0.21 g of 3,5-dichloro-N'-(3,4-difluorobenzoyl)pyridine-4-carbazine and 5 mL of acetonitrile, p-toluenesulfonyl group was added sequentially at room temperature. 0.17g and 0.35mL of triethylamine, stir at room temperature for 3 hours. A saturated aqueous sodium bicarbonate solution was added to the resulting mixture, and the mixture was extracted with ethyl acetate. The obtained organic layer was dried over anhydrous magnesium sulfate and concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography (ethyl acetate:hexane=1:10) to obtain 0.11 g of the present compound 25 represented by the following formula. Compound 25: 1H-NMR (CDCl3) δ: 8.77 (2H, s), 8.04-7.95 (2H, m), 7.44-7.38 (1H, m).

[0086] Production Example 4 To a mixture of 0.53 g of 3-methoxypyridine-4-carboxylic acid and 15 mL of toluene, 0.3 mL of thionyl chloride and 0.1 mL of DMF were added at room temperature, and the mixture was stirred under reflux for 3 hours. After cooling to room temperature, toluene was distilled off, and 5 mL of THF was added to the resulting residue. A mixture of 0.4 g of 3,4-difluorobenzenecarboxyliminamide and 10 mL of THF, and 0.86 mL of diazadobicycloundecene were added sequentially to the resulting mixture at room temperature, and the mixture was stirred at room temperature for 3 hours. A saturated aqueous sodium bicarbonate solution was added to the resulting mixture, and the mixture was extracted with ethyl acetate. The obtained organic layer was dried over anhydrous magnesium sulfate and concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography (ethyl acetate:hexane=1:10) to obtain 0.24 g of the present compound 26 represented by the following formula. Compound 26: 1H-NMR (CDCl3) δ: 8.65 (1H, s), 8.51 (1H, d), 8.08-7.99 (3H, m), 7.39-7.30 (1H, m), 4.18 (3H, s) .

[0087] Production Example 5 900 mg of 3-(3,4-difluorophenyl)-1H-pyrazole, 910 mg of 3,4,5-trichloropyridine, were produced by the method described in International Publication No. 2020 / 043866. A mixture of 1.0 g of potassium carbonate and 10 mL of DMF was stirred at 50°C for 8 hours. Water was added to the obtained mixture, and the mixture was extracted with ethyl acetate. The obtained organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography (ethyl acetate:hexane=30:70) to obtain 1.0 g of the compound 27 of the present invention represented by the following formula. Compound 27 of the present invention: 1H-NMR (CDCl3) δ: 8.70 (2H, s), 7.71-7.69 (2H, m), 7.59-7.58 (1H, m), 7.23-7.20 (1H, m), 6.80 (1H , d).

[0088] Production Example 6 2.2 g of 3,5-dichloropyridine-4-carbazide, 1.38 g of 4-chlorobenzonitrile, 1.38 g of potassium carbonate, and produced by the method described in International Publication No. 2012 / 098416 A mixture of 20 mL of 1-butanol was stirred at 140°C for 6 hours. Water was added to the obtained mixture, and the mixture was extracted with ethyl acetate. The obtained organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography (ethyl acetate:hexane=30:70) to obtain 390 mg of the present compound 28 represented by the following formula. Compound 28: LCMS: 325 [M+H]+, RT = 1.94 minutes

[0089] Production Example 6-1 The compound produced according to Production Example 6 and its physical property values ​​are shown below. Compound 33: 1H-NMR (CDCl3) δ: 8.68 (2H, s), 8.38 (1H, s), 8.28 (1H, d), 7.76 (1H, d), 7.68-7.63 (1H, m).

[0090] This compound 34: 1H-NMR (CDCl3) δ: 8.68 (2H, s), 7.83-7.79 (2H, m), 7.10-7.05 (1H, m).

[0091] Production Example 7 A mixture of 390 mg of this compound 28, 94 μL of methyl iodide, 492 mg of cesium carbonate, and 5 mL of DMF was stirred at room temperature for 6 hours. Water was added to the obtained mixture, and the mixture was extracted with ethyl acetate. The obtained organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography (ethyl acetate:hexane=30:70) to obtain 50 mg of the present compound 29 represented by the following formula. This compound 29: 8.62 (2H, s), 7.73 (2H, d), 7.53 (2H, d), 4.12 (3H, s).

[0092] Production Example 8 The compound produced according to Production Example 7 and its physical property values ​​are shown below. Compound 30: 1H-NMR (CDCl3) δ: 8.63 (2H, s), 7.74 (1H, d), 7.65-7.60 (2H, m), 7.41 (1H, d), 4.15 (3H, s).

[0093] Compound 31 of the present invention: 1H-NMR (CDCl3) δ: 8.72 (2H, s), 7.85-7.80 (2H, m), 7.04-7.00 (1H, m), 3.83 (3H, s).

[0094] This compound 32: 1H-NMR (CDCl3) δ: 8.63 (2H, s), 8.05-8.03 (1H, m), 7.86 (1H, m), 7.73 (1H, s), 4.16 (3H, s) ).

[0095] This compound 35: 1H-NMR (CDCl3) δ: 8.72 (2H, s), 8.43 (1H, s), 8.33 (1H, d), 7.70-7.67 (1H, m), 7.61-7.57 (1H , m), 3.83 (3H, s).

[0096] Production Example 9 160 mg of this compound 49, 65.8 mg of methylboronic acid, 52.7 mg of [1,1'-bis(diphenylphosphino)ferrocene]dichloropalladium(II), 469 mg of cesium carbonate and A mixture of 2 mL of DME was stirred at 80°C for 4 hours under a nitrogen atmosphere. Water was added to the obtained mixture, and the mixture was extracted with ethyl acetate. The obtained organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography analysis to obtain 30 mg of the present compound 50 represented by the following formula. Compound 50: 1H-NMR (CDCl3) δ: 8.76 (1H, s), 8.54 (1H, s), 8.51 (1H, s), 8.42 (1H, d), 7.93-7.91 (1H, m), 7.78 -7.73 (1H, m), 2.32 (3H, s).

[0097] Production Example 10 The compound produced according to Production Example 9 and its physical property values ​​are shown below. Compound 51 of the present invention: 1H-NMR (CDCl3) δ: 8.72 (1H, s), 8.51 (1H, s), 8.43 (1H, d), 8.33 (1H, s), 7.93-7.90 (1H, m), 7.75 (1H, t), 1.87-1.79 (1H, m), 0.95-0.90 (2H, m), 0.82-0.78 (2H, m).

[0098] Compound 52 of the present invention: 1H-NMR (CDCl3) δ: 8.52 (1H, s), 8.43 (1H, d), 8.25 (2H, s), 7.92-7.90 (1H, m), 7.75 (1H, t), 1.88-1.81 (2H, m), 0.90-0.83 (4H, m), 0.77-0.73 (4H, m).

[0099] Production Example 11 To a mixture of 0.2 g of sodium hydride (oil, 60%), 180 mg of this compound 21, and 2 mL of THF, 1 mL of methanol was added and the mixture was stirred at 80° C. for 4 hours. Water was added to the obtained mixture, and the mixture was extracted with ethyl acetate. The obtained organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The obtained residue was subjected to silica gel column chromatography analysis to obtain 90 mg of the compound 53 of the present invention represented by the following formula. Compound 53 of the present invention: 1H-NMR (CDCl3) δ: 8.50 (1H, s), 8.45 (1H, s), 8.41 (1H, d), 8.38 (1H, s), 7.90 (1H, d), 7.73 ( 1H, t), 3.96 (3H, s).

[0100] Production Example 11-1 The compound produced according to Production Example 11 and its physical property values ​​are shown below. Among the compounds represented by formula (C-1), the combination of R1, R2, R3, R4, R5, R6 and R7 is a compound of any combination described in [Table C-1] and [Table C-2].

[0101]

[0102] Compound 54 of the present invention: 1H-NMR (CDCl3) δ: 8.50 (1H, s), 8.41 (2H, d), 8.36 (1H, s), 7.90 (1H, d), 7.73 (1H, t) , 4.22 (2H, q), 1.36 (3H, t). Compound 55 of the present invention: 1H-NMR (CDCl3) δ: 8.50 (1H, s), 8.43-8.32 (3H, m), 7.89 (1H, d) , 7.73 (1H, t), 4.74-4.68 (1H, m), 1.32 (6H, d). Compound 57 of the present invention: 1H-NMR (CDCl3) δ: 8.45 (1H, s), 8.38 (1H, s) , 8.04-8.01 (1H, m), 7.95-7.91 (1H, m), 7.60-7.53 (1H, m), 7.38-7.33 (1H, m), 3.96 (3H, s). Compound 58 of the present invention: 1H -NMR (CDCl3) δ: 8.42 (1H, s), 8.35 (1H, s), 8.04-8.01 (1H, m), 7.94-7.90 (1H, m), 7.60-7.53 (1H, m), 7.38- 7.32 (1H, m), 4.22 (2H, q), 1.36 (3H, t). Compound 59 of the present invention: 1H-NMR (CDCl3) δ: 8.57 (1H, s), 8.53 (1H, s), 8.05- 8.01 (1H, m), 7.95-7.91 (1H, m), 7.60-7.54 (1H, m), 7.38-7.33 (1H, m), 2.55 (3H, s). Compound 60 of the present invention: 1H-NMR ( CDCl3) δ: 8.45 (1H, s), 8.38 (1H, s), 8.24-8.22 (1H, m), 8.13-8.09 (1H, m), 7.64-7.60 (1H, m), 7.52 (1H, t ), 3.95 (3H, s). Compound 61 of the present invention: 1H-NMR (CDCl3) δ: 8.39 (1H, s), 8.37 (1H, s), 8.24-8.21 (1H, m), 8.13-8.10 (1H , m), 7.64-7.60 (1H, m), 7.53 (1H, t), 4.73-4.67 (1H, m), 1.33 (6H, d). Compound 62 of the present invention: 1H-NMR (CDCl3) δ: 8.44 (1H, s), 8.36 (1H, s), 8.05 (1H, s), 8.03-8.00 (1H, m), 7.46-7.44 (2H, m), 3.95 (3H, s), 2.46 (3H, s ). Compound 63 of the present invention: 1H-NMR (CDCl3) δ: 8.41 (1H, s), 8.34 (1H, s), 8.05 (1H, s), 8.03-8.01 (1H, m), 7.46-7.44 (2H , m), 4.21 (2H, q), 2.46 (3H, s), 1.35 (3H, t). Compound 64 of the present invention: 1H-NMR (CDCl3) δ: 8.43 (1H, s), 8.35 (1H, s ), 7.84-7.82 (2H, m), 7.26-7.24 (1H, m), 3.93 (3H, s), 2.41 (6H, s). Compound 65 of the present invention: 1H-NMR (CDCl3) δ: 8.42 (1H , s), 8.35 (1H, s), 8.19-8.16 (1H, m), 8.08 (1H, s), 7.63 (1H, t), 7.52-7.48 (1H, m), 4.22 (2H, q), 1.36 (3H, t). Compound 66 of the present invention: 1H-NMR (CDCl3) δ: 8.69-8.66 (2H, m), 8.42-8.40 (1H, m), 8.14-8.09 (1H, m), 7.04-7.00 (1H, m), 4.22 (2H, q), 1.54 (3H, t). Compound 67: 1H-NMR (CDCl3) δ: 8.42-8.41 (1H, m), 8.40 (1H, s), 8.33 ( 1H, s), 8.13-8.09 (1H, m), 7.01 (1H, d), 4.26-4.17 (4H, m), 1.53 (3H, t), 1.35 (3H, t). This compound 68: 1H- NMR (CDCl3) δ: 8.39 (1H, s), 8.36 (1H, s), 7.53-7.51 (1H, m), 7.50-7.46 (1H, m), 6.87-6.83 (1H, m), 4.73-4.61 (2H, m), 1.39 (6H, d), 1.33 (6H, d). Compound 69 of the present invention: 1H-NMR (CDCl3) δ: 8.58 (1H, s), 8.54 (1H, s), 8.52-8.50 (1H, m), 8.44-8.41 (1H, m), 7.93-7.90 (1H, m), 7.77-7.72 (1H, m), 2.56 (3H, s). Compound 70 of the present invention: 1H-NMR (CDCl3 ) δ: 8.57 (1H, s), 8.53 (1H, s), 8.25-8.23 (1H, m), 8.14-8.10 (1H, m), 7.64-7.61 (1H, m), 7.53 (1H, t) , 2.55 (3H, s). Compound 71 of the present invention: 1H-NMR (CDCl3) δ: 8.45 (2H, s), 8.23 ​​(1H, s), 8.15-8.09 (1H, m), 7.65-7.58 (1H, m), 7.56-7.49 (1H, m), 2.52 (6H, s). Compound 77 of the present invention: 1H-NMR (CDCl3) δ: 8.56 (1H, s), 8.53 (1H, s), 7.78-7.74 ( 2H, m), 7.13-7.07 (1H, m), 2.54 (3H, s). Compound 78 of the present invention: 1H-NMR (CDCl3) δ: 8.55 (1H, s), 8.50 (1H, s), 7.84 ( 2H, s), 7.26 (1H, s), 2.53 (3H, s), 2.41 (6H, s).

[0103] Production Example 12 A mixture of 160 mg of the present compound 69, 2 mL of chloroform, and 212 mg of m-chloroperoxybenzoic acid was stirred at room temperature for 2 hours. The obtained mixture was washed sequentially with sodium thiosulfate aqueous solution and sodium bicarbonate aqueous solution. The obtained organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The obtained residue was subjected to silica gel chromatography analysis to obtain 150 mg of the compound 72 of the present invention represented by the following formula. Compound 72 of the present invention: 1H-NMR (CDCl3) δ: 9.30 (1H, s), 9.07 (1H, s), 8.48 (1H, s), 8.41 (1H, d), 7.92 (1H, d), 7.75 ( 1H, t), 3.36 (3H, s).

[0104] Production Example 13 A mixture of 360 mg of this compound 21, 4 mL of chloroform, and 247 mg of m-chloroperoxybenzoic acid was stirred at 70° C. for 2 hours. The obtained mixture was washed with sodium thiosulfate aqueous solution and sodium bicarbonate aqueous solution in sequence. The obtained organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The obtained residue was subjected to silica gel chromatography analysis to obtain 250 mg of the present compound 73 represented by the following formula. Compound 73: 1H-NMR (CDCl3) δ: 8.49 (1H, s), 8.41 (1H, d), 8.32 (2H, s), 7.93 (1H, d), 7.75 (1H, t).

[0105] Production Example 14 A mixture of 50 mg of the present compound 69, 2 mL of chloroform, and 33 mg of m-chloroperoxybenzoic acid was stirred at 0° C. for 1 hour. The obtained mixture was washed sequentially with sodium thiosulfate aqueous solution and sodium bicarbonate aqueous solution. The obtained organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The obtained residue was subjected to silica gel chromatography analysis to obtain 40 mg of compound 74 of the present invention represented by the following formula. Compound 74 of the present invention: 1H-NMR (CDCl3) δ: 9.32 (1H, s), 8.96 (1H, s), 8.47 (1H, s), 8.41 (1H, d), 7.95 (1H, d), 7.78 ( 1H, t), 3.07 (3H, s).

[0106] Production Example 15 The compound produced according to Production Example 14 and its physical property values ​​are shown below. Compound 75 of the present invention: 1H-NMR (CDCl3) δ: 9.32 (1H, s), 8.96 (1H, s), 8.03-8.00 (1H, m), 7.92-7.88 (1H, m), 7.64-7.58 (1H , m), 7.43-7.38 (1H, m), 3.08 (3H, s).

[0107] Compound 76 of the present invention: 1H-NMR (CDCl3) δ: 9.32 (1H, s), 8.96 (1H, s), 8.20-8.18 (1H, m), 8.12-8.08 (1H, m), 7.68- 7.65 (1H, m), 7.58-7.54 (1H, m), 3.07 (3H, s).

[0108] Next, examples of the present compound and the compound of the present invention produced according to any of the production examples described in the Examples and the production methods described in this specification are shown below.

[0109] In the compound represented by formula (L-1) (hereinafter, referred to as compound (L-1)), R1 is a fluorine atom, R2 is a hydrogen atom, R4, R5, R6 and R7 are hydrogen atoms, and R3 is Compounds having any of the substituents described in [Table L1] (hereinafter, referred to as compound group SX1).

[0110]

[0111] In the compound (L-1), R1 and R2 are fluorine atoms, R4, R5, R6 and R7 are hydrogen atoms, and R3 is a compound containing any substituent described in [Table L1] (hereinafter, referred to as compound Group SX2). In the compound (L-1), R1 is a chlorine atom, R2 is a hydrogen atom, R4, R5, R6 and R7 are hydrogen atoms, and R3 is a compound containing any substituent described in [Table L1] (hereinafter, referred to as compound Group SX3). In the compound (L-1), R1 and R2 are chlorine atoms, R4, R5, R6 and R7 are hydrogen atoms, and R3 is any substituent described in [Table L1] (hereinafter, referred to as compound group SX4 ). In the compound (L-1), R1 is a bromine atom, R2 is a hydrogen atom, R4, R5, R6 and R7 are hydrogen atoms, and R3 is a compound containing any substituent described in [Table L1] (hereinafter, referred to as compound Group SX5). In the compound (L-1), R1 and R2 are bromine atoms, R4, R5, R6 and R7 are hydrogen atoms, and R3 is any substituent described in [Table L1] (hereinafter, referred to as compound group SX6 ). In the compound (L-1), R1 is an iodine atom, R2 is a hydrogen atom, R4, R5, R6 and R7 are hydrogen atoms, and R3 is a compound containing any substituent described in [Table L1] (hereinafter, referred to as compound Group SX7). In the compound (L-1), R1 and R2 are iodine atoms, R4, R5, R6 and R7 are hydrogen atoms, and R3 is any substituent described in [Table L1] (hereinafter, referred to as compound group SX8 ). In the compound (L-1), R1 is a methyl group, R2 is a hydrogen atom, R4, R5, R6 and R7 are hydrogen atoms, and R3 is a compound containing any substituent described in [Table L1] (hereinafter, referred to as compound Group SX9). In the compound (L-1), R1 and R2 are methyl groups, R4, R5, R6 and R7 are hydrogen atoms, and R3 is any substituent described in [Table L1] (hereinafter, referred to as compound group SX10 ). In compound (L-1), R1 is an ethyl group, R2 is a hydrogen atom, R4, R5, R6 and R7 are hydrogen atoms, and R3 is a compound in which any substituent described in [Table L1] is used (hereinafter, referred to as compound Group SX11). In compound (L-1), R1 and R2 are ethyl groups, R4, R5, R6 and R7 are hydrogen atoms, and R3 is any substituent described in [Table L1] (hereinafter, referred to as compound group SX12) . In the compound (L-1), R1 is a propyl group, R2 is a hydrogen atom, R4, R5, R6 and R7 are hydrogen atoms, and R3 is a compound containing any substituent described in [Table L1] (hereinafter, referred to as compound Group SX13). In compound (L-1), R1 and R2 are propyl groups, R4, R5, R6 and R7 are hydrogen atoms, and R3 is any substituent described in [Table L1] (hereinafter, referred to as compound group SX14 ). In the compound (L-1), R1 is an isopropyl group, R2 is a hydrogen atom, R4, R5, R6 and R7 are hydrogen atoms, and R3 is a compound in which any substituent described in [Table L1] (hereinafter, referred to as Compound group SX15). In compound (L-1), R1 and R2 are isopropyl groups, R4, R5, R6 and R7 are hydrogen atoms, and R3 is any substituent described in [Table L1] (hereinafter, referred to as compound group SX16). In the compound (L-1), R1 is a cyclopropyl group, R2 is a hydrogen atom, R4, R5, R6 and R7 are hydrogen atoms, and R3 is a compound in which any substituent described in [Table L1] (hereinafter, referred to as Compound group SX17). In the compound (L-1), R1 and R2 are cyclopropyl groups, R4, R5, R6 and R7 are hydrogen atoms, and R3 is any substituent described in [Table L1] (hereinafter, referred to as compound group SX18). In compound (L-1), R1 is CF3, R2 is a hydrogen atom, R4, R5, R6 and R7 are hydrogen atoms, and R3 is a compound containing any substituent described in [Table L1] (hereinafter, referred to as compound group Group SX19). In compound (L-1), R1 and R2 are CF3, R4, R5, R6 and R7 are hydrogen atoms, and R3 is any substituent described in [Table L1] (hereinafter, referred to as compound group SX20) .

[0112] In the compound (L-1), R1 is a chlorine atom, R2 is a bromine atom, R4, R5, R6 and R7 are hydrogen atoms, and R3 is a compound containing any substituent described in [Table L1] (hereinafter, Denoted as compound group SX21). In the compound (L-1), R1 is a chlorine atom, R2 is an iodine atom, R4, R5, R6 and R7 are hydrogen atoms, and R3 is a compound containing any substituent described in [Table L1] (hereinafter, referred to as compound Group SX22). In the compound (L-1), R1 is a chlorine atom, R2 is a methyl group, R4, R5, R6 and R7 are hydrogen atoms, and R3 is a compound containing any substituent described in [Table L1] (hereinafter, referred to as compound Group SX23). In the compound (L-1), R1 is a chlorine atom, R2 is an ethyl group, R4, R5, R6 and R7 are hydrogen atoms, and R3 is a compound containing any substituent described in [Table L1] (hereinafter, referred to as compound Group SX24). In compound (L-1), R1 is a chlorine atom, R2 is a propyl group, R4, R5, R6 and R7 are hydrogen atoms, and R3 is a compound containing any substituent described in [Table L1] (hereinafter, referred to as compound Group SX25). In the compound (L-1), R1 is a chlorine atom, R2 is an isopropyl group, R4, R5, R6 and R7 are hydrogen atoms, and R3 is a compound in which any substituent described in [Table L1] (hereinafter, referred to as Compound group SX26). In compound (L-1), R1 is a chlorine atom, R2 is a cyclopropyl group, R4, R5, R6 and R7 are hydrogen atoms, and R3 is a compound in which any substituent described in [Table L1] (hereinafter, referred to as Compound group SX27). In compound (L-1), R1 is a chlorine atom, R2 is CF3, R4, R5, R6 and R7 are hydrogen atoms, and R3 is a compound containing any substituent described in [Table L1] (hereinafter, referred to as compound group Group SX28). In compound (L-1), R1 is a bromine atom, R2 is an iodine atom, R4, R5, R6 and R7 are hydrogen atoms, and R3 is a compound containing any substituent described in [Table L1] (hereinafter, referred to as compound Group SX29). In compound (L-1), R1 is a bromine atom, R2 is a methyl group, R4, R5, R6 and R7 are hydrogen atoms, and R3 is a compound containing any substituent described in [Table L1] (hereinafter, referred to as compound Group SX30). In compound (L-1), R1 is a bromine atom, R2 is an ethyl group, R4, R5, R6 and R7 are hydrogen atoms, and R3 is a compound containing any substituent described in [Table L1] (hereinafter, referred to as compound Group SX31). In compound (L-1), R1 is a bromine atom, R2 is a propyl group, R4, R5, R6 and R7 are hydrogen atoms, and R3 is a compound containing any substituent described in [Table L1] (hereinafter, referred to as compound Group SX32). In the compound (L-1), R1 is a bromine atom, R2 is an isopropyl group, R4, R5, R6 and R7 are hydrogen atoms, and R3 is a compound in which any substituent described in [Table L1] (hereinafter, referred to as Compound group SX33). In compound (L-1), R1 is a bromine atom, R2 is a cyclopropyl group, R4, R5, R6 and R7 are hydrogen atoms, and R3 is a compound in which any substituent described in [Table L1] (hereinafter, referred to as Compound group SX34). In compound (L-1), R1 is a bromine atom, R2 is CF3, R4, R5, R6 and R7 are hydrogen atoms, and R3 is a compound containing any substituent described in [Table L1] (hereinafter, referred to as compound group Group SX35). In the compound (L-1), R1 is a methyl group, R2 is an ethyl group, R4, R5, R6 and R7 are hydrogen atoms, and R3 is a compound containing any substituent described in [Table L1] (hereinafter, referred to as compound Group SX36). In the compound (L-1), R1 is a methyl group, R2 is a propyl group, R4, R5, R6 and R7 are hydrogen atoms, and R3 is a compound containing any substituent described in [Table L1] (hereinafter, referred to as compound Group SX37). In compound (L-1), R1 is an ethyl group, R2 is a propyl group, R4, R5, R6 and R7 are hydrogen atoms, and R3 is a compound containing any substituent described in [Table L1] (hereinafter, referred to as compound Group SX38).

[0113] In compound (L-1), R1 is a fluorine atom, R2 is a hydrogen atom, R3, R5, R6 and R7 are hydrogen atoms, and R4 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX39). In compound (L-1), R1 and R2 are fluorine atoms, R3, R5, R6 and R7 are hydrogen atoms, and R4 is any substituent described in any one of [Table L1] to [Table L3]. (Hereinafter, referred to as compound group SX40). In compound (L-1), R1 is a chlorine atom, R2 is a hydrogen atom, R3, R5, R6 and R7 are hydrogen atoms, and R4 is any substitution described in any one of [Table L1] to [Table L3] base compound (hereinafter, referred to as compound group SX41). In compound (L-1), R1 and R2 are chlorine atoms, R3, R5, R6 and R7 are hydrogen atoms, and R4 is any substituent described in any one of [Table L1] to [Table L3]. (Hereinafter, referred to as compound group SX42). In compound (L-1), R1 is a bromine atom, R2 is a hydrogen atom, R3, R5, R6 and R7 are hydrogen atoms, and R4 is any substitution described in any one of [Table L1] to [Table L3] base compound (hereinafter, referred to as compound group SX43). In compound (L-1), R1 and R2 are bromine atoms, R3, R5, R6 and R7 are hydrogen atoms, and R4 is any substituent described in any one of [Table L1] to [Table L3]. (Hereinafter, referred to as compound group SX44). In compound (L-1), R1 is an iodine atom, R2 is a hydrogen atom, R3, R5, R6 and R7 are hydrogen atoms, and R4 is any substitution described in any one of [Table L1] to [Table L3] base compound (hereinafter, referred to as compound group SX45). In compound (L-1), R1 and R2 are iodine atoms, R3, R5, R6 and R7 are hydrogen atoms, and R4 is any substituent described in any one of [Table L1] to [Table L3]. (Hereinafter, referred to as compound group SX46). In compound (L-1), R1 is a methyl group, R2 is a hydrogen atom, R3, R5, R6 and R7 are hydrogen atoms, and R4 is any substitution described in any one of [Table L1] to [Table L3]. base compound (hereinafter, referred to as compound group SX47). In compound (L-1), R1 and R2 are methyl groups, R3, R5, R6 and R7 are hydrogen atoms, and R4 is any substituent described in any one of [Table L1] to [Table L3]. (Hereinafter, referred to as compound group SX48). In compound (L-1), R1 is an ethyl group, R2 is a hydrogen atom, R3, R5, R6 and R7 are hydrogen atoms, and R4 is any substitution described in any one of [Table L1] to [Table L3] base compound (hereinafter, referred to as compound group SX49). In compound (L-1), R1 and R2 are ethyl groups, R3, R5, R6 and R7 are hydrogen atoms, and R4 is any substituent described in any one of [Table L1] to [Table L3]. (Hereinafter, referred to as compound group SX50). In compound (L-1), R1 is a propyl group, R2 is a hydrogen atom, R3, R5, R6 and R7 are hydrogen atoms, and R4 is any substitution described in any one of [Table L1] to [Table L3] base compound (hereinafter, referred to as compound group SX51). In compound (L-1), R1 and R2 are propyl groups, R3, R5, R6 and R7 are hydrogen atoms, and R4 is any substituent described in any one of [Table L1] to [Table L3]. (Hereinafter, referred to as compound group SX52). In compound (L-1), R1 is an isopropyl group, R2 is a hydrogen atom, R3, R5, R6 and R7 are hydrogen atoms, and R4 is any one described in any one of [Table L1] to [Table L3] A compound with a substituent (hereinafter, referred to as compound group SX53). In compound (L-1), R1 and R2 are isopropyl groups, R3, R5, R6 and R7 are hydrogen atoms, and R4 is any substituent described in any one of [Table L1] to [Table L3]. compound (hereinafter, referred to as compound group SX54). In compound (L-1), R1 is a cyclopropyl group, R2 is a hydrogen atom, R3, R5, R6 and R7 are hydrogen atoms, and R4 is any one described in any one of [Table L1] to [Table L3] A compound with a substituent (hereinafter, referred to as compound group SX55). In compound (L-1), R1 and R2 are cyclopropyl groups, R3, R5, R6 and R7 are hydrogen atoms, and R4 is any substituent described in any one of [Table L1] to [Table L3] compound (hereinafter, referred to as compound group SX56). In compound (L-1), R1 is CF3, R2 is a hydrogen atom, R3, R5, R6 and R7 are hydrogen atoms, and R4 is any substituent described in any one of [Table L1] to [Table L3] compound (hereinafter, referred to as compound group SX57). In compound (L-1), R1 and R2 are CF3, R3, R5, R6 and R7 are hydrogen atoms, and R4 is any substituent described in any one of [Table L1] to [Table L3] ( Hereinafter, it is referred to as compound group SX58).

[0114] In compound (L-1), R1 is a chlorine atom, R2 is a bromine atom, R3, R5, R6 and R7 are hydrogen atoms, and R4 is as described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX59). In compound (L-1), R1 is a chlorine atom, R2 is an iodine atom, R3, R5, R6 and R7 are hydrogen atoms, and R4 is any substitution described in any one of [Table L1] to [Table L3] base compound (hereinafter, referred to as compound group SX60). In compound (L-1), R1 is a chlorine atom, R2 is a methyl group, R3, R5, R6 and R7 are hydrogen atoms, and R4 is any substitution described in any one of [Table L1] to [Table L3] base compound (hereinafter, referred to as compound group SX61). In compound (L-1), R1 is a chlorine atom, R2 is an ethyl group, R3, R5, R6 and R7 are hydrogen atoms, and R4 is any substitution described in any one of [Table L1] to [Table L3] base compound (hereinafter, referred to as compound group SX62). In compound (L-1), R1 is a chlorine atom, R2 is a propyl group, R3, R5, R6 and R7 are hydrogen atoms, and R4 is any substitution described in any one of [Table L1] to [Table L3] base compound (hereinafter, referred to as compound group SX63). In the compound (L-1), R1 is a chlorine atom, R2 is an isopropyl group, R3, R5, R6 and R7 are a hydrogen atom, and R4 is any one described in any one of [Table L1] to [Table L3] compounds with substituents (hereinafter, referred to as compound group SX64). In compound (L-1), R1 is a chlorine atom, R2 is a cyclopropyl group, R3, R5, R6 and R7 are hydrogen atoms, and R4 is any one described in any one of [Table L1] to [Table L3] Compounds with substituents (hereinafter, referred to as compound group SX65). In compound (L-1), R1 is a chlorine atom, R2 is CF3, R3, R5, R6 and R7 are hydrogen atoms, and R4 is any substituent described in any one of [Table L1] to [Table L3] compound (hereinafter, referred to as compound group SX66). In compound (L-1), R1 is a bromine atom, R2 is an iodine atom, R3, R5, R6 and R7 are hydrogen atoms, and R4 is any substitution described in any one of [Table L1] to [Table L3] base compound (hereinafter, referred to as compound group SX67). In compound (L-1), R1 is a bromine atom, R2 is a methyl group, R3, R5, R6 and R7 are hydrogen atoms, and R4 is any substitution described in any one of [Table L1] to [Table L3] base compound (hereinafter, referred to as compound group SX68). In compound (L-1), R1 is a bromine atom, R2 is an ethyl group, R3, R5, R6 and R7 are hydrogen atoms, and R4 is any substitution described in any one of [Table L1] to [Table L3] base compound (hereinafter, referred to as compound group SX69). In compound (L-1), R1 is a bromine atom, R2 is a propyl group, R3, R5, R6 and R7 are hydrogen atoms, and R4 is any substitution described in any one of [Table L1] to [Table L3] base compound (hereinafter, referred to as compound group SX70). In the compound (L-1), R1 is a bromine atom, R2 is an isopropyl group, R3, R5, R6 and R7 are a hydrogen atom, and R4 is any one described in any one of [Table L1] to [Table L3] A compound with a substituent (hereinafter, referred to as compound group SX71). In compound (L-1), R1 is a bromine atom, R2 is a cyclopropyl group, R3, R5, R6 and R7 are hydrogen atoms, and R4 is any one described in any one of [Table L1] to [Table L3] A compound with a substituent (hereinafter, referred to as compound group SX72). In compound (L-1), R1 is a bromine atom, R2 is CF3, R3, R5, R6 and R7 are hydrogen atoms, and R4 is any substituent described in any one of [Table L1] to [Table L3] compound (hereinafter, referred to as compound group SX73). In compound (L-1), R1 is a methyl group, R2 is an ethyl group, R3, R5, R6 and R7 are hydrogen atoms, and R4 is any substitution described in any one of [Table L1] to [Table L3] base compound (hereinafter, referred to as compound group SX74). In compound (L-1), R1 is a methyl group, R2 is a propyl group, R3, R5, R6 and R7 are hydrogen atoms, and R4 is any substitution described in any one of [Table L1] to [Table L3] base compound (hereinafter, referred to as compound group SX75). In compound (L-1), R1 is an ethyl group, R2 is a propyl group, R3, R5, R6 and R7 are hydrogen atoms, and R4 is any substitution described in any one of [Table L1] to [Table L3] base compound (hereinafter, referred to as compound group SX76).

[0115] In the compound (L-1), R1 is a fluorine atom, R2 is a hydrogen atom, R3, R4, R6 and R7 are hydrogen atoms, and R5 is described in any one of [Table L1] to [Table L2] Compounds with any substituent (hereinafter, referred to as compound group SX77). In compound (L-1), R1 and R2 are fluorine atoms, R3, R4, R6 and R7 are hydrogen atoms, and R5 is any substituent described in any one of [Table L1] to [Table L2]. (Hereinafter, referred to as compound group SX78). In compound (L-1), R1 is a chlorine atom, R2 is a hydrogen atom, R3, R4, R6 and R7 are hydrogen atoms, and R5 is any substitution described in any one of [Table L1] to [Table L2] base compound (hereinafter, referred to as compound group SX79). In compound (L-1), R1 and R2 are chlorine atoms, R3, R4, R6 and R7 are hydrogen atoms, and R5 is any substituent described in any one of [Table L1] to [Table L2]. (Hereinafter, referred to as compound group SX80). In compound (L-1), R1 is a bromine atom, R2 is a hydrogen atom, R3, R4, R6 and R7 are hydrogen atoms, and R5 is any substitution described in any one of [Table L1] to [Table L2] base compound (hereinafter, referred to as compound group SX81). In compound (L-1), R1 and R2 are bromine atoms, R3, R4, R6 and R7 are hydrogen atoms, and R5 is any substituent described in any one of [Table L1] to [Table L2]. (Hereinafter, referred to as compound group SX82). In compound (L-1), R1 is an iodine atom, R2 is a hydrogen atom, R3, R4, R6 and R7 are hydrogen atoms, and R5 is any substitution described in any one of [Table L1] to [Table L2] base compound (hereinafter, referred to as compound group SX83). In compound (L-1), R1 and R2 are iodine atoms, R3, R4, R6 and R7 are hydrogen atoms, and R5 is any substituent described in any one of [Table L1] to [Table L2]. (Hereinafter, referred to as compound group SX84). In compound (L-1), R1 is a methyl group, R2 is a hydrogen atom, R3, R4, R6 and R7 are hydrogen atoms, and R5 is any substitution described in any one of [Table L1] to [Table L2] base compound (hereinafter, referred to as compound group SX85). In compound (L-1), R1 and R2 are methyl groups, R3, R4, R6 and R7 are hydrogen atoms, and R5 is any substituent described in any one of [Table L1] to [Table L2]. (Hereinafter, referred to as compound group SX86). In compound (L-1), R1 is an ethyl group, R2 is a hydrogen atom, R3, R4, R6 and R7 are hydrogen atoms, and R5 is any substitution described in any one of [Table L1] to [Table L2] base compound (hereinafter, referred to as compound group SX87). In compound (L-1), R1 and R2 are ethyl groups, R3, R4, R6 and R7 are hydrogen atoms, and R5 is any substituent described in any one of [Table L1] to [Table L2]. (Hereinafter, referred to as compound group SX88). In compound (L-1), R1 is a propyl group, R2 is a hydrogen atom, R3, R4, R6 and R7 are hydrogen atoms, and R5 is any substitution described in any one of [Table L1] to [Table L2] base compound (hereinafter, referred to as compound group SX89). In compound (L-1), R1 and R2 are propyl groups, R3, R4, R6 and R7 are hydrogen atoms, and R5 is any substituent described in any one of [Table L1] to [Table L2]. (Hereinafter, referred to as compound group SX90). In compound (L-1), R1 is an isopropyl group, R2 is a hydrogen atom, R3, R4, R6 and R7 are hydrogen atoms, and R5 is any one described in any one of [Table L1] to [Table L2] A compound with a substituent (hereinafter, referred to as compound group SX91). In compound (L-1), R1 and R2 are isopropyl groups, R3, R4, R6 and R7 are hydrogen atoms, and R5 is any substituent described in any one of [Table L1] to [Table L2]. compound (hereinafter, referred to as compound group SX92). In compound (L-1), R1 is a cyclopropyl group, R2 is a hydrogen atom, R3, R4, R6 and R7 are hydrogen atoms, and R5 is any one described in any one of [Table L1] to [Table L2] A compound with a substituent (hereinafter, referred to as compound group SX93). In compound (L-1), R1 and R2 are cyclopropyl groups, R3, R4, R6 and R7 are hydrogen atoms, and R5 is any substituent described in any one of [Table L1] to [Table L2] compound (hereinafter, referred to as compound group SX94). In compound (L-1), R1 is CF3, R2 is a hydrogen atom, R3, R4, R6 and R7 are hydrogen atoms, and R5 is any substituent described in any one of [Table L1] to [Table L2] compound (hereinafter, referred to as compound group SX95). In compound (L-1), R1 and R2 are CF3, R3, R4, R6 and R7 are hydrogen atoms, and R5 is any substituent described in any one of [Table L1] to [Table L2] ( Hereinafter, it is referred to as compound group SX96).

[0116] In compound (L-1), R1 is a chlorine atom, R2 is a bromine atom, R3, R4, R6 and R7 are hydrogen atoms, and R5 is described in any one of [Table L1] to [Table L2] Compounds with any substituent (hereinafter, referred to as compound group SX97). In compound (L-1), R1 is a chlorine atom, R2 is an iodine atom, R3, R4, R6 and R7 are hydrogen atoms, and R5 is any substitution described in any one of [Table L1] to [Table L2] base compound (hereinafter, referred to as compound group SX98). In compound (L-1), R1 is a chlorine atom, R2 is a methyl group, R3, R4, R6 and R7 are hydrogen atoms, and R5 is any substitution described in any one of [Table L1] to [Table L2] base compound (hereinafter, referred to as compound group SX99). In compound (L-1), R1 is a chlorine atom, R2 is an ethyl group, R3, R4, R6 and R7 are hydrogen atoms, and R5 is any substitution described in any one of [Table L1] to [Table L2] base compound (hereinafter, referred to as compound group SX100). In compound (L-1), R1 is a chlorine atom, R2 is a propyl group, R3, R4, R6 and R7 are hydrogen atoms, and R5 is any substitution described in any one of [Table L1] to [Table L2] base compound (hereinafter, referred to as compound group SX101). In the compound (L-1), R1 is a chlorine atom, R2 is an isopropyl group, R3, R4, R6 and R7 are a hydrogen atom, and R5 is any one described in any one of [Table L1] to [Table L2] compounds with substituents (hereinafter, referred to as compound group SX102). In compound (L-1), R1 is a chlorine atom, R2 is a cyclopropyl group, R3, R4, R6 and R7 are hydrogen atoms, and R5 is any one described in any one of [Table L1] to [Table L2] compounds with substituents (hereinafter, referred to as compound group SX103). In compound (L-1), R1 is a chlorine atom, R2 is CF3, R3, R4, R6 and R7 are hydrogen atoms, and R5 is any substituent described in any one of [Table L1] to [Table L2] compound (hereinafter, referred to as compound group SX104). In compound (L-1), R1 is a bromine atom, R2 is an iodine atom, R3, R4, R6 and R7 are hydrogen atoms, and R5 is any substitution described in any one of [Table L1] to [Table L2] base compound (hereinafter, referred to as compound group SX105). In compound (L-1), R1 is a bromine atom, R2 is a methyl group, R3, R4, R6 and R7 are hydrogen atoms, and R5 is any substitution described in any one of [Table L1] to [Table L2] base compound (hereinafter, referred to as compound group SX106). In compound (L-1), R1 is a bromine atom, R2 is an ethyl group, R3, R4, R6 and R7 are hydrogen atoms, and R5 is any substitution described in any one of [Table L1] to [Table L2] base compound (hereinafter, referred to as compound group SX107). In compound (L-1), R1 is a bromine atom, R2 is a propyl group, R3, R4, R6 and R7 are hydrogen atoms, and R5 is any substitution described in any one of [Table L1] to [Table L2] base compound (hereinafter, referred to as compound group SX108). In the compound (L-1), R1 is a bromine atom, R2 is an isopropyl group, R3, R4, R6 and R7 are a hydrogen atom, and R5 is any one described in any one of [Table L1] to [Table L2] compounds with substituents (hereinafter, referred to as compound group SX109). In compound (L-1), R1 is a bromine atom, R2 is a cyclopropyl group, R3, R4, R6 and R7 are hydrogen atoms, and R5 is any one described in any one of [Table L1] to [Table L2] compounds with substituents (hereinafter, referred to as compound group SX110). In compound (L-1), R1 is a bromine atom, R2 is CF3, R3, R4, R6 and R7 are hydrogen atoms, and R5 is any substituent described in any one of [Table L1] to [Table L2] compound (hereinafter, referred to as compound group SX111). In compound (L-1), R1 is a methyl group, R2 is an ethyl group, R3, R4, R6 and R7 are hydrogen atoms, and R5 is any substitution described in any one of [Table L1] to [Table L2] base compound (hereinafter, referred to as compound group SX112). In compound (L-1), R1 is a methyl group, R2 is a propyl group, R3, R4, R6 and R7 are hydrogen atoms, and R5 is any substitution described in any one of [Table L1] to [Table L2] base compound (hereinafter, referred to as compound group SX113). In compound (L-1), R1 is an ethyl group, R2 is a propyl group, R3, R4, R6 and R7 are hydrogen atoms, and R5 is any substitution described in any one of [Table L1] to [Table L2] base compound (hereinafter, referred to as compound group SX114).

[0117] In compound (L-1), R1 is a fluorine atom, R2 is a hydrogen atom, R3 is a fluorine atom, R4, R6 and R7 are hydrogen atoms, and R5 is any one of [Table L1] ~ [Table L2] Compounds with any substituent described in (hereinafter, referred to as compound group SX115). In the compound (L-1), R1 is a fluorine atom, R2 is a hydrogen atom, R3 is a chlorine atom, R4, R6 and R7 are hydrogen atoms, and R5 is described in any one of [Table L1] to [Table L2] Compounds with any substituent (hereinafter, referred to as compound group SX116). In the compound (L-1), R1 is a fluorine atom, R2 is a hydrogen atom, R3 is a bromine atom, R4, R6 and R7 are hydrogen atoms, and R5 is described in any one of [Table L1] to [Table L2] Compounds with any substituent (hereinafter, referred to as compound group SX117). In compound (L-1), R1 is a fluorine atom, R2 is a hydrogen atom, R3 is an iodine atom, R4, R6 and R7 are hydrogen atoms, and R5 is described in any one of [Table L1] to [Table L2] Compounds with any substituent (hereinafter, referred to as compound group SX118). In compound (L-1), R1 is a fluorine atom, R2 is a hydrogen atom, R3 is a methyl group, R4, R6 and R7 are hydrogen atoms, and R5 is described in any one of [Table L1] to [Table L2] Compounds with any substituent (hereinafter, referred to as compound group SX119). In compound (L-1), R1 is a fluorine atom, R2 is a hydrogen atom, R3 is a methoxy group, R4, R6 and R7 are hydrogen atoms, and R5 is any one of [Table L1] to [Table L2]. Compounds with any substituent (hereinafter, referred to as compound group SX120). In compound (L-1), R1 is a fluorine atom, R2 is a hydrogen atom, R3 is CF3, R4, R6 and R7 are hydrogen atoms, and R5 is any one of the compounds described in any one of [Table L1] to [Table L2]. A compound with a single substituent (hereinafter, referred to as compound group SX121). In compound (L-1), R1 is a fluorine atom, R2 is a hydrogen atom, R3 is OCF3, R4, R6 and R7 are hydrogen atoms, and R5 is any of the compounds described in any one of [Table L1] to [Table L2]. A compound with a single substituent (hereinafter, referred to as compound group SX122). In the compound (L-1), R1 is a fluorine atom, R2 is a hydrogen atom, R5 is a fluorine atom, R3, R6 and R7 are hydrogen atoms, and R4 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX123). In the compound (L-1), R1 is a fluorine atom, R2 is a hydrogen atom, R5 is a chlorine atom, R3, R6 and R7 are hydrogen atoms, and R4 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX124). In the compound (L-1), R1 is a fluorine atom, R2 is a hydrogen atom, R5 is a bromine atom, R3, R6 and R7 are hydrogen atoms, and R4 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX125). In the compound (L-1), R1 is a fluorine atom, R2 is a hydrogen atom, R5 is an iodine atom, R3, R6 and R7 are hydrogen atoms, and R4 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX126). In compound (L-1), R1 is a fluorine atom, R2 is a hydrogen atom, R5 is a methyl group, R3, R6 and R7 are hydrogen atoms, and R4 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX127). In compound (L-1), R1 is a fluorine atom, R2 is a hydrogen atom, R5 is a methoxy group, R3, R6 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX128). In compound (L-1), R1 is a fluorine atom, R2 is a hydrogen atom, R5 is CF3, R3, R6 and R7 are hydrogen atoms, and R4 is any of the compounds described in any one of [Table L1] to [Table L3]. A compound with a single substituent (hereinafter, referred to as compound group SX129). In compound (L-1), R1 is a fluorine atom, R2 is a hydrogen atom, R5 is OCF3, R3, R6 and R7 are hydrogen atoms, and R4 is any of the compounds described in any one of [Table L1] to [Table L3]. A compound with a single substituent (hereinafter, referred to as compound group SX130). In the compound (L-1), R1 is a fluorine atom, R2 is a hydrogen atom, R4 is a fluorine atom, R3, R5 and R7 are hydrogen atoms, and R6 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX131). In the compound (L-1), R1 is a fluorine atom, R2 is a hydrogen atom, R4 is a chlorine atom, R3, R5 and R7 are hydrogen atoms, and R6 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX132). In the compound (L-1), R1 is a fluorine atom, R2 is a hydrogen atom, R4 is a bromine atom, R3, R5 and R7 are hydrogen atoms, and R6 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX133). In the compound (L-1), R1 is a fluorine atom, R2 is a hydrogen atom, R4 is an iodine atom, R3, R5 and R7 are hydrogen atoms, and R6 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX134). In the compound (L-1), R1 is a fluorine atom, R2 is a hydrogen atom, R4 is a methyl group, R3, R5 and R7 are hydrogen atoms, and R6 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX135). In compound (L-1), R1 is a fluorine atom, R2 is a hydrogen atom, R4 is a methoxy group, R3, R5 and R7 are hydrogen atoms, and R6 is any one of [Table L1] to [Table L3]. A compound with any substituent (hereinafter, referred to as compound group SX136). In compound (L-1), R1 is a fluorine atom, R2 is a hydrogen atom, R4 is CF3, R3, R5 and R7 are hydrogen atoms, and R6 is any one of the compounds described in any one of [Table L1] to [Table L3]. A compound with a single substituent (hereinafter, referred to as compound group SX137). In compound (L-1), R1 is a fluorine atom, R2 is a hydrogen atom, R4 is OCF3, R3, R5 and R7 are hydrogen atoms, and R6 is any of the compounds described in any one of [Table L1] to [Table L3]. A compound with a single substituent (hereinafter, referred to as compound group SX138).

[0118] In compound (L-1), R1 is a chlorine atom, R2 is a hydrogen atom, R5 is a fluorine atom, R3, R6 and R7 are hydrogen atoms, and R4 is any one of [Table L1] ~ [Table L3] Compounds with any substituent described in (hereinafter, referred to as compound group SX139). In compound (L-1), R1 is a chlorine atom, R2 is a hydrogen atom, R5 is a chlorine atom, R3, R6 and R7 are hydrogen atoms, and R4 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX140). In compound (L-1), R1 is a chlorine atom, R2 is a hydrogen atom, R5 is a bromine atom, R3, R6 and R7 are hydrogen atoms, and R4 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX141). In compound (L-1), R1 is a chlorine atom, R2 is a hydrogen atom, R5 is an iodine atom, R3, R6 and R7 are hydrogen atoms, and R4 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX142). In compound (L-1), R1 is a chlorine atom, R2 is a hydrogen atom, R5 is a methyl group, R3, R6 and R7 are hydrogen atoms, and R4 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX143). In compound (L-1), R1 is a chlorine atom, R2 is a hydrogen atom, R5 is a methoxy group, R3, R6 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX144). In compound (L-1), R1 is a chlorine atom, R2 is a hydrogen atom, R5 is CF3, R3, R6 and R7 are hydrogen atoms, and R4 is any of the compounds described in any one of [Table L1] to [Table L3]. A compound with a single substituent (hereinafter, referred to as compound group SX145). In compound (L-1), R1 is a chlorine atom, R2 is a hydrogen atom, R5 is OCF3, R3, R6 and R7 are hydrogen atoms, and R4 is any of the compounds described in any one of [Table L1] to [Table L3]. A compound with a single substituent (hereinafter, referred to as compound group SX146). In the compound (L-1), R1 is a chlorine atom, R2 is a hydrogen atom, R4 is a fluorine atom, R3, R5 and R7 are hydrogen atoms, and R6 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX147). In compound (L-1), R1 is a chlorine atom, R2 is a hydrogen atom, R4 is a chlorine atom, R3, R5 and R7 are hydrogen atoms, and R6 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX148). In the compound (L-1), R1 is a chlorine atom, R2 is a hydrogen atom, R4 is a bromine atom, R3, R5 and R7 are hydrogen atoms, and R6 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX149). In the compound (L-1), R1 is a chlorine atom, R2 is a hydrogen atom, R4 is an iodine atom, R3, R5 and R7 are hydrogen atoms, and R6 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX150). In the compound (L-1), R1 is a chlorine atom, R2 is a hydrogen atom, R4 is a methyl group, R3, R5 and R7 are hydrogen atoms, and R6 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX151). In compound (L-1), R1 is a chlorine atom, R2 is a hydrogen atom, R4 is a methoxy group, R3, R5 and R7 are hydrogen atoms, and R6 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX152). In compound (L-1), R1 is a chlorine atom, R2 is a hydrogen atom, R4 is CF3, R3, R5 and R7 are hydrogen atoms, and R6 is any of the compounds described in any one of [Table L1] to [Table L3]. A compound with a single substituent (hereinafter, referred to as compound group SX153). In the compound (L-1), R1 is a chlorine atom, R2 is a hydrogen atom, R4 is OCF3, R3, R5 and R7 are hydrogen atoms, and R6 is any one described in any one of [Table L1] to [Table L3]. A compound with a single substituent (hereinafter, referred to as compound group SX154).

[0119] In compound (L-1), R1 is a bromine atom, R2 is a hydrogen atom, R5 is a fluorine atom, R3, R6 and R7 are hydrogen atoms, and R4 is any one of [Table L1] ~ [Table L3] Compounds with any substituent described in (hereinafter, referred to as compound group SX155). In compound (L-1), R1 is a bromine atom, R2 is a hydrogen atom, R5 is a chlorine atom, R3, R6 and R7 are hydrogen atoms, and R4 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX156). In compound (L-1), R1 is a bromine atom, R2 is a hydrogen atom, R5 is a bromine atom, R3, R6 and R7 are hydrogen atoms, and R4 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX157). In compound (L-1), R1 is a bromine atom, R2 is a hydrogen atom, R5 is an iodine atom, R3, R6 and R7 are hydrogen atoms, and R4 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX158). In compound (L-1), R1 is a bromine atom, R2 is a hydrogen atom, R5 is a methyl group, R3, R6 and R7 are hydrogen atoms, and R4 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX159). In compound (L-1), R1 is a bromine atom, R2 is a hydrogen atom, R5 is a methoxy group, R3, R6 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX160). In compound (L-1), R1 is a bromine atom, R2 is a hydrogen atom, R5 is CF3, R3, R6 and R7 are hydrogen atoms, and R4 is any one of the compounds described in any one of [Table L1] to [Table L3]. A compound with a single substituent (hereinafter, referred to as compound group SX161). In compound (L-1), R1 is a bromine atom, R2 is a hydrogen atom, R5 is OCF3, R3, R6 and R7 are hydrogen atoms, and R4 is any of the compounds described in any one of [Table L1] to [Table L3]. A compound with a single substituent (hereinafter, referred to as compound group SX162). In the compound (L-1), R1 is a bromine atom, R2 is a hydrogen atom, R6 is a fluorine atom, R3, R5 and R7 are hydrogen atoms, and R4 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX163). In compound (L-1), R1 is a bromine atom, R2 is a hydrogen atom, R6 is a chlorine atom, R3, R5 and R7 are hydrogen atoms, and R4 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX164). In compound (L-1), R1 is a bromine atom, R2 is a hydrogen atom, R6 is a bromine atom, R3, R5 and R7 are hydrogen atoms, and R4 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX165). In the compound (L-1), R1 is a bromine atom, R2 is a hydrogen atom, R6 is an iodine atom, R3, R5 and R7 are hydrogen atoms, and R4 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX166). In the compound (L-1), R1 is a bromine atom, R2 is a hydrogen atom, R6 is a methyl group, R3, R5 and R7 are hydrogen atoms, and R4 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX167). In compound (L-1), R1 is a bromine atom, R2 is a hydrogen atom, R6 is a methoxy group, R3, R5 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX168). In compound (L-1), R1 is a bromine atom, R2 is a hydrogen atom, R6 is CF3, R3, R5 and R7 are hydrogen atoms, and R4 is any of the compounds described in any one of [Table L1] to [Table L3]. A compound with a single substituent (hereinafter, referred to as compound group SX169). In compound (L-1), R1 is a bromine atom, R2 is a hydrogen atom, R6 is OCF3, R3, R5 and R7 are hydrogen atoms, and R4 is any of the compounds described in any one of [Table L1] to [Table L3]. A compound with a single substituent (hereinafter, referred to as compound group SX170).

[0120] In compound (L-1), R1 is an iodine atom, R2 is a hydrogen atom, R5 is a fluorine atom, R3, R6 and R7 are hydrogen atoms, and R4 is any one of [Table L1] ~ [Table L3] Compounds with any substituent described in (hereinafter, referred to as compound group SX171). In the compound (L-1), R1 is an iodine atom, R2 is a hydrogen atom, R5 is a chlorine atom, R3, R6 and R7 are hydrogen atoms, and R4 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX172). In the compound (L-1), R1 is an iodine atom, R2 is a hydrogen atom, R5 is a bromine atom, R3, R6 and R7 are hydrogen atoms, and R4 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX173). In the compound (L-1), R1 is an iodine atom, R2 is a hydrogen atom, R5 is an iodine atom, R3, R6 and R7 are hydrogen atoms, and R4 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX174). In compound (L-1), R1 is an iodine atom, R2 is a hydrogen atom, R5 is a methyl group, R3, R6 and R7 are hydrogen atoms, and R4 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX175). In compound (L-1), R1 is an iodine atom, R2 is a hydrogen atom, R5 is a methoxy group, R3, R6 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX176). In compound (L-1), R1 is an iodine atom, R2 is a hydrogen atom, R5 is CF3, R3, R6 and R7 are hydrogen atoms, and R4 is any of the compounds described in any one of [Table L1] to [Table L3]. A compound with a single substituent (hereinafter, referred to as compound group SX177). In the compound (L-1), R1 is an iodine atom, R2 is a hydrogen atom, R5 is OCF3, R3, R6 and R7 are hydrogen atoms, and R4 is any one described in any one of [Table L1] to [Table L3]. A compound with a single substituent (hereinafter, referred to as compound group SX178). In the compound (L-1), R1 is an iodine atom, R2 is a hydrogen atom, R6 is a fluorine atom, R3, R5 and R7 are hydrogen atoms, and R4 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX179). In the compound (L-1), R1 is an iodine atom, R2 is a hydrogen atom, R6 is a chlorine atom, R3, R5 and R7 are hydrogen atoms, and R4 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX180). In the compound (L-1), R1 is an iodine atom, R2 is a hydrogen atom, R6 is a bromine atom, R3, R5 and R7 are hydrogen atoms, and R4 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX181). In the compound (L-1), R1 is an iodine atom, R2 is a hydrogen atom, R6 is an iodine atom, R3, R5 and R7 are hydrogen atoms, and R4 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX182). In the compound (L-1), R1 is an iodine atom, R2 is a hydrogen atom, R6 is a methyl group, R3, R5 and R7 are hydrogen atoms, and R4 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX183). In compound (L-1), R1 is an iodine atom, R2 is a hydrogen atom, R6 is a methoxy group, R3, R5 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX184). In the compound (L-1), R1 is an iodine atom, R2 is a hydrogen atom, R6 is CF3, R3, R5 and R7 are hydrogen atoms, and R4 is any one described in any one of [Table L1] to [Table L3]. A compound with a single substituent (hereinafter, referred to as compound group SX185). In the compound (L-1), R1 is an iodine atom, R2 is a hydrogen atom, R6 is OCF3, R3, R5 and R7 are hydrogen atoms, and R4 is any one described in any one of [Table L1] to [Table L3]. A compound with a single substituent (hereinafter, referred to as compound group SX186).

[0121] In compound (L-1), R1 is a methyl group, R2 is a hydrogen atom, R5 is a fluorine atom, R3, R6 and R7 are hydrogen atoms, and R4 is any one of [Table L1] ~ [Table L3] Compounds with any substituent described in (hereinafter, referred to as compound group SX187). In the compound (L-1), R1 is a methyl group, R2 is a hydrogen atom, R5 is a chlorine atom, R3, R6 and R7 are hydrogen atoms, and R4 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX188). In the compound (L-1), R1 is a methyl group, R2 is a hydrogen atom, R5 is a bromine atom, R3, R6 and R7 are hydrogen atoms, and R4 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX189). In the compound (L-1), R1 is a methyl group, R2 is a hydrogen atom, R5 is an iodine atom, R3, R6 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX190). In the compound (L-1), R1 is a methyl group, R2 is a hydrogen atom, R5 is a methyl group, R3, R6 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX191). In compound (L-1), R1 is a methyl group, R2 is a hydrogen atom, R5 is a methoxy group, R3, R6 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX192). In compound (L-1), R1 is a methyl group, R2 is a hydrogen atom, R5 is CF3, R3, R6 and R7 are hydrogen atoms, and R4 is any of the compounds described in any one of [Table L1] to [Table L3]. A compound with a single substituent (hereinafter, referred to as compound group SX193). In compound (L-1), R1 is a methyl group, R2 is a hydrogen atom, R5 is OCF3, R3, R6 and R7 are hydrogen atoms, and R4 is any of the compounds described in any one of [Table L1] to [Table L3]. A compound with a single substituent (hereinafter, referred to as compound group SX194). In the compound (L-1), R1 is a methyl group, R2 is a hydrogen atom, R6 is a fluorine atom, R3, R5 and R7 are hydrogen atoms, and R4 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX195). In the compound (L-1), R1 is a methyl group, R2 is a hydrogen atom, R6 is a chlorine atom, R3, R5 and R7 are hydrogen atoms, and R4 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX196). In the compound (L-1), R1 is a methyl group, R2 is a hydrogen atom, R6 is a bromine atom, R3, R5 and R7 are hydrogen atoms, and R4 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX197). In the compound (L-1), R1 is a methyl group, R2 is a hydrogen atom, R6 is an iodine atom, R3, R5 and R7 are hydrogen atoms, and R4 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX198). In the compound (L-1), R1 is a methyl group, R2 is a hydrogen atom, R6 is a methyl group, R3, R5 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX199). In compound (L-1), R1 is a methyl group, R2 is a hydrogen atom, R6 is a methoxy group, R3, R5 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX200). In compound (L-1), R1 is a methyl group, R2 is a hydrogen atom, R6 is CF3, R3, R5 and R7 are hydrogen atoms, and R4 is any of the compounds described in any one of [Table L1] to [Table L3]. A compound with a single substituent (hereinafter, referred to as compound group SX201). In compound (L-1), R1 is a methyl group, R2 is a hydrogen atom, R6 is OCF3, R3, R5 and R7 are hydrogen atoms, and R4 is any of the compounds described in any one of [Table L1] to [Table L3]. A compound with a single substituent (hereinafter, referred to as compound group SX202).

[0122] In compound (L-1), R1 is an ethyl group, R2 is a hydrogen atom, R5 is a fluorine atom, R3, R6 and R7 are hydrogen atoms, and R4 is any one of [Table L1] ~ [Table L3] Compounds with any substituent described in (hereinafter, referred to as compound group SX203). In the compound (L-1), R1 is an ethyl group, R2 is a hydrogen atom, R5 is a chlorine atom, R3, R6 and R7 are hydrogen atoms, and R4 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX204). In the compound (L-1), R1 is an ethyl group, R2 is a hydrogen atom, R5 is a bromine atom, R3, R6 and R7 are hydrogen atoms, and R4 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX205). In the compound (L-1), R1 is an ethyl group, R2 is a hydrogen atom, R5 is an iodine atom, R3, R6 and R7 are hydrogen atoms, and R4 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX206). In compound (L-1), R1 is an ethyl group, R2 is a hydrogen atom, R5 is a methyl group, R3, R6 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX207). In compound (L-1), R1 is an ethyl group, R2 is a hydrogen atom, R5 is a methoxy group, R3, R6 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX208). In compound (L-1), R1 is an ethyl group, R2 is a hydrogen atom, R5 is CF3, R3, R6 and R7 are hydrogen atoms, and R4 is any of the compounds described in any one of [Table L1] to [Table L3]. A compound with a single substituent (hereinafter, referred to as compound group SX209). In compound (L-1), R1 is an ethyl group, R2 is a hydrogen atom, R5 is OCF3, R3, R6 and R7 are hydrogen atoms, and R4 is any of the compounds described in any one of [Table L1] to [Table L3]. A compound with a single substituent (hereinafter, referred to as compound group SX210). In the compound (L-1), R1 is an ethyl group, R2 is a hydrogen atom, R6 is a fluorine atom, R3, R5 and R7 are hydrogen atoms, and R4 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX211). In the compound (L-1), R1 is an ethyl group, R2 is a hydrogen atom, R6 is a chlorine atom, R3, R5 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX212). In the compound (L-1), R1 is an ethyl group, R2 is a hydrogen atom, R6 is a bromine atom, R3, R5 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX213). In the compound (L-1), R1 is an ethyl group, R2 is a hydrogen atom, R6 is an iodine atom, R3, R5 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX214). In the compound (L-1), R1 is an ethyl group, R2 is a hydrogen atom, R6 is a methyl group, R3, R5 and R7 are hydrogen atoms, and R4 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX215). In compound (L-1), R1 is an ethyl group, R2 is a hydrogen atom, R6 is a methoxy group, R3, R5 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX216). In compound (L-1), R1 is an ethyl group, R2 is a hydrogen atom, R6 is CF3, R3, R5 and R7 are hydrogen atoms, and R4 is any of the compounds described in any one of [Table L1] to [Table L3]. A compound with a single substituent (hereinafter, referred to as compound group SX217). In compound (L-1), R1 is an ethyl group, R2 is a hydrogen atom, R6 is OCF3, R3, R5 and R7 are hydrogen atoms, and R4 is any of the compounds described in any one of [Table L1] to [Table L3]. A compound with a single substituent (hereinafter, referred to as compound group SX218).

[0123] In compound (L-1), R1 is CF3, R2 is a hydrogen atom, R5 is a fluorine atom, R3, R6 and R7 are hydrogen atoms, and R4 is any one of [Table L1] ~ [Table L3] Compounds with any of the substituents described (hereinafter, referred to as compound group SX219). In compound (L-1), R1 is CF3, R2 is a hydrogen atom, R5 is a chlorine atom, R3, R6 and R7 are hydrogen atoms, and R4 is any of the compounds described in any one of [Table L1] to [Table L3]. A compound with a single substituent (hereinafter, referred to as compound group SX220). In the compound (L-1), R1 is CF3, R2 is a hydrogen atom, R5 is a bromine atom, R3, R6 and R7 are hydrogen atoms, and R4 is any one described in any one of [Table L1] to [Table L3]. A compound with a single substituent (hereinafter, referred to as compound group SX221). In compound (L-1), R1 is CF3, R2 is a hydrogen atom, R5 is an iodine atom, R3, R6 and R7 are hydrogen atoms, and R4 is any one of the compounds described in any one of [Table L1] to [Table L3]. A compound with a single substituent (hereinafter, referred to as compound group SX222). In compound (L-1), R1 is CF3, R2 is a hydrogen atom, R5 is a methyl group, R3, R6 and R7 are hydrogen atoms, and R4 is any one of the compounds described in any one of [Table L1] to [Table L3]. A compound with a single substituent (hereinafter, referred to as compound group SX223). In compound (L-1), R1 is CF3, R2 is a hydrogen atom, R5 is a methoxy group, R3, R6 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX224). In compound (L-1), R1 is CF3, R2 is a hydrogen atom, R5 is CF3, R3, R6 and R7 are hydrogen atoms, and R4 is any one described in any one of [Table L1] to [Table L3] A compound with a substituent (hereinafter, referred to as compound group SX225). In compound (L-1), R1 is CF3, R2 is a hydrogen atom, R5 is OCF3, R3, R6 and R7 are hydrogen atoms, and R4 is any one described in any one of [Table L1] to [Table L3] A compound with a substituent (hereinafter, referred to as compound group SX226). In the compound (L-1), R1 is CF3, R2 is a hydrogen atom, R6 is a fluorine atom, R3, R5 and R7 are hydrogen atoms, and R4 is any one described in any one of [Table L1] to [Table L3]. A compound with a single substituent (hereinafter, referred to as compound group SX227). In compound (L-1), R1 is CF3, R2 is a hydrogen atom, R6 is a chlorine atom, R3, R5 and R7 are hydrogen atoms, and R4 is any of the compounds described in any one of [Table L1] to [Table L3]. A compound with a single substituent (hereinafter, referred to as compound group SX228). In compound (L-1), R1 is CF3, R2 is a hydrogen atom, R6 is a bromine atom, R3, R5 and R7 are hydrogen atoms, and R4 is any one of the compounds described in any one of [Table L1] to [Table L3]. A compound with a single substituent (hereinafter, referred to as compound group SX229). In compound (L-1), R1 is CF3, R2 is a hydrogen atom, R6 is an iodine atom, R3, R5 and R7 are hydrogen atoms, and R4 is any one of the compounds described in any one of [Table L1] to [Table L3]. A compound with a single substituent (hereinafter, referred to as compound group SX230). In compound (L-1), R1 is CF3, R2 is a hydrogen atom, R6 is a methyl group, R3, R5 and R7 are hydrogen atoms, and R4 is any of the compounds described in any one of [Table L1] to [Table L3]. A compound with a single substituent (hereinafter, referred to as compound group SX231). In compound (L-1), R1 is CF3, R2 is a hydrogen atom, R6 is a methoxy group, R3, R5 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX232). In compound (L-1), R1 is CF3, R2 is a hydrogen atom, R6 is CF3, R3, R5 and R7 are hydrogen atoms, and R4 is any one described in any one of [Table L1] to [Table L3] A compound with a substituent (hereinafter, referred to as compound group SX233). In compound (L-1), R1 is CF3, R2 is a hydrogen atom, R6 is OCF3, R3, R5 and R7 are hydrogen atoms, and R4 is any one described in any one of [Table L1] to [Table L3] A compound with a substituent (hereinafter, referred to as compound group SX234).

[0124] In compound (L-1), R1 is a cyclopropyl group, R2 is a hydrogen atom, R5 is a fluorine atom, R3, R6 and R7 are hydrogen atoms, and R4 is any one of [Table L1] ~ [Table L3] Compounds having any substituent described in them (hereinafter, referred to as compound group SX235). In compound (L-1), R1 is a cyclopropyl group, R2 is a hydrogen atom, R5 is a chlorine atom, R3, R6 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX236). In compound (L-1), R1 is a cyclopropyl group, R2 is a hydrogen atom, R5 is a bromine atom, R3, R6 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX237). In compound (L-1), R1 is a cyclopropyl group, R2 is a hydrogen atom, R5 is an iodine atom, R3, R6 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX238). In compound (L-1), R1 is a cyclopropyl group, R2 is a hydrogen atom, R5 is a methyl group, R3, R6 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX239). In compound (L-1), R1 is a cyclopropyl group, R2 is a hydrogen atom, R5 is a methoxy group, R3, R6 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3] Compounds with any of the substituents described (hereinafter, referred to as compound group SX240). In compound (L-1), R1 is a cyclopropyl group, R2 is a hydrogen atom, R5 is CF3, R3, R6 and R7 are hydrogen atoms, and R4 is as described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX241). In compound (L-1), R1 is a cyclopropyl group, R2 is a hydrogen atom, R5 is OCF3, R3, R6 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX242). In compound (L-1), R1 is a cyclopropyl group, R2 is a hydrogen atom, R6 is a fluorine atom, R3, R5 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX243). In compound (L-1), R1 is a cyclopropyl group, R2 is a hydrogen atom, R6 is a chlorine atom, R3, R5 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX244). In compound (L-1), R1 is a cyclopropyl group, R2 is a hydrogen atom, R6 is a bromine atom, R3, R5 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX245). In compound (L-1), R1 is a cyclopropyl group, R2 is a hydrogen atom, R6 is an iodine atom, R3, R5 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX246). In compound (L-1), R1 is a cyclopropyl group, R2 is a hydrogen atom, R6 is a methyl group, R3, R5 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX247). In compound (L-1), R1 is a cyclopropyl group, R2 is a hydrogen atom, R6 is a methoxy group, R3, R5 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3] Compounds with any of the substituents described (hereinafter, referred to as compound group SX248). In compound (L-1), R1 is a cyclopropyl group, R2 is a hydrogen atom, R6 is CF3, R3, R5 and R7 are hydrogen atoms, and R4 is as described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX249). In compound (L-1), R1 is a cyclopropyl group, R2 is a hydrogen atom, R6 is OCF3, R3, R5 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX250).

[0125] In compound (L-1), R1 is a methylthio group, R2 is a hydrogen atom, R5 is a fluorine atom, R3, R6 and R7 are hydrogen atoms, and R4 is any one of [Table L1] ~ [Table L3] Compounds having any substituent described in them (hereinafter, referred to as compound group SX251). In compound (L-1), R1 is a methylthio group, R2 is a hydrogen atom, R5 is a chlorine atom, R3, R6 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX252). In compound (L-1), R1 is a methylthio group, R2 is a hydrogen atom, R5 is a bromine atom, R3, R6 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX253). In compound (L-1), R1 is a methylthio group, R2 is a hydrogen atom, R5 is an iodine atom, R3, R6 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX254). In compound (L-1), R1 is a methylthio group, R2 is a hydrogen atom, R5 is a methyl group, R3, R6 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX255). In compound (L-1), R1 is a methylthio group, R2 is a hydrogen atom, R5 is a methoxy group, R3, R6 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3] Compounds with any of the substituents described (hereinafter, referred to as compound group SX256). In compound (L-1), R1 is a methylthio group, R2 is a hydrogen atom, R5 is CF3, R3, R6 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX257). In compound (L-1), R1 is a methylthio group, R2 is a hydrogen atom, R5 is OCF3, R3, R6 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX258). In compound (L-1), R1 is a methylthio group, R2 is a hydrogen atom, R6 is a fluorine atom, R3, R5 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX259). In compound (L-1), R1 is a methylthio group, R2 is a hydrogen atom, R6 is a chlorine atom, R3, R5 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX260). In compound (L-1), R1 is a methylthio group, R2 is a hydrogen atom, R6 is a bromine atom, R3, R5 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX261). In compound (L-1), R1 is a methylthio group, R2 is a hydrogen atom, R6 is an iodine atom, R3, R5 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX262). In compound (L-1), R1 is a methylthio group, R2 is a hydrogen atom, R6 is a methyl group, R3, R5 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX263). In compound (L-1), R1 is a methylthio group, R2 is a hydrogen atom, R6 is a methoxy group, R3, R5 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3] Compounds with any of the substituents described (hereinafter, referred to as compound group SX264). In the compound (L-1), R1 is a methylthio group, R2 is a hydrogen atom, R6 is CF3, R3, R5 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX265). In compound (L-1), R1 is a methylthio group, R2 is a hydrogen atom, R6 is OCF3, R3, R5 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX266).

[0126] In compound (L-1), R1 is a methylthio group, R2 is a hydrogen atom, R7 is C-F, R3, R5 and R6 are hydrogen atoms, and R4 is any one of [Table L1] ~ [Table L3] Compounds with any substituent described in (hereinafter, referred to as compound group SX267). In compound (L-1), R1 is a methylthio group, R2 is a hydrogen atom, R7 is C-Cl, R3, R5 and R6 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any of the substituents described (hereinafter, referred to as compound group SX268). In compound (L-1), R1 is a methylthio group, R2 is a hydrogen atom, R7 is C-Br, R3, R5 and R6 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3] Compounds with any of the substituents described (hereinafter, referred to as compound group SX269). In compound (L-1), R1 is a methylthio group, R2 is a hydrogen atom, R7 is C-I, R3, R5 and R6 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX270). In compound (L-1), R1 is a methylthio group, R2 is a hydrogen atom, R7 is C-Me, R3, R5 and R6 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3] Compounds with any of the substituents described (hereinafter, referred to as compound group SX271). In compound (L-1), R1 is a methylthio group, R2 is a hydrogen atom, R7 is C-OMe, R3, R5 and R6 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3] Compounds with any of the substituents described (hereinafter, referred to as compound group SX272). In compound (L-1), R1 is a methylthio group, R2 is a hydrogen atom, R7 is C-CF3, R3, R5 and R6 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any of the substituents described (hereinafter, referred to as compound group SX273). In compound (L-1), R1 is a methylthio group, R2 is a hydrogen atom, R7 is C-OCF3, R3, R5 and R6 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any of the substituents described (hereinafter, referred to as compound group SX274). In compound (L-1), R1 is a methylthio group, R2 is a hydrogen atom, R5 is a fluorine atom, R3, R6 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX275). In compound (L-1), R1 is a methylthio group, R2 is a hydrogen atom, R5 is a chlorine atom, R3, R6 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX276). In compound (L-1), R1 is a methylthio group, R2 is a hydrogen atom, R5 is a bromine atom, R3, R6 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX277). In compound (L-1), R1 is a methylthio group, R2 is a hydrogen atom, R5 is an iodine atom, R3, R6 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX278). In compound (L-1), R1 is a methylthio group, R2 is a hydrogen atom, R5 is a methyl group, R3, R6 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX279). In compound (L-1), R1 is a methylthio group, R2 is a hydrogen atom, R5 is a methoxy group, R3, R6 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3] Compounds with any of the substituents described (hereinafter, referred to as compound group SX280). In compound (L-1), R1 is a methylthio group, R2 is a hydrogen atom, R5 is CF3, R3, R6 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX281). In compound (L-1), R1 is a methylthio group, R2 is a hydrogen atom, R5 is OCF3, R3, R6 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX282). In compound (L-1), R1 is a methylthio group, R2 is a hydrogen atom, R6 is a fluorine atom, R3, R5 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX283). In compound (L-1), R1 is a methylthio group, R2 is a hydrogen atom, R6 is a chlorine atom, R3, R5 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX284). In compound (L-1), R1 is a methylthio group, R2 is a hydrogen atom, R6 is a bromine atom, R3, R5 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX285). In compound (L-1), R1 is a methylthio group, R2 is a hydrogen atom, R6 is an iodine atom, R3, R5 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX286). In compound (L-1), R1 is a methylthio group, R2 is a hydrogen atom, R6 is a methyl group, R3, R5 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX287). In compound (L-1), R1 is a methylthio group, R2 is a hydrogen atom, R6 is a methoxy group, R3, R5 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3] Compounds with any of the substituents described (hereinafter, referred to as compound group SX288). In compound (L-1), R1 is a methylthio group, R2 is a hydrogen atom, R6 is CF3, R3, R5 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX289). In compound (L-1), R1 is a methylthio group, R2 is a hydrogen atom, R6 is OCF3, R3, R5 and R7 are hydrogen atoms, and R4 is any one of [Table L1] to [Table L3]. Compounds with any substituent (hereinafter, referred to as compound group SX290).

[0127] In the compound (L-1), R1 and R2 are fluorine atoms, R5 is a fluorine atom, R3, R6 and R7 are hydrogen atoms, and R4 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX291). In compound (L-1), R1 and R2 are fluorine atoms, R5 is a chlorine atom, R3, R6 and R7 are hydrogen atoms, and R4 is any substitution described in any one of [Table L1] to [Table L3] base compound (hereinafter, referred to as compound group SX292). In compound (L-1), R1 and R2 are fluorine atoms, R5 is a bromine atom, R3, R6 and R7 are hydrogen atoms, and R4 is any substitution described in any one of [Table L1] to [Table L3] base compound (hereinafter, referred to as compound group SX293). In compound (L-1), R1 and R2 are fluorine atoms, R5 is an iodine atom, R3, R6 and R7 are hydrogen atoms, and R4 is any substitution described in any one of [Table L1] to [Table L3] base compound (hereinafter, referred to as compound group SX294). In compound (L-1), R1 and R2 are fluorine atoms, R5 is methyl, R3, R6 and R7 are hydrogen atoms, and R4 is any substitution described in any one of [Table L1] to [Table L3] base compound (hereinafter, referred to as compound group SX295). In compound (L-1), R1 and R2 are fluorine atoms, R5 is a methoxy group, R3, R6 and R7 are hydrogen atoms, and R4 is any one described in any one of [Table L1] to [Table L3] A compound with a substituent (hereinafter, referred to as compound group SX296). In compound (L-1), R1 and R2 are fluorine atoms, R5 is CF3, R3, R6 and R7 are hydrogen atoms, and R4 is any substituent described in any one of [Table L1] to [Table L3] compound (hereinafter, referred to as compound group SX297). In compound (L-1), R1 and R2 are fluorine atoms, R5 is OCF3, R3, R6 and R7 are hydrogen atoms, and R4 is any substituent described in any one of [Table L1] to [Table L3] compound (hereinafter, referred to as compound group SX298). In the compound (L-1), R1 and R2 are fluorine atoms, R6 is a fluorine atom, R3, R5 and R7 are hydrogen atoms, and R4 is any substitution described in any one of [Table L1] to [Table L3] base compound (hereinafter, referred to as compound group SX299). In compound (L-1), R1 and R2 are fluorine atoms, R6 is a chlorine atom, R3, R5 and R7 are hydrogen atoms, and R4 is any substitution described in any one of [Table L1] to [Table L3] based compound (hereinafter, referred to as compound group SX300). In compound (L-1), R1 and R2 are fluorine atoms, R6 is a bromine atom, R3, R5 and R7 are hydrogen atoms, and R4 is any substitution described in any one of [Table L1] to [Table L3] base compound (hereinafter, referred to as compound group SX301). In compound (L-1), R1 and R2 are fluorine atoms, R6 is an iodine atom, R3, R5 and R7 are hydrogen atoms, and R4 is any substitution described in any one of [Table L1] to [Table L3] base compound (hereinafter, referred to as compound group SX302). In compound (L-1), R1 and R2 are fluorine atoms, R6 is methyl, R3, R5 and R7 are hydrogen atoms, and R4 is any substitution described in any one of [Table L1] to [Table L3] base compound (hereinafter, referred to as compound group SX303). In the compound (L-1), R1 and R2 are fluorine atoms, R6 is a methoxy group, R3, R5 and R7 are hydrogen atoms, and R4 is any one described in any one of [Table L1] to [Table L3] compounds with substituents (hereinafter, referred to as compound group SX304). In compound (L-1), R1 and R2 are fluorine atoms, R6 is CF3, R3, R5 and R7 are hydrogen atoms, and R4 is any substituent described in any one of [Table L1] to [Table L3] compound (hereinafter, referred to as compound group SX305). In compound (L-1), R1 and R2 are fluorine atoms, R6 is OCF3, R3, R5 and R7 are hydrogen atoms, and R4 is any substituent described in any one of [Table L1] to [Table L3] compound (hereinafter, referred to as compound group SX306).

[0128] In the compound (L-1), R1 and R2 are chlorine atoms, R5 is a fluorine atom, R3, R6 and R7 are hydrogen atoms, and R4 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX307). In compound (L-1), R1 and R2 are chlorine atoms, R5 is a chlorine atom, R3, R6 and R7 are hydrogen atoms, and R4 is any substitution described in any one of [Table L1] to [Table L3] base compound (hereinafter, referred to as compound group SX308). In the compound (L-1), R1 and R2 are chlorine atoms, R5 is a bromine atom, R3, R6 and R7 are hydrogen atoms, and R4 is any substitution described in any one of [Table L1] to [Table L3] base compound (hereinafter, referred to as compound group SX309). In compound (L-1), R1 and R2 are chlorine atoms, R5 is an iodine atom, R3, R6 and R7 are hydrogen atoms, and R4 is any substitution described in any one of [Table L1] to [Table L3] base compound (hereinafter, referred to as compound group SX310). In compound (L-1), R1 and R2 are chlorine atoms, R5 is methyl, R3, R6 and R7 are hydrogen atoms, and R4 is any substitution described in any one of [Table L1] to [Table L3] base compound (hereinafter, referred to as compound group SX311). In the compound (L-1), R1 and R2 are chlorine atoms, R5 is a methoxy group, R3, R6 and R7 are hydrogen atoms, and R4 is any one described in any one of [Table L1] to [Table L3] A compound with a substituent (hereinafter, referred to as compound group SX312). In compound (L-1), R1 and R2 are chlorine atoms, R5 is CF3, R3, R6 and R7 are hydrogen atoms, and R4 is any substituent described in any one of [Table L1] to [Table L3] compound (hereinafter, referred to as compound group SX313). In compound (L-1), R1 and R2 are chlorine atoms, R5 is OCF3, R3, R6 and R7 are hydrogen atoms, and R4 is any substituent described in any one of [Table L1] to [Table L3] compound (hereinafter, referred to as compound group SX314). In the compound (L-1), R1 and R2 are chlorine atoms, R6 is a fluorine atom, R3, R5 and R7 are hydrogen atoms, and R4 is any substitution described in any one of [Table L1] to [Table L3] base compound (hereinafter, referred to as compound group SX315). In compound (L-1), R1 and R2 are chlorine atoms, R6 is a chlorine atom, R3, R5 and R7 are hydrogen atoms, and R4 is any substitution described in any one of [Table L1] to [Table L3] base compound (hereinafter, referred to as compound group SX316). In compound (L-1), R1 and R2 are chlorine atoms, R6 is bromine atom, R3, R5 and R7 are hydrogen atoms, and R4 is any substitution described in any one of [Table L1] to [Table L3] base compound (hereinafter, referred to as compound group SX317). In the compound (L-1), R1 and R2 are chlorine atoms, R6 is an iodine atom, R3, R5 and R7 are hydrogen atoms, and R4 is any substitution described in any one of [Table L1] to [Table L3] base compound (hereinafter, referred to as compound group SX318). In compound (L-1), R1 and R2 are chlorine atoms, R6 is methyl, R3, R5 and R7 are hydrogen atoms, and R4 is any substitution described in any one of [Table L1] to [Table L3] base compound (hereinafter, referred to as compound group SX319). In the compound (L-1), R1 and R2 are chlorine atoms, R6 is a methoxy group, R3, R5 and R7 are hydrogen atoms, and R4 is any one described in any one of [Table L1] to [Table L3] compounds with substituents (hereinafter, referred to as compound group SX320). In compound (L-1), R1 and R2 are chlorine atoms, R6 is CF3, R3, R5 and R7 are hydrogen atoms, and R4 is any substituent described in any one of [Table L1] to [Table L3] compound (hereinafter, referred to as compound group SX321). In compound (L-1), R1 and R2 are chlorine atoms, R6 is OCF3, R3, R5 and R7 are hydrogen atoms, and R4 is any substituent described in any one of [Table L1] to [Table L3] compound (hereinafter, referred to as compound group SX322).

[0129] In the compound (L-1), R1 and R2 are bromine atoms, R5 is a fluorine atom, R3, R6 and R7 are hydrogen atoms, and R4 is described in any one of [Table L1] to [Table L3] Compounds with any substituent (hereinafter, referred to as compound group SX323). In compound (L-1), R1 and R2 are bromine atoms, R5 is a chlorine atom, R3, R6 and R7 are hydrogen atoms, and R4 is any substitution described in any one of [Table L1] to [Table L3] base compound (hereinafter, referred to as compound group SX324). In compound (L-1), R1 and R2 are bromine atoms, R5 is a bromine atom, R3, R6 and R7 are hydrogen atoms, and R4 is any substitution described in any one of [Table L1] to [Table L3] base compound (hereinafter, referred to as compound group SX325). In the compound (L-1), R1 and R2 are bromine atoms, R5 is an iodine atom, R3, R6 and R7 are hydrogen atoms, and R4 is any substitution described in any one of [Table L1] to [Table L3] base compound (hereinafter, referred to as compound group SX326). In compound (L-1), R1 and R2 are bromine atoms, R5 is methyl, R3, R6 and R7 are hydrogen atoms, and R4 is any substitution described in any one of [Table L1] to [Table L3] base compound (hereinafter, referred to as compound group SX327). In compound (L-1), R1 and R2 are bromine atoms, R5 is a methoxy group, R3, R6 and R7 are hydrogen atoms, and R4 is any one described in any one of [Table L1] to [Table L3] A compound with a substituent (hereinafter, referred to as compound group SX328). In compound (L-1), R1 and R2 are bromine atoms, R5 is CF3, R3, R6 and R7 are hydrogen atoms, and R4 is any substituent described in any one of [Table L1] to [Table L3] compound (hereinafter, referred to as compound group SX329). In compound (L-1), R1 and R2 are bromine atoms, R5 is OCF3, R3, R6 and R7 are hydrogen atoms, and R4 is any substituent described in any one of [Table L1] to [Table L3] compound (hereinafter, referred to as compound group SX330). In the compound (L-1), R1 and R2 are bromine atoms, R6 is a fluorine atom, R3, R5 and R7 are hydrogen atoms, and R4 is any substitution described in any one of [Table L1] to [Table L3] base compound (hereinafter, referred to as compound group SX331). In compound (L-1), R1 and R2 are bromine atoms, R6 is a chlorine atom, R3, R5 and R7 are hydrogen atoms, and R4 is any substitution described in any one of [Table L1] to [Table L3] base compound (hereinafter, referred to as compound group SX332). In compound (L-1), R1 and R2 are bromine atoms, R6 is a bromine atom, R3, R5 and R7 are hydrogen atoms, and R4 is any substitution described in any one of [Table L1] to [Table L3] base compound (hereinafter, referred to as compound group SX333). In the compound (L-1), R1 and R2 are bromine atoms, R6 is an iodine atom, R3, R5 and R7 are hydrogen atoms, and R4 is any substitution described in any one of [Table L1] to [Table L3] base compound (hereinafter, referred to as compound group SX334). In compound (L-1), R1 and R2 are bromine atoms, R6 is methyl, R3, R5 and R7 are hydrogen atoms, and R4 is any substitution described in any one of [Table L1] to [Table L3] base compound (hereinafter, referred to as compound group SX335). In compound (L-1), R1 and R2 are bromine atoms, R6 is a methoxy group, R3, R5 and R7 are hydrogen atoms, and R4 is any one described in any one of [Table L1] to [T...

Claims

1. A compound of formula (II) or a salt thereof, wherein, [R21 represents a C1-C6 chain hydrocarbon group or halogen atom that can be replaced by one or more halogen atoms, R22 represents a C1-C6 chain hydrocarbon group, halogen atom or hydrogen atom that can be replaced by one or more halogen atoms, R23, R25 and R27 are the same or different and represent fluorine atom or hydrogen atom, R24 represents a C1-C6 alkoxy group or fluorine atom that can be replaced by one or more halogen atoms, and R26 represents halogen atom or hydrogen atom].

2. A compound of formula (II-a) or a salt thereof, [wherein, R21a represents a C1-C6 alkoxy group, a C3-C7 cycloalkyl group {the C1-C6 alkoxy group and the C3-C7 cycloalkyl group may be substituted by one or more halogen atoms}, or S(O)rR28a; R22a represents a C1-C6 alkoxy group, a C3-C7 cycloalkyl group {the C1-C6 alkoxy group and the C3-C7 cycloalkyl group may be substituted by one or more halogen atoms}, S(O)sR29a or a halogen atom; R23a, R25a and R27a are the same or different and represent a halogen atom or a hydrogen atom; R24a represents a C1-C6 chain hydrocarbon group that may be substituted by one or more halogen atoms, a C1-C6 alkoxy group substituted by one or more halogen atoms, or a halogen atom, R26a represents a C1-C6 chain hydrocarbon group, halogen atom, or hydrogen atom that can be replaced by one or more halogen atoms. R28a and R29a may be the same or different, representing a C1-C6 chain hydrocarbon group that can be replaced by one or more halogen atoms. r and s are independent, representing 0, 1, or 2.